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Background: Patient and public involvement (PPI) is a prerequisite for many funding bodies and NHS
research ethics approval. PPI in research is defined as research carried out with or by the public rather than
to, about or for them. While the benefits of PPI have been widely discussed, there is a lack of evidence
on the impact and outcomes of PPI in research.
Objectives: To determine the types of PPI in funded research, describe key processes, analyse the contextual
and temporal dynamics of PPI and explore the experience of PPI in research for all those involved. Mechanisms
contributing to the routine incorporation of PPI in the research process were assessed, the impact of PPI on
research processes and outcomes evaluated, and barriers and enablers to effective PPI identified.
Design: A three-staged realist evaluation drawing on Normalisation Process Theory to understand how
far PPI was embedded within health-care research in six areas: diabetes mellitus, arthritis, cystic fibrosis,
dementia, public health and learning disabilities. The first two stages comprised a scoping exercise and
online survey to chief investigators to assess current PPI activity. The third stage consisted of case studies
tracked over 18 months through interviews and document analysis. The research was conducted in four
regions of England.
Participants: Non-commercial studies currently running or completed within the previous 2 years eligible
for adoption on the UK Clinical Research Network portfolio. A total of 129 case study participants included
researchers and PPI representatives from 22 research studies, and representatives from funding bodies and
PPI networks.
Results: In the scoping 51% (n= 92) of studies had evidence of PPI and in the survey 79% (n= 80),
with funder requirements and study design the strongest influence on the extent of PPI. There was little
transparency about PPI in publicly accessible information. In case studies, context–mechanism–outcome
configurations suggested that six salient actions were required for effective PPI. These were a clear
purpose, role and structure for PPI; ensuring diversity; whole research team engagement with PPI; mutual
understanding and trust between the researchers and lay representatives; ensuring opportunities for PPI
throughout the research process; and reflecting on, appraising and evaluating PPI within a research study.
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PPI models included a ‘one-off’ model with limited PPI, a fully intertwined model in which PPI was fully
embedded and an outreach model with lay representatives linking to broader communities. Enabling
contexts included funder, topic/design, resources, research host, organisation of PPI and, most importantly,
relationships. In some case studies, lack of coherence in defining PPI persisted, with evidence of a dual
role of PPI representative/study participant. Evidence of PPI outcomes included changes to study design,
improvements to recruitment materials and rates, and dissemination.
Conclusions: Six salient actions were required for effective PPI and were characterised by a shared
understanding of moral and methodological purposes of PPI, a key individual co-ordinating PPI, ensuring
diversity, a research team positive about PPI input and fully engaged with it, based on relationships that
were established and maintained over time, and PPI being evaluated in a proactive and systematic
approach. Future work recommendations include exploring the impact of virtual PPI, cost analysis and
economic evaluation of the different models of PPI, and a longer-term follow-up study of the outcomes of
PPI on research findings and impact on services and clinical practice.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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I t is generally accepted that patient and public involvement (PPI) is ‘a good thing’ and it is now arequirement before most health research is funded. However, there is a need for evidence showing
whether or not PPI really makes a difference and, if so, what works and what situations help to create
good PPI. This study set out to find that evidence. PPI representatives were involved in this study from start
to finish.
We wanted to know:
l what people understood by PPI
l how much and what sort of PPI is in health research
l how PPI changes over time
l the experience of PPI for lay people and researchers
l how PPI works in everyday practice in research teams and organisations
l what impact PPI has on research
l what helps or hinders PPI working well.
Our research looked at cystic fibrosis, arthritis, diabetes mellitus, dementia, public health, and intellectual
and developmental disabilities studies in the UK. There were three stages: scoping (looking at research
documents), survey (researchers filling in online questionnaires) and case studies. Twenty-two studies were
followed for 18 months, with 206 researchers, PPI representatives, funders and network staff interviewed.
Findings showed a range of positive outcomes from PPI. These included identifying research questions
and improving recruitment. Good relationships and regular contact between PPI representatives and
researchers throughout the study are very important. PPI representatives also need to know if they have
been useful. Researchers tended to get better results if they had people skills, were flexible and offered
lots of opportunities for involvement.
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This report explores the context, processes, mechanisms and impact of patient and public involvement (PPI)
in health research. The ReseArch with Patient and Public invOlvement: a RealisT evaluation (RAPPORT)
study was conducted 8 years after PPI became an expectation for research projects that are part of the UK
Clinical Research Network (UKCRN) portfolio, and it was therefore timely to assess how embedded PPI is as
part of normal research processes.
‘Involvement’ differs from being a participant in research, indicating input into the research process
itself; that is carrying out research with members of the public, rather than conducting research on or
about the public or patients. There are two main arguments for PPI in health research. The moral
argument suggests that involvement is a right, so that the citizen can have a voice in publicly funded
research. It also includes an ethical perspective that individuals have the right to be involved with any
research intervention potentially being done ‘to’ them. The methodological argument suggests PPI leads
to higher-quality research with greater impact. The policy response to these arguments has been
development of infrastructures to support PPI in research. INVOLVE, a national advisory body, is funded
by and is part of the National Institute for Health Research (NIHR), and leads on PPI across the NIHR.
Despite this growing emphasis on PPI in health research, there is little evidence of its impact. Previous
evaluations have failed to use methodologies that take into account the complexity of PPI. This complexity
arises from PPI being a multifaceted social process, making it difficult to pinpoint impact and individual
contributions. This is compounded by a lack of robust and routine reporting of PPI outcomes by the
research community. The RAPPORT study was designed to address this gap in the evidence.
Objectives
The RAPPORT study sought to evaluate how different approaches to PPI in research with different
populations influence the identification of priorities, research conception, design, process, findings and
dissemination. Specifically, it aimed to identify what PPI approaches have applicability across all research
domains, which ones are context specific and whether or not different types of public involvement achieve
different outcomes for the research process, findings, dissemination and implementation of PPI.
The specific research questions were to:
1. determine the variation in types and extent of public involvement in funded research in exemplar
areas – diabetes mellitus, arthritis, cystic fibrosis (CF), dementia, public health and intellectual and
developmental disabilities (IDDs)
2. describe key processes and mechanisms of public involvement in research
3. critically analyse the contextual and temporal dynamics of public involvement in research
4. explore the experience of public involvement in research for the researchers and members of
public involved
5. assess the mechanisms which contribute to public involvement being routinely incorporated in the
research process
6. evaluate the impact of public involvement on research processes and outcomes
7. identify barriers and enablers to effective public involvement in research.
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Methods
The study was underpinned by realist evaluation utilising mixed methods, conducted in three stages.
Six topic areas were focused on arthritis, CF, dementia, diabetes mellitus, IDDs and public health. These
were purposively selected to ensure a range of study designs, participant populations and histories of PPI.
Reflecting mainstream high-quality health research, the sample was confined to non-commercial research
eligible for adoption by the UKCRN portfolio. The RAPPORT study design, data collection, analysis,
management and dissemination have been conducted in partnership with two lay coapplicants/
co-researchers, one co-researcher, two service user reference groups and four lay members of the study
advisory group.
Setting
Stage 1 was conducted in England and Wales. Stages 2 and 3 were conducted in four geographical
regions in England. These were purposively selected to ensure a range of research centre densities,
rural/urban populations and numbers of established PPI groups in research.
Stage 1: national scoping of studies
A national scoping was undertaken of studies currently funded or completed within the previous 2 years.
Details of each study were electronically searched via the UKCRN database and relevant documentation
was reviewed for any evidence of the nature and extent of PPI. A scoping framework was used to
assess the stages of the research at which PPI took place, whether involvement was of lay groups or lay
individuals and where it was located on the continuum of PPI from user-led to minimal PPI. As there was
very little reference to PPI in the publicly available documents, we contacted research teams via funding
organisations or directly to obtain further information. Of the 478 eligible studies identified, we obtained
information on 38% (n= 182).
Stage 2: survey
An online survey tool was administered to all chief investigators of current studies or studies completed
within the previous 2 years. The survey questions were drawn from previous published consensus on the
requirements for successful PPI in research. We identified 360 eligible studies, and following one e-mail
reminder had a response rate of 28% (n= 101). Data were transferred to SPSS (version 20, IBM SPSS
Statistics, Armonk, NY, USA) for analysis. This analysis was mapped against the results of the scoping to
identify any recurring patterns within and between types of research, stages in research process where PPI
occurred and topic areas. The survey was also used as one of the ways to identify research teams who
would be interested in taking part in stage 3.
Stage 3: case studies
This final stage provided an in-depth realist evaluation of the context, mechanisms and outcomes in
specific research settings to increase understanding of at what points PPI has the most impact and
effect on outcomes. Twenty-two case studies were included and, while case study availability varied
across the six example areas, there was a broad range of study designs from basic science to qualitative.
Initial in-depth telephone interviews were conducted with each research team and PPI representatives;
these were followed up by regular tracking telephone interviews to capture any changes in PPI processes
and outcomes over time. We also conducted telephone interviews with representatives from the main
funding organisations, and with any associated PPI co-ordinator in the host organisations or clinical
research networks. Initial interviews were recorded and transcribed, and detailed notes were taken of
tracking interviews. A total of 206 interviews were completed. Documents with evidence of PPI impact
were collected from each case study; these included notes of meetings and track-changed participant
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information sheets. Normalisation Process Theory (NPT) was used as a middle-range programme theory to
understand the processes and mechanisms required to embed PPI as normal practice within each case
study. Interview guides and coding frameworks were informed by NPT. All data were coded independently,
then analysed jointly in team meetings and uploaded into NVivo 9 (QSR International, Warrington, UK).
The NPT toolkit was also used to develop radar plots of each case study as a visual representation of how
embedded PPI was.
Results
Stages 1 and 2
The scoping and survey provided evidence of the current landscape of PPI in health research. In the
scoping, 51% (n= 92) of studies had some evidence of PPI, and in the survey 79% (n= 80), with funder
requirements and study design appearing to be the strongest influence on the extent of PPI within a study.
The most common PPI activities undertaken were steering committee membership and reviewing patient
information leaflets. There was evidence of some blurring of roles, with research participants also
undertaking involvement activities in an advisory capacity on the same study. We found that routinely
collected information about PPI was difficult to access or not collected.
Stage 3
Six context–mechanism–outcome configurations based on case studies’ salient actions were tested.
These were a clear purpose, role and structure for PPI; ensuring diversity; whole research team
engagement with PPI; mutual understanding and trust between the researchers and lay representatives;
ensuring opportunities for PPI throughout the research process; and reflecting on, appraising and
evaluating PPI within a research study.
Key enabling contexts were found that influenced mechanisms for PPI:
l Research funder. Funders appeared to prioritise either the methodological (to improve research quality)
or the moral (PPI as a right) arguments. Their preferences appeared to influence the operational
requirements for PPI in grant applications and their focus in developing PPI processes.
l Topic and study design. Established ways of working in PPI influenced how PPI was operationalised in
case studies. For example, the commitment to including end-users with IDDs showed that PPI was
embedded in all these case studies. Some study designs inherently required PPI but basic science and
tissue bank designs also had effective PPI.
l Host organisation. Organisations hosting research varied considerably in resources available to support
PPI, and whether research was core business or sporadic projects. Research conducted within the
clinical setting had easier access to the target population and potential PPI representatives.
l Organisation of PPI. A dynamic framework for PPI includes ways in which the lay representatives
had input; for example, whether they were utilised as individual representatives or organised
through a group/panel. It also included different approaches (consultation, collaboration/consensus
or co-researching) and forums as the settings in which researchers and lay representatives came
together, such as a trial steering committee. The framework was found to be dynamic, because it
developed and shifted with time and the research process; PPI frameworks were rarely static in the
lifetime of a study. Within this framework we identified three models of PPI:
¢ One-off model. Lay representatives were brought into the study for a limited researcher-identified
task. This was often accomplished through an established external (to research team) PPI panel
from which PPI was ‘bought in’ as a commodity.
¢ Fully intertwined model. Research question or priorities were often identified by lay representatives
and they worked alongside researchers as partners throughout the research process. This model
had strongly embedded PPI but was resource-intensive.
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¢ Outreach model. This model had regular points of contact between researchers and lay
representatives throughout the research. The important features of this model were that, although
there tended to be fewer PPI representatives, they acted as a bridge between the research and
the wider community. The lay representatives in this model had strong links and networks
with populations the research was aiming to recruit. This was an effective model of PPI, was
less resource-intensive for researchers and was found in a range of research designs. However,
it did require finding lay representatives able to provide this link and is unsustainable without
appropriate funding for charities undertaking this role.
l Positive experience of PPI. For both lay representatives and researchers a positive experience created a
virtuous cycle whereby PPI became increasingly embedded.
Mechanisms to embed patient and public involvement as normal practice
(Normalisation Process Theory)
Normalisation Process Theory suggests four main areas of work to embed as normal practice a complex
intervention such as PPI.
1. Coherence: making sense of PPI. Higher levels of agreement on the purpose of PPI usually led to more
embedded PPI. In newly formed groups of researchers and lay representatives, this may take time to
achieve. Junior members of the research team tended to have more difficulties in differentiating
between participation and involvement. A dual role of participation/involvement was sometimes used
to capture the target population perspective.
2. Participation: relational work to build and sustain a community of practice for PPI. An assigned,
resourced PPI co-ordinator role was important in sustaining PPI. However, it was also important that
the research team did not abdicate PPI responsibility to the co-ordinator and was also fully committed
to PPI.
3. Collective action: the operational work to enact PPI practices. Flexible approaches to enable use of lay
representatives’ individual skill sets and their personal circumstances were required. Establishing and
maintaining good relationships between researchers and lay representatives was crucial. This was done
by regular communication, managing meetings in order to address power imbalances and providing
opportunities for informal engagement. There was some evidence that this was hard to achieve when
PPI was conducted purely through virtual media.
4. Reflexive monitoring: the appraisal work to evaluate PPI. There was little systematic appraisal within
the case studies. The majority of researchers and PPI representatives felt that PPI is worthwhile but its
impact difficult to prove.
Outcomes
All the case studies had evidence of PPI outcomes, including research priority/question setting, study
marketing, changes to the design including interventions, ensuring participant safety and recruitment.
Observable evidence of impact was more difficult to find, although one case study did report rises in
recruitment rates since PPI representatives had made changes to participant information sheets. Range of
outcomes per case study was influenced by design and the model of PPI, and case studies with the most
embedded PPI were likely to demonstrate the greatest number of PPI-related outcomes. These studies
were also likely to demonstrate outcomes from the moral perspective, such as increased self-worth for lay
representatives. In the one-off model of PPI, potential outcomes were limited by the researcher.
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Conclusions
The research findings indicate what works best in PPI, and in what circumstances:
l Six salient actions were required for positive outcomes and impact of PPI. These were characterised
by (1) the researchers and lay representatives having a shared understanding of the moral and
methodological purpose of PPI, (2) a key individual co-ordinating PPI, (3) lay representatives having a
strong connection with the target study population, (4) the whole research team being positive about
PPI input and fully engaged with it, (5) efforts to develop relationships established and maintained over
time and (6) PPI is evaluated in a proactive and systematic approach.
l In research studies being conducted in environments with less developed infrastructure resources, or
with designs in which PPI was deemed most appropriate at discrete points in the research process,
having some PPI representatives who could act as a link to broader constituencies was also an
effective model.
l Studies that have little embedded PPI for lack of resources, vision or infrastructure should in future
focus on developing and sustaining relationships between researchers and lay representatives, as this
appears to be the minimal work required for PPI impact.
The research findings point to areas that merit further research:
l evaluating context, mechanisms and outcomes of PPI conducted through virtual media
l engaging young people in PPI
l exploring the PPI training needs of researchers, using the findings of the study and the NPT process as
a curriculum framework
l further evaluation of the impact of PPI on issues of participant safety in clinical trials
l cost analysis of different models of PPI
l exploring implications and outcomes of being a participant/involvee
l longer-term evaluation of PPI-related outcomes on research findings and implementation.
Funding
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S ince the late 1990s, a plethora of policies have emerged aimed at embedding public involvementwithin the NHS,1–4 and this impetus has been mirrored within health research within the UK.
Researchers have increasingly been required through national governance frameworks5,6 to involve
members of the public through working with them, rather than conducting research on them. This has
been further encouraged through the integration of patient and public involvement (PPI) by most of the
main UK funders of health research.7 This drive towards public involvement in research is not limited
to the UK; internationally there has been an increasing recognition of the importance of involving patients
and the public in health-care governance and research.8–11
The PPI in health has its roots in the increasing unease with and challenges to the medical institution.12 The
ethical argument for PPI grew and was taken up by policy-makers as characterised by the phrase ‘nothing
about me without me’.13 Politically, PPI is also seen as a way of addressing the democratic deficit by giving
voice to the public in publicly funded health organisations and research.14 In addition to the moral and
political rationales for PPI, there are also a number of methodological claims regarding the positive impact
of PPI in health research. These include increased relevance of the research through identifying research
questions and prioritising research agendas, appropriate research conduct, addressing ethical tensions and
matching research with policy objectives.12,15–19
These three drivers have resulted in PPI being imperative for health research in the UK. However, despite
this, PPI is poorly defined and conceptualised,20,21 with varied definitions and terms used to describe it.22
Definition of patient and public involvement within the
RAPPORT study
Within the ReseArch with Patient and Public invOlvement: a RealisT evaluation (RAPPORT) study, we define
the process of PPI in research according to the definition offered by INVOLVE ‘as research being carried out
“with” or “by” members of the public rather than “to”, “about” or “for” them’ (p. 6).23 However, while
the underpinning process of PPI is relatively clearly defined, albeit potentially not embraced or understood
by the entire research community, the name is perhaps more contentious. INVOLVE and others24,25 use the
term ‘public involvement’, as they argue this covers ‘patients, potential patients, carers and people who
use health and social care services as well as people from organisations that represent people who use
services’ (p. 6).23 Conversely, others suggest that this fails to capture the ‘expert’ nature of the experiential
knowledge brought specifically by patients or service users.22 Equally, the connotation of passivity that the
term ‘patient’ brings has also been criticised,26 as has the political dimension to the term ‘consumer’
involvement.27 Jordan and Court22 suggest that controversy around the different labels used is unsurprising,
as they are derived from a multitude of contexts and interests. They suggest that the term ‘lay’ is to be
preferred, as it denotes a broader alternative perspective to that of the professional. What is clear is that
no single label will be acceptable to everyone,28 and we took a pragmatic approach by agreeing with the
RAPPORT PPI representatives what terms should be used within the report. We use two terms
interchangeably: ‘PPI representatives’ to emphasise individuals undertaking diverse roles from patient
representative through to a member of the general public, and ‘lay representatives’ to emphasise the
overall perspective these individuals bring.
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Rationale for the study
The relatively small amount of empirical evidence on the impact of PPI in research29 has been criticised
as poorly reported21 and methodologically weak, often failing to fully explore the contextual factors
surrounding PPI as a complex intervention.30 Not only is there a notable lack of evidence on outcomes
and impact of PPI,31 but what little there is tends to be observational evaluations which rarely consider
the links between the context (when and where PPI happens), models of PPI (how it functions) and the
outcomes of PPI (what difference it made).32 As outlined in the next section, the RAPPORT study aimed to
address these significant gaps in the evidence.
Aims and objectives of the RAPPORT study
The RAPPORT study sought to evaluate how different approaches to public involvement in research with
different populations influence the identification of priorities, research conception, design, process,
findings and knowledge transfer. Specifically, it aimed to identify what PPI approaches have applicability
across all research domains, which are context specific and whether or not different types of public
involvement achieve different outcomes for the research process, findings, dissemination and
implementation of PPI. The RAPPORT study objectives are listed in Box 1.
Structure of the report
The report presents the main findings from the RAPPORT study and discusses them within the context of
the National Institute for Health Research (NIHR) Clinical Research Network portfolio. This portfolio consists
of high-quality clinical research studies that are eligible for support from the NIHR Clinical Research
Network in England. In Chapter 2 we provide scene setting through presenting the dominant arguments
for PPI and an overview of the roots of PPI in health research, and summarise the existing available
evidence of PPI impact. Chapter 3 sets out the underpinning methodology and methods used. We provide
a discrete chapter to describe PPI within the RAPPORT study and evaluate the impact on the RAPPORT
study itself. Chapter 5 presents findings from the national scoping and survey of PPI in research, and in
Chapter 6 we provide the findings from our 22 case studies. Chapter 7 discusses our findings and in
Chapter 8 we summarise the main conclusions of our research with particular regard to our key research
questions. Drawing on our findings and discussion, we then identify implications for the research
community and PPI representatives, and make recommendations for future research.
BOX 1 The RAPPORT study objectives
The study objectives were to:
1. determine the variation in types and extent of public involvement in funded research in the areas of
diabetes mellitus, arthritis, cystic fibrosis, dementia, public health, and intellectual and
developmental disabilities
2. describe key processes and mechanisms of public involvement in research
3. critically analyse the contextual and temporal dynamics of public involvement in research
4. explore the experience of public involvement in research for the researchers and members of public involved
5. assess the mechanisms which contribute to public involvement being routinely incorporated in the
research process
6. evaluate the impact of public involvement on research processes and outcomes
7. identify barriers and enablers to effective public involvement in research.
INTRODUCTION
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Chapter 2 Background
This chapter of the report sets the scene for PPI in health research. We set out the dominant argumentsfor PPI within the UK health system: the moral argument, founded on ethical and democratic principles,
and the methodological argument. We briefly overview the roots of PPI within the NHS as a whole, then
focus specifically on PPI in research and map out the policy frame for PPI in research. Although we have
not undertaken a structured review of the literature, we provide an overview of a broad range of papers
reporting PPI in research, and complete the chapter by presenting evidence from five structured reviews of
the evidence on PPI in health research.
Search strategy
Literature was searched from 1995 to 2013 on the following electronic databases: MEDLINE, Cumulative
Index to Nursing and Allied Health Literature (CINAHL), PsycINFO and The Cochrane Library. The InvoNet
database was also searched for grey literature and published papers. Lateral searches were conducted from
retrieved papers to provide historical background. Papers were restricted to those in English. Combinations
of terms, one from each column in Table 1, were searched for.
Links with experts in PPI also provided further papers and grey literature.
TABLE 1 Search terms
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Patient and public involvement: historical roots
Patient and public involvement in health and social care is emblematic of the postmodern democracy.
Challenges to the unquestioned authority of medicine from health service user groups can be traced
back to the 1950s, with growing disillusionment over health-care decisions being made which failed to
include the views and perspectives of the service user.12 In the UK, health service users have evolved a
collective voice and formed a number of groups which actively campaign for the right to have a voice in
decisions directly affecting them. While such groups are often organised in relation to a specific health
condition (such as diabetes mellitus) or a shared experience (such as domestic violence), the overall
movement has questioned conventional assumptions of, for example, disability, and also provided the
means for advocacy, political lobbying, provision of alternative forms of health and care services, and
user-led research and training.33,34 Further impetus for the challenge against biomedical authority was
provided by a series of high-profile medical scandals including the retention of deceased children’s body
parts for research without the knowledge or consent of parents35 and unexpectedly high mortality rates
for children undergoing heart surgery.36,37 This backdrop of a changing health service user response to
established biomedical authority underpins one of the three main claims of PPI legitimacy: the moral
argument. It has also actively shaped the second claim: the policy argument.
Patient and public involvement: the moral argument
A clear case for PPI is laid out as the right of citizens to have a voice in the public services for which they
are paying through taxes and labour; this is particularly relevant to health and care services or publicly
funded health research. This argument is founded on the notion of a previous democratic deficit38 and the
concepts of rights and citizenship.39 This right to be involved as a citizen has been further developed
internationally,11 but it has also been criticised as often comprising too narrow a view of citizens, with
the reality that the involved citizen is generally retired, white, middle-class and highly educated.38 An
alternative viewpoint is the ethical argument that the individual has a right to be fully involved about any
health care or research intervention being done ‘to’ them as a person. As well as this ethical standpoint,
there are also a range of emancipatory approaches40 that explicitly validate subjective knowledge and
openly challenge the traditional medical model of knowledge. Characterised by user-led research, this
approach attempts to give voice to knowledge that is seldom heard.41 A key influence on this movement
was the work of Paul Hunt, a resident of Leonard Cheshire Homes who was an early campaigner for
residents’ rights in the 1970s and 1980s. The then Department of Health and Social Security commissioned
research to explore the potential for residents’ participation in the running of care homes; the resulting
report was heavily criticised by Hunt for failing to include the resident perspective.42 That event was seen
as a catalyst in the development of service user-led research.43 However, while there is growing recognition
of the importance of experiential knowledge being addressed alongside scientific understanding,44 there
is also clearly often an intrinsic resistance to acknowledging lay knowledge, particularly in the sphere of
biomedical research.44,45
Patient and public involvement: the policy argument
Although some parts of the scientific community have contested what knowledge is credible,46 the public
crisis in confidence in the way health and care services were being run contributed towards a policy shift
through the 1990s whereby governance moved towards partnership and community involvement.37 The
consumerist movement in the 1980s provided a focus on customer satisfaction, and the involvement of
patients and the public was perceived as a feedback system to ensure that the NHS was meeting the
needs of service users.47 However, with the advent of the 1990s and a procession of significant changes to
the NHS48 there began a concerted effort to involve patients and the public in key decisions about the
purchasing and delivery of health and care services.49 The pace of policy change speeded up considerably
with the new Labour government in the late 1990s. ‘Third way’ policy, with its emphasis on concurrent
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rights and responsibilities,50 produced a number of initiatives including developing patient expertise in
self-management26 as a tool to increase an individual’s confidence and skills in involvement in their care.
Public involvement became a statutory duty within the NHS and all organisations were required to involve
patients and the public in planning and operational decisions about services. In the light of increasing
political expectations of PPI, the NHS has had a succession of involvement bodies including community
health councils (abolished in 2002), PPI forums (abolished in 2007), local involvement networks and, from
2013, Healthwatch. This frequent restructuring of mechanisms designed to enable the patient and public
voice suggests that policy-makers are still seeking more effective ways of operationalising PPI.47
While the policy argument has been presented in terms of PPI within the NHS as a whole, PPI within health
research, although more recently established,46 has equally been shaped by policy-makers.
The policy approach to patient and public involvement
in research
Since the 1990s, and mirroring the policy changes outlined above, there has been increasing mainstream
acceptance of PPI in research. In 1996 the Department of Health set up an advisory group to support PPI in
research. Originally known as Consumers in NHS Research (now INVOLVE), it commissioned a literature
review on service user involvement51 which highlighted the need for flexibility, funding, shared values
and the importance of the political philosophy. These key areas are reflected in the main policy papers,
whereby PPI became a statutory part of the research governance framework,5 and which made the case for
PPI to improve the relevance and more likely implementation of research findings.6 The 2008 Health and
Social Care Act consolidated legislation around PPI in the health service and health research, and in
a relatively short time PPI has become embedded within the main UK health research funding streams,
regulators and medical Royal Colleges.52 Researchers applying to NIHR and most medical charity funding
streams are now required to demonstrate how PPI has shaped the research proposal and how service users
and the public will continue to be involved in the study.
Patient and public involvement: the methodological argument
In addition to the moral arguments, policy-makers have been receptive to the consequentialist case that PPI
improves quality within the health service, particularly in terms of service delivery and patient outcomes.
There is a growing body of evidence that involvement in care leads to improved health outcomes53,54 and
patient experience,55,56 but less evidence on any impact of PPI on the planning and commissioning of
health services.57
Within the health research arena, the policy approach to PPI has been underpinned by various claims
regarding the impact of PPI. It has been suggested that PPI in setting research priorities has had an impact on
the amount of research conducted on rare conditions,28,29 and has shaped the research agenda for more
common conditions, such as breast cancer.58 Beyond priority setting, PPI is seen as having an important role in
identifying specific research questions,59,60 with subsequent applications for funding being more successful.61
Furthermore, PPI can ensure that the patient and carer perspectives are explicitly addressed within the research
questions,62 and may result in research questions being further refined17,63 or even abandoning a research
application if PPI suggests that the research questions are not meaningful for the target patient and service
user population.64
In addition to influencing researchers’ priorities, PPI has increasingly played a part in advising funding
bodies on priority setting, for example in medical products,65 spinal cord injury66 and burns research.67 Lay
involvement in the review of research grant applications is seen to raise issues not previously identified and
challenges scientist reviewers to think more about the service user perspective within their deliberations.68,69
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Overall, making PPI explicit within the research proposal development is seen as lending more credibility to
the proposal and hence offering a greater chance of funding.70,71 In particular, PPI is seen as being key
to the development of plain English summaries as a requirement in many grant applications.24,62
There are also claims that PPI improves the overall design in trials,72 particularly by ensuring the design is
acceptable for potential participants.73 Contributing to the design of interventions is reported as being an
important aspect of PPI; examples include stroke research interventions74 and advising on the timing of
interventions within Parkinson’s disease research.75 PPI also has a role in ensuring that research tools are
refined to more closely reflect the issues important for the target research population,76 ensuring tools
are culturally sensitive and designing measures of patient expectations of treatment.77 However, the most
frequently cited claim for the value of PPI is in recruitment to studies,78 most commonly by ensuring that
protocols and participant information are more relevant and accessible to participant groups.70 PPI input is
also seen as having importance in shaping the recruitment strategy by bringing local knowledge,79 or
important links to the target population.80 There are also examples where PPI has contributed to accessing
marginalised and seldom heard populations81,82 and those with rare conditions,83 and played a role in
promoting acceptance of researchers by previously sceptical communities.84 More active involvement
in mainly qualitative data analysis has been identified as improving interpretation of findings through
the drawing out of relevant themes.79,85–87 Moreover, qualitative data collection by service users as
co-researchers has been claimed to improve validity and provide better-quality data.88–90 Dissemination of
research findings is also reported as gaining from PPI networks to increase access to peers81 and relevant
sections of the community,15 and making information more broadly readable.31,72 There are fewer
published claims for PPI as playing a significant role in implementing findings, but, in a US public health
research programme, Krieger et al.86 report PPI-related implementation of changes by increasing their
cultural relevance. Several researchers have identified that PPI has helped them address ethical
dilemmas,17,71,78,85,91 for example ethically appropriate ways of contacting women with recently diagnosed
breast cancer and the use of routine patient data.92 There is also some suggestion that lay co-researchers
have a role to play in helping safeguard potentially vulnerable participants.82
The impact of PPI has a moral dimension in the reported outcomes for service users and the public
involved in the study. This includes an increased sense of self-worth,87,93 peer support,94 improved quality
of life95,96 and acting as a stepping stone to employment.88 Being involved with a research team also
provides service users and the public with a means of becoming more knowledgeable about health
conditions, services and the research process.58,93,95 Within community-based public health research,
benefits of PPI are also reported in enhancing the capacity of community-based organisations to raise
their value to their communities.86
Finally, there are claims that PPI brings benefits to researchers beyond just the research study. Working
with the public and service users is found to be a process whereby researchers learn to share control and
develop facilitation skills.88,97 PPI not only increases researchers’ confidence in their studies72 but perhaps
most importantly fosters their greater understanding of the service user or patient perspective.81,98
The evidence base for patient and public involvement
in research
Despite the growing body of literature outlined in the previous section, there is relatively little evidence of
PPI’s impact and outcomes.99 Several factors contribute to the weak evidence base for PPI. First, previous
evaluations have failed to use methodologies that take into account its complexity,100 arising from PPI
being an interconnected, multifaceted social process, making it difficult to pinpoint specific impacts and
contributions.19 Second, there is little systematic appraisal and reporting of PPI impact and outcomes,101
further constrained by the conventions of academic publishing.21 Nevertheless, there is a limited number of
evidence reviews,19,29,99,101,102 here presented chronologically to illustrate the developing evidence base.
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The systematic review by Oliver et al.102 was the first to examine the evidence base on the impact of PPI
on identifying and prioritising possible topics for research and development. They found detailed reports of
87 examples of PPI influencing the identification or prioritisation of research topics. While these reports
highlighted the collective experience of research programmes in involving patients and the public, gaps
were identified in training and preparing lay people. It also highlighted multiple barriers to service users’
ideas influencing research agendas, and a lack of collaborative working between the research programmes
and lay people to address the way forward in collective decision-making. In addition, the majority of
included reports were descriptive accounts written by researchers rather than service user representatives.
Staley’s 200919 review of the literature appraised papers published from 2007 within the INVOLVE
collection of articles, systematically searched electronic databases and drew on grey literature obtained
through networks via INVOLVE. A total of 89 articles (71 published papers and 18 from ‘grey’ informally
published literature) were included in the review. While there was some evidence around the impact of PPI
on influencing research questions, design, data collection, dissemination, implementation and research
ethics, the most substantial body of evidence was on PPI’s impact on recruitment. However, particular
gaps in evidence were found on PPI impact around grant-funding decisions, and on involvement in data
analysis apart from qualitative methodology. There was some evidence of both positive and negative
impacts of PPI on the public and researchers involved, and there were examples of positive impact for
research participants in terms of PPI influencing a better research process, and impact on the wider
community. However, as with Oliver et al.’s review,102 because of the nature of the evidence available,
inconsistent reporting and the context-dependent nature of PPI, it was not possible to carry out an
in-depth analysis of different kinds of impact, or to judge the quality of the evidence and determine how
generalisable the results were.
The Patient and Public Involvement in Research: Impact, Conceptualisation, Outcomes and Measurement
(PIRICOM) systematic review29 aimed to examine the conceptualisation, measurement, impact and outcomes
of PPI in health and social care research. Ninety papers published between 1995 and 2009 were included.
Data were extracted from 83 papers (the remaining seven were not written in a format suitable for data
extraction but were deemed sufficiently important to include within the conceptualisation of PPI). Of the
83 papers, 2 were randomised controlled trials (RCTs), 52 qualitative studies, 15 case study methodology,
4 cross-sectional studies and 10 structured reviews. As in Staley’s review,19 the papers provided more
evidence around the processes of PPI rather than impact and outcomes, and found scant evidence of PPI
impact on funding decisions. Hence, while there appears to be a reasonably robust level of evidence around
the ‘architecture of PPI’, reporting of outcomes continues to be poor. Brett et al.29 argue that most studies
have attempted to conceptualise PPI mainly around context and process and have not sufficiently theoretically
grasped the complexities of PPI. They did not find any evidence around systematic measurement of PPI
outcomes, and furthermore found a lack of clarity on the differences between PPI impact and outcomes.
Jagosh et al.103 addressed the complexity of PPI by utilising a realist review design.104 Focusing on
participatory research, which they define as the ‘co-construction of research between researchers and
people affected by the issues under study . . . and/or decision-makers who apply research findings’,
they reviewed published papers and grey literature on 23 studies or programmes of research where both
service users and researchers either identified or set the research questions, selected the methodology,
collected or analysed data and used or disseminated the research findings. In each example they
attempted to map out the relationship between the context (any condition that triggers or modifies the
behaviour of a mechanism), mechanism (a generative force that leads to outcomes) and outcomes
(intended and unintended). As part of their realist review they generated three hypotheses to test within
each example. Drawing on the concept of ‘partnership synergy’,105 their hypotheses were that partnerships
are not always synergistic (e.g. because of previous history); that multiple stakeholder collaboration will
enhance research outcomes beyond that which would be expected without the collaboration; and that
partnerships may become more synergistic with time. They were unable to test the first hypothesis because
of a lack of information about the history and previous context of each example. However, the other two
hypotheses were supported in several examples. They conclude that partnership synergy often generates a
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virtuous circle, so that conflict and disagreement between the stakeholders is not necessarily a bad thing,
as it may build more robust synergies through successful negotiation and resolution. However, as with the
earlier reviews, Jagosh et al.103 highlight the limited reporting of PPI and also suggest that negative
outcomes are less likely to be reported.
In a study published a year later, Shippee et al.101 develop a conceptual framework (Figure 1) from
their systematic review. They critique previous reviews as focusing on only one part of their proposed
framework, suggesting that their approach is more comprehensive and recommending its use to guide
future reporting of PPI. From an original 202 papers, the review included 41, with the findings mapped
against the framework. They conclude that the evidence of PPI impact on funding decisions continues
to be weak, with a notable lack of studies identifying the impact of PPI in data collection and analysis.
In contrast, there is a growing body of evidence on the impact of PPI in addressing ethical issues and
enhancing the validity of findings. The authors recommend that research be undertaken to compare and
systematically report different methods of PPI, and that there be more robust indexing of such studies.
Essential components of PPI
• Early PPI within
   research
• PPI should consist of
   people reflecting the
   community for whom
   the outcomes are
   relevant
• Scope for an active
   role 
Patient and service
user initiation
• Researchers see PPI as
   equal partners
• All stakeholders know
   their respective roles
• Colearning process
• Reassessment and
   feedback 
Building reciprocal
relationships
Phases of research with PPI
• Agenda setting
   and funding 
Preparatory phase
• Study design and









FIGURE 1 Framework for PPI in research.101
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Conclusion
Embedding PPI in research continues within an overall policy framework which is built on specific
contemporary moral and consequentialist arguments. However, while the body of literature describing PPI
processes and the architecture required to enable PPI continues to grow, it still provides only comparatively
weak evidence for impact and outcomes. One reason for this is the difficulty that confused terminology
or poor reporting poses for finding evidence of PPI impact in the literature. What evidence there is tends
to be descriptive, largely qualitative, often retrospective case studies,19,29,106 with only a few exceptional
prospective longitudinal case studies,15 comparative multiproject evaluations107 or studies employing
quantitative designs.108 This reflects the significant methodological challenges in evaluating PPI as a complex
intervention, and the length of time before impact may become visible. Key messages from the cumulative
reviews of evidence on PPI in research suggest that an appropriate methodological approach must be
sensitive to context and processes and their influence on outcomes, that PPI within a research study may
shift and develop with time so that there is a need for a longitudinal approach, and that different models of
PPI need to be evaluated and compared through a standardised design. In the next chapter we present our
methodology designed with these conclusions in mind.
DOI: 10.3310/hsdr03380 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 38
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9

Chapter 3 Research design and methods
As outlined in the previous chapter, PPI in research is a complex social phenomenon, and can act asan ‘intervention’.109 Providing a more robust evidence base for PPI policy requires moving beyond
observational evaluations of PPI.29,30 More conventional approaches to empirical evaluation would seek to
examine whether or not programmes, interventions or innovations are effective using controlled trial designs
to measure specified effects of each of a number of variables on outcomes. Although such designs are well
suited to assess the effectiveness of clinical treatments, it has long been recognised110 that such research
designs are less able to identify how exactly variables combine to create outcomes111 or to fully explain the
processes through which programmes actually work. Furthermore, controlled trials are, by definition, able
neither to examine the dynamic nature of those interventions which, will, of necessity, evolve over time nor to
explore the effect and complexity of the wider social systems within which PPI takes place. For example, an
experimental evaluation (RCT) which investigated the impact of PPI in developing participant information
sheets (PISs) for a clinical trial108 concluded that PPI had little or no impact on participants’ understanding of
the trial or on recruitment and retention, and the authors were able only to speculate that a wide range of
contextual factors and limited understanding of the mechanism of gaining consent were responsible for this
negative outcome. Yet, as Staley et al. argue:
If an experimental evaluation is not designed in a way that considers the contextual factors and
aspects of the mechanism that have the potential to influence impact, then it may produce inaccurate
or over-simplified conclusions about when and how involvement makes a difference.
p. 632
Realist evaluation (RE) is one of several theory-based approaches to evaluation developed within the social
sciences, which seeks to address dynamism and context, rather than control for them, to explain more
adequately how and, importantly, under what circumstances programmes, interventions or innovations will
‘work’ in real-world complex systems, such as those related to health care/research systems.112 Such social
science approaches highlight, specifically, how it can be the reasoning and actions of people (social actors),
rather than inherent characteristics of the interventions themselves, that make them work.113
In conclusion here, the evaluation of PPI in research necessitates a method of enquiry capable of capturing
the interplay between outcomes and processes and the context in which PPI is conducted. As other authors
have advocated in reviewing the evaluation evidence for PPI,32 a realist evaluation approach114,115 offered this
research the capability of more fully investigating and understanding what type of PPI provided what kind of
outcome in relation to different types of research and settings. We employed an overarching critical realist
framework116,117 focused on the mechanisms embedded within PPI, to facilitate our understanding of
outcomes present or absent depending on how they were triggered, blocked or modified.118,119 RE,115 which
draws upon this perspective, was used to inform the research design.
We continue this chapter with a brief introduction to RE and its application in this study. We then explain
the three-stage research design and methods employed to test the links between context, mechanisms
and outcomes of PPI. We also introduce Normalisation Process Theory (NPT) as the candidate programme
theory to explain the ‘work’ required to embed PPI as normal practice. In particular, the focus of NPT on
social action can help understand how and how far PPI may be ‘embedded’ within and across
contemporary health-care research.
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Method of enquiry: realist evaluation with Normalisation
Process Theory
Both RE and NPT are theoretically informed approaches that can help researchers to further investigate,
develop and refine middle-range theories (MRTs) to explain specific parts of programmes and interventions.
Merton defines MRTs as ‘theories that lie between the minor but necessary working hypotheses and the
all-inclusive systematic efforts to develop a unified theory that will explain all the observed uniformities of
social behaviour, social organisation and social change’ (p. 39).120 MRTs are thus sufficiently abstract to be
applied to differing spheres of social behaviour and structure, but do not offer a set of general laws about
these at societal level. Specifying the range of the theory is important here. The limited scope, conceptual
range and claims of MRTs are what make them practically workable in analysing practice; both approaches
(RE and NPT) can be applied across different types of social programmes at different scales.
The bodies of literature on empirical applications of both these approaches are relatively recent,112
especially NPT; its third and final development phase was reported only in 2009.121
Realist evaluation is rooted in the philosophy of science situated between extremes of positivism and
relativism, known as realism.115,122 Realism understands the world as an open system, with structures and
layers that interact to form mechanisms and contexts. RE research is concerned with the identification of
underlying causal mechanisms, how they work, under what conditions and for whom.115,123 The approach
employs three key terms, for which definitions are provided in Box 2.
BOX 2 Definitions of terms of RE as applied to PPI in research (adapted from Pawson and Tilley115 and
Jagosh et al.99)
Context
Context often pertains to the ‘backdrop’ of programmes (PPI in research): those conditions within which
programmes are introduced that are relevant to operating the programme mechanisms (e.g. the research
arena, previous working relationships or funding body). As these conditions change over time, the context may
reflect aspects of those changes while the programme is implemented. Context can be broadly understood as
any condition that triggers and/or modifies the mechanism.
Mechanism
Mechanisms are the unit of analysis of RE. Mechanisms describe what it is about programmes and interventions
(PPI in research) that bring about any effects (outcomes). Mechanisms are often hidden, as with a clock’s
workings; they cannot be seen but drive the patterned movements of the clock’s hands. Mechanisms are linked
to, but not synonymous with, the programme’s strategies (e.g. a strategy may be an intended plan of action for
PPI in research, whereas a mechanism involves the researchers’ and PPI representatives’ reaction or response to
the intentional offer of incentives or resources). Identifying the mechanisms (e.g. the design of PPI roles within
research projects) advances the synthesis beyond describing what happened to theorising why it happened, for
whom and under what circumstances.
Outcomes
Outcomes are either intended or unintended consequences of programmes, resulting from the activation of
different mechanisms in different contexts (e.g. if the research recruited more successfully because of PPI).
Outcomes can be proximal, intermediate or final.
RESEARCH DESIGN AND METHODS
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Because causal mechanisms are always embedded within particular contexts and social processes, their
complex relationship with the effect of context on their operationalisation and outcome needs to be
understood. Pawson and Tilley115 describe this as: context (C)+mechanism (M)= outcome (O). Rather
than identifying simple cause-and-effect relationships, RE is concerned with finding out about what
mechanisms work, in what conditions, why, to produce which outcomes and for whom.124 RE does this
through testing and refining configurations of context, mechanism and outcome (CMO) within analysis of
data, as described in Box 3.
Although Pawson and Tilley did not provide a set of methodological rules for RE, and these are still much
debated,112,125 they nonetheless suggest some principles for guiding evaluators. These include the
identification of mechanisms and testing/refining of CMO configurations; stakeholder involvement and
engagement; and a generative conception of causality (i.e. an explanation not of variables that are
inter-related to one another but rather of how they are associated).124
In practice, REs start with a MRT and end with a refined MRT, following four main stages as described by
Pawson and Tilley.114 The MRT can be formulated on the basis of existing theory, past experience and
previous evaluations or research studies. The result is discussed with the stakeholders and finally results in
the MRT that will be tested. The field study is then designed in relation to the MRT: the design, data
collection tools and analysis tools are developed to enable testing the elements of the MRT. The outcomes
of the fourth stage should lead to policy advice and recommendations. The application of these four







• Map outcomes across
   cases
• Develop CMO 
   configurations
• Identify salient actions
   that could explain 
   outcome patterns
Test propositions




  on CMO configurations
• Refinement of 
   programme theories
• Confirmation of
   transferable salient 
   actions
Refinement
FIGURE 2 Stages in the RE process (adapted from Pawson and Tilley115 and Hewitt et al.126).
BOX 3 Definition of CMO configurations (adapted from Pawson and Tilley115 and Jagosh et al.99)
Context, mechanism and outcome configurations
Context, mechanism and outcome configuring is a heuristic tool used to generate causative explanations
pertaining to outcomes in the observed data. The process draws out and reflects on the relationship of CMO of
interest in a particular programme. A CMO configuration may pertain either to the whole programme or only
to certain aspects. One CMO may be embedded in another or configured in a series (in which the outcome of
one CMO becomes the context for the next in the chain of implementation steps). Configuring CMOs is a basis
for generating and/or refining the theory that becomes the final product of the evaluation. RE thus develops
and tests CMOs conjectures empirically.
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Both a published literature review112 and critical discussions in the applied literature cite several
methodological challenges associated with a RE approach, including deciding what constitutes a mechanism,127
and indeed differentiating between what is a mechanism and what is context. Barnes et al.,128 for example,
also caution against interpreting context as a purely external factor, arguing that context is shaped by actors as
much as it constrains their activities.
Middle-range theories and hypotheses
Before the empirical work, we conducted a search of the literature to identify programme theories that
would inform candidate CMOs. As described in Chapter 2, PPI can be defined through three different
perspectives: moral, methodological and policy. We therefore sought explanatory theories that would
underpin these approaches and predict outcomes. These are illustrated in Table 2.
TABLE 2 Realist framework of perspectives on PPI
Dimension Moral Methodological Policy
Purpose To ensure citizens’ rights




To support and embed PPI in





rather than ‘doing to’
patients and the public
Patient and public satisfaction




relevance for patients and
the public
Improved overall research
design leading to safer and
more ethically robust
research, participant-sensitive
data collection tools, better
recruitment rates, increased





patients and the public
involved, and for researchers
Democratic deficit addressed
Researchers ‘working with’
rather than ‘doing to’ patients
and the public
Patient and public satisfaction
with levels of involvement
Lay people and researchers




relevance for patients and the
public
Improved overall research
design leading to safer and
more ethically robust
research, participant-sensitive
data collection tools, better
recruitment rates, increased












Development of models of PPI
and supportive infrastructure






Programme theory Critical theory (Habermas
1972129)
Emancipatory concept of PPI
(Gibson et al. 2012130)
Architecture of involvement
(Brett et al. 2010131)
Multidimensional conceptual
framework of PPI in health
research (Oliver et al. 2008132)
Partnership synergy
(Lasker et al. 2001105)
Normalisation Process Theory
(May and Finch 2009121)
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We drew on the work of Habermas129 to predict the outcomes of PPI when operationalised through
the moral perspective. Habermas proposes that critical theory challenges the traditional superiority of
scientific knowledge and unmasks ideologies that seek to prevent the voice of marginalised groups from
being heard. The case for emancipatory knowledge is put forward where personal knowledge is gained
through self-reflection and leads to personal empowerment. This is amplified through communicative
action where the interpersonal knowledge of groups comes together through mutual understanding.129
Habermas’s work, alongside others, is used by Gibson et al.130 to develop an emancipatory concept of PPI.
For the methodological perspective on PPI we used the multidimensional conceptual framework of PPI
proposed by Oliver et al.,132 the indicators of successful PPI developed by Boote et al.,133 through consensus
methodology, and the systematic review of Brett et al.,29 which suggested the architecture required to
enable effective PPI. As the methodological paradigm also depicts PPI in research as leading to improved
outcomes for the research and for all those involved, we also drew on the partnership synergy model of
Lasker et al.,105 which proposes that synergistic partnerships (between PPI representatives and researchers)
lead to high-quality (research) plans with more chance of a successful outcome.
A key MRT that informed our research approach was NPT.121 Specifically, it is a candidate MRT to inform
the policy perspective on PPI, but we found in practice that its constructs systematically inform all three
viewpoints and therefore we used it explicitly to similarly inform our methodological approach (see Table 2).
Normalisation Process Theory
In attempts to help understand why it is that seemingly effective innovations often fail to flourish when
rolled out in practice (context), NPT addresses two important problems that face service improvers as they
try to get innovations into practice:
l process problems – about the implementation of new ways of thinking, acting and organising
l structural problems – about the integration of new systems of practice into existing organisational and
professional settings.
Because PPI in research is not an entirely ‘new’ innovation, intervention, programme or phenomenon, but
also is not yet fully normalised within contemporary research practice, it has been suggested15 that NPT
offers unique potential for helping theorise how PPI is/is not routinely operationalised (embedded) and
sustained (or not) in practice.
As an ‘action’ theory, NPT also sharpens our analytical focus on the actual work that people performing PPI
do, or do not do, rather than people’s attitudes (how they feel about what they do) or their intentions
(what they say they are going to do).134 NPT distinguishes action according to a set of four constructs. Each
of these represents a generative mechanism of social action. That is, each construct represents different kinds
of work that people do in orienting themselves to a set of practices of PPI in research. These constructs and
their components (domains) (Table 3) address the ways that people make sense of the work entailed in
implementing and integrating PPI (coherence); how they engage with this work (cognitive participation);
how they enact it (collective action); and how they appraise its effects and modify it (reflexive monitoring).
Normalisation Process Theory has been developed for using in a flexible and dynamic way and can both
direct and sensitise the practical and analytic trajectories of a research project. There is currently no
published review of its empirical application, but it has been seen to have been applied to good effect in a
number of social and health-care settings.121,134,135 Of relevance in the RAPPORT study, and discussed in the
following sections, is that case study methods have been seen to be more robust when theoretical
propositions to guide data collection and analysis have been previously developed.136 We have used NPT
constructs and domains both to direct our data collection and to guide our analysis, particularly within our
case study work. In effect, these domains map across to the RE, and are most significant in theorising PPI
mechanisms and outcomes, and to some extent the context, but, as discussed below, were combined with
additional questioning and coding to inductively explore other emerging significant themes.
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We also drew on previous work focused on the architecture and infrastructure29,137 required for PPI to
be operationalised.
Research design and methods
Both RE and NPT are method-neutral and often employ both qualitative and quantitative methods to
collect sufficient information on the context (the setting and focus of the research), processes (type of
involvement and formal support processes), structure and agency (organisational structures such as PPI
frameworks and actions of stakeholders including researchers and lay representatives) within each case.
Utilising a sequential, mixed-methods approach, the study was conducted in three stages, from May 2011
to February 2014. The project flow chart, shown in Figure 3, illustrates the phases of the research and
methods employed and PPI.
The first two stages of the study comprised a scoping and survey which provided us with a contextual
backdrop to PPI in current and recent research. These methods also informed us about what is recognised
as PPI, and gave us an indication of the current level of PPI across six health research topic areas
(see below). These findings informed the development of a sampling frame for the subsequent (third)
phase, in-depth case studies.
TABLE 3 Normalisation Process Theory constructs and their components
NPT construct Description Components (domains)
Coherence The sense-making work that people do individually and
collectively when they are faced with the problem of





Cognitive participation The relational work that people do to build and sustain a






Collective action The operational work that people do to enact a set of






Reflective monitoring The appraisal work that people do to assess and understand
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Research activity Public involvement activity
NRES approval processes 
National scoping of studies in
six exemplar areas 
Identification of CIs
 for survey 
Online survey of CIs
 in four regions of
England





















Reference groups and co-researchers
discuss and contribute to final report
Co-researchers participate in dissemination
seminars
Reference groups advise
on data collection tools










for data collection  
Co-researchers interview
PPI members in case
studies
Co-researchers trained
for data analysis and




from case studies 
FIGURE 3 RAPPORT flow chart. AMRC, Association of Medical Research Charities; CI, chief investigator;
CLRN, comprehensive local research network; NRES, National Research Ethics Service; RDS, Research Design Service.
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To demonstrate which elements of PPI in research influence its outcomes, regardless of setting, those that
are context specific, and what different approaches can and cannot achieve, we purposively selected six
exemplar areas that by their focus and research tradition could capture the full continuum of PPI. These are:
1. Cystic fibrosis (CF). This life-limiting condition affects children and younger adults. Services are located
within secondary care and specialist centres. There is a strong current laboratory-based research focus on
gene therapy. Compared with the other topic areas, there is less of a history of PPI, with particular
challenges in recruiting children and younger people.
2. Diabetes mellitus. This is characterised by a clear clinical diagnosis and its treatment emphasises
self-management and lifestyle change. The disease affects people across the lifespan and services are
predominantly delivered in primary care. PPI is well established particularly through powerful
patient organisations.
3. Arthritis. This occurs through the lifespan but predominantly in older people. There are a range of
treatments in a range of settings with an emphasis on preventing further deterioration. A strong patient
organisation and recent history of involvement in research have informed the development of Expert
Patients Programme.
4. Dementia. This is a condition of later life with a limited life expectancy. Characteristics that can shape
PPI include the unclear trajectory of the disease, the stigmatising nature of the condition, reduced
mental capacity and a population predominantly of older persons within a primary care setting. There is
a well-established history of PPI in the identification of research priorities in the Alzheimer’s Society
Quality Research in Dementia Network and an increasing recognition of the need to develop research
to be inclusive for this population.
5. Intellectual and developmental disabilities (IDDs, also known as learning disabilities). Widely varying
conditions mark out a marginalised group in terms of health-care delivery and health research. Despite
the challenges of making research accessible for this group, there are a well-established history of PPI
and well-developed theoretical and policy participative frameworks that inform policy, practice
and research.
6. Public health. This includes participants across the lifespan who do not see themselves as service
users. It may include community interventions and user-led projects in a variety of settings, but faces
challenges in PPI, particularly in harder-to-reach groups.
These topic areas represented a diverse range of studies and associated models of PPI. They included
studies with participants recruited across the lifespan (such as children and young people in CF studies,
and older people in dementia studies), as well as different research designs (basic science to qualitative),
settings (acute care, primary care) and traditions and history of PPI. For example, diabetes mellitus has a
strong national patient organisation with a record of being involved in research and commissioning of
health services. Both diabetes mellitus and dementia have a national research infrastructure that
has well-established PPI mechanisms,78,138 and the IDD community at both policy and research levels has
focused on inclusive practice.139 Public health was incorporated to include community interventions and
user-led projects and local populations who may not consider themselves as patients.
We built quality and rigour into the research process, from the method of sampling research studies for
each stage, through data collection, to the ‘audit trail’ created during analytic phases.
Inclusion and exclusion criteria
We included researchers and service users and members of the public who:
l were involved in a study eligible for adoption on the UK Clinical Research Network (UKCRN) portfolio
in one of the six exemplar areas
l were 13 years old and over
l gave informed consent.
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We excluded researchers and service users and members of the public who:
l were not involved in a study eligible for adoption on the UKCRN portfolio in one of the six
exemplar areas
l were under the age of 13 years
l did not give informed consent.
Ethical approval
This project had NHS approval (REC reference: 11/EM/0332), obtaining favourable approval by Nottingham
Research Ethics Committee 1 Proportionate Review Sub-Committee on 13 August 2011 with no changes
to the research protocol.
Ethical issues
It was not expected that any major ethical issues would emerge from this project. However, we were aware
that we might be including younger people, people with IDDs and users of dementia services. The team was
skilled in working in sensitive areas and with these groups, although few such participants were involved with
or recruited to the case study phase of this research. We also foresaw that there might also be sensitivities in
discussing experiences of a project with the potential to expose bad practice and misuse of PPI, so we were
careful to remain neutral in our reactions to reports of practice, while also probing carefully in order to clarify
understandings and gain fuller explanations. Informed consent was taken from all participants participating in
interviews in stage 3.
Stage 1: national scoping of studies
To address objective 1, a national scoping of studies within the six exemplar areas was undertaken
(October–December 2011).
Sample
Our sample here included current studies or those completed in the previous 2 years in the six exemplar
areas and being undertaken in England. To ensure relevance to the NHS and scientific robustness, studies
were limited to those registered with the UKCRN portfolio, excluding commercially funded studies. To
ensure inclusion of studies most likely to have been designed since the embedding of PPI in the research
governance framework,1 we excluded studies older than 2 years (end date of recruitment before
1 September 2009). We also excluded studies funded by commercial organisations because, despite
current criticisms of the lack of transparency in drug trials,140,141 access to the study documents required
was likely to be limited.
Data collection
Studies were identified using the using the search terms in Table 4.
Details of each study were electronically searched via funding body databases. Relevant documentation
such as reports, abstracts and protocols was reviewed for the type of research (e.g. laboratory based or
qualitative) and any evidence of the nature and extent of PPI. Where information was not available
electronically, the funding body was contacted and requested to provide further relevant details of the
study. Indeed, one of our findings from this initial scoping exercise is that there is minimal direct open
access to such study documentation. Significantly, even when the protocol was available on the funder’s or
study’s website, there was little information about PPI. Therefore, we also contacted study teams directly
or through collaboration with the Association of Medical Research Charities (AMRC) for PPI information.
DOI: 10.3310/hsdr03380 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 38
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
19
Scoping response
In total, 1464 studies in the six broad topic/exemplar areas were downloaded from the UKCRN database.
One hundred and two were excluded as not in the specific topic areas, 263 as more than 2 years old
and 261 as commercially funded. A total of 838 studies were included (Table 5). These were then divided
into the 478 included in the scoping, and 360 for the online survey. All of the latter group were within
the four selected regions of England (Figure 4).
In the UK, clinical research networks have been established in each of the four UK nations funded by
their health departments. These national networks form UKCRN. The UKCRN portfolio of studies was
used as one single database to identify relevant research studies, and information including study title,
sample size, end date of recruitment and contact details was downloaded into an Excel® (version 14,
Microsoft Corporation, Redmond, WA, USA) spreadsheet.
For studies not covered by the online survey, that is running outside the four selected geographical regions,
including studies in Scotland, Wales and Northern Ireland, direct requests were made. Documents or e-mail
replies were then reviewed by two team members independently for background study information and
any evidence of the nature, extent and activities of PPI. The scoping exercise obtained information about
PPI from 182 studies out of a possible total of 478 (38%) (Table 6). Documents received in response to
requests for PPI information included 93 protocols, 12 journal articles, 64 e-mail replies, 10 interim/final
reports and 3 Integrated Research Application System (IRAS) forms. Other documents (such as grant
applications, reports to funders and lay summaries) were also provided. Some studies provided more than
one source of information. The studies in the scoping had sample sizes ranging from 12 to 250,000,
TABLE 4 Search terms for topic areas accessed on UKCRN portfolio
Topic area Focus and key words/terms
CF Key word ‘cystic fibrosis’
Diabetes mellitus Type 1 and type 2 and other
Arthritis Musculoskeletal, inflammatory and immune, genetics, primary care
Dementia Dementia and neurodegenerative diseases, Huntington’s disease, motor neurone disease, Parkinson’s
disease, other
IDD Searched on key words: ‘learning’, ‘attention’, ‘Downs’, intellectual’, ‘autism’, ‘Asperger’. Mental
health: learning difficulties theme. Specific syndromes listed by Royal College of Psychiatry142
Public health Primary care, infection, key word ‘public health’
All topics Generic relevance and cross-cutting themes
TABLE 5 Search of UKCRN portfolio in six topic areas
Topic area






CF 23 8 35
Diabetes mellitus 512 277 54
Arthritis 399 188 46
Dementia 282 192 68
IDD 90 51 57
Public health 158 122 77
Total 1464 838 57
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Search UKCRN portfolio database
to identify current studies or those completed




(n = 478) 
Studies located in four
geographical regions of
England (North East, London,
East of England and
South West)
(n = 360)
UKCRN portfolio: link for protocol request
Protocol available on funder’s or study’s website
On authors’ behalf, funder requests PPI
information from study team 
Authors directly approach chief investigator







FIGURE 4 Flow diagram of scoping and survey.
TABLE 6 Scoping response rate by topic area
Topic Scoping response rate (%)
CF 40 (n= 2 of 5)
Diabetes mellitus 34 (n= 46 of 137)
Arthritis 42 (n= 55 of 132)
Dementia 38 (n= 35 of 93)
IDD 38 (n= 11 of 29)
Public health 40 (n= 33 of 82)
Total 38 (n= 182 of 478)
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with a median of 250. The two main funders were NIHR (29%) and charities (29%). The remaining funders
were a mix of government departments, the European Union, research councils and others. Forty-two per
cent of the scoping studies were clinical trials, 33% were mixed methods (qualitative and quantitative
non-clinical trials), 10% were basic science and 15% were tissue bank/database.
Analysis
Variations in PPI were mapped against the type of research, topic area and funding body. Drawing on the
conceptual framework of Oliver et al.132 and the PIRICOM systematic review,29 a scoping framework was
used to assess the stages of the research at which PPI took place, whether involvement was of lay groups
or individuals and where it was located on the continuum of PPI from user-led to minimal PPI. We also
assessed evidence of the ‘architecture of involvement’:29 those processes needed to enable PPI in research,
which included a budget for PPI, defined roles for lay people, training and support, and means of
communication between researchers and lay people. This was used to evidence the range of resources
supporting PPI. The results from this analysis are presented in Chapter 5.
Stage 2: survey of lead researchers
Objectives 2, 3 and 6 were addressed by conducting an online survey (see Appendix 1) of lead
investigators (January–February 2012). The design of the survey was drawn from indicators of successful
PPI identified by Boote et al.,133 including roles, resources, training and support, and recruitment. Informed
by the findings of stage 1, the survey was conducted in four regions.
Sample
Four geographical regions in England were purposively selected for the survey to ensure maximum
variation: the South West has a relatively large rural population and a long history of PPI;143 the East
of England has established PPI networks144 with rural and urban areas; there is less evidence of any
long-established PPI history in the North East, which has one major research hub and socioeconomic factors
affected by a heavily industrialised past; and London is the most densely clustered in terms of research
centres and has a relatively high population of people from black and minority ethnic (BME) groups.
Data collection
Drawing on the findings of the PIRICOM study,29 a validated online survey tool (Bristol Online Surveys,
University of Bristol, Bristol, UK) was designed to collect data to assess how PPI is operationalised and
its perceived impact on each study. Although the PIRICOM study found little evidence of PPI being
theoretically conceptualised, there has been some work to develop a consensus on the principles and
indicators of successful PPI,133 and this was used to underpin the survey design. The research team’s
previous experience of using online survey tools suggested that good response rates are achieved when
the survey remains focused, it takes no longer than 15 minutes to complete and rapid feedback is
promised to participants. There was close working with the appropriate comprehensive local research
network, specialty networks and local specialty groups to publicise and disseminate information about the
study. The survey was electronically distributed to lead investigators across the four diverse regions and its
findings also provided the test-bed for stage 3. Participants received a summary of findings.
Survey response and study characteristics
From the UKCRN portfolio 360 studies across the four regions were identified and an e-mailed invitation
and link to complete the survey was sent out to all named chief investigators (CIs) or researchers. From the
first e-mail there was a 17% response rate and following the reminder there was a total of 101 responses
to the survey (28% response rate) (Table 7).
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The 101 studies surveyed ranged in sample size from 5 to 300,000, and grants awarded ranged from
less than £50,000 (8% of sample) to 30 over £1M (30% of sample). Funding was split evenly between
NIHR (40%) and charities (40%). The survey included 40% clinical trials, 33% quantitative and qualitative,
12% basic science and 7% tissue/bank database and a further 7% were coded ‘other’ (as insufficient
information to classify).
Analysis
The focus of the stage 2 survey was to describe researchers’ experiences and perceptions of positive and
negative outcomes of PPI, and benefits and challenges of PPI for researchers. The focus of analysis in this
stage was therefore the use of summary statistics alongside qualitative analysis of open-text responses.
Using an electronic survey tool enabled rapid access to data that were readily transferred to SPSS
(version 20, IBM SPSS Statistics, Armonk, NY, USA) for analysis. This analysis was mapped against the
results of the scoping in stage 1 to identify any recurring patterns within and between types of research,
stages in research process where PPI occurred and topic areas. The findings from these two phases were
used to develop a sampling frame for the final case study phase. The survey findings were then used as
one of the ways to identify research teams likely to be interested in taking part in stage 3.
Stage 3: case studies
Objectives 2–7 were addressed through in-depth case studies. Stages 1 and 2 provided a contextual
backdrop, and findings from these stages informed what was recognised as PPI in current and recent
research. Stage 3 delivered an in-depth RE of the CMO in specific research settings to increase understanding
of at what points PPI has the most impact and effect on outcomes.
Case study methods are a recognised and well-established approach to conducting research in a variety of
‘real life’ settings including health care.145 Yin146 defines case study research as ‘an empirical study that
investigates contemporary phenomena within a real life context, when the boundaries between the
phenomena and context are not clearly evident and which multiple sources of evidence are used’ (p. 18).
This approach allowed us to employ a range of social science research techniques and designs, mainly
qualitative, to gain in-depth understanding of the nature of engagement between service users, the public
and local NHS organisations within their specific organisations. It also provided the methodological
flexibility to generate some theoretical insights from our results.147 We were thereby able to adopt an
interactive approach to data collection and analysis, allowing theory development grounded in empirical
evidence, which was the main strength of this design.148
TABLE 7 Survey response by topic area
Topic Number replying Total number sent
CF 2 3




Public health 21 40
Total 101 360
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Sample
To ensure typicality and sufficient variation across topic areas, types of research and geographical regions,
a sampling frame (Figure 5) developed from the previous stages was used to purposively select up to
20 case studies where the case is a single research study. This enabled maximum variation, but also
allowed comparison within and between region, topic area and type of research.
Data collection and recruitment
To ensure a range of studies that varied in their stage of research implementation, several recruitment
strategies were employed:
(a) Potential studies were identified from the survey.
(b) Suitable early stage studies that had been awarded funding but had not yet been adopted on the
UKCRN portfolio were identified by local Research Design Services (RDSs), by relevant charitable
funding organisations from the AMRC, and by networks such as the Primary Care Research Network
from their futures list. The RDSs, AMRC organisations and local research networks such as the Primary
Care Research Network sent out information about the RAPPORT study and investigators interested in
participating were asked to contact the RAPPORT study team.
Data were collected from each case study to inform the three stages of realist enquiry – context,
generative mechanisms and outcomes119 – using the methods of documentary analysis, semistructured
interviews with key informants from case studies, tracking and semistructured interviews with research
funders and networks as follows:
Documentary analysis
Key documents from each project were requested and analysed149 to situate the project historically and capture
the temporal dynamics of PPI at three levels of scale: micro (project), meso (host organisation) and macro
(funding body). Documents requested included those pertaining to PPI policy, structures and support
mechanisms (e.g. training) in the host [e.g. higher education institution (HEI)] and funding organisations.
Project team and advisory/steering group meeting notes or minutes were also requested from participating
case studies and (once anonymised) were added to the documentation collected in stage 1. Other relevant
documents included, for example, PISs or publicity materials, which provided records or evidence of PPI
impact/outcomes. Documents were requested and added to analysis throughout the data collection period of
the RAPPORT study. A total of 278 documents were collated and analysed in the case study phase.
North East London
East of England South West
Type of










FIGURE 5 Sampling frame. Arth, arthritis; Dem, dementia; Diab, diabetes mellitus; PH, public health.
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Semistructured interviews
Semistructured interviews were conducted with key informants in each case study. Depending on the study,
this included the PPI members, lead/senior researcher, coapplicants, researchers, clinical partners and
sometimes PPI co-ordinators within a host organisation. To maximise recruitment and participant convenience,
interviews were conducted mainly by telephone and designed to take about half an hour to complete.
The option of face-to-face interviews was also open to participants where preferred.
The interview guides developed (see Appendix 2) drew on, and were cross-referenced to, NPT,121 and
focused on mechanisms and associated impact and outcomes of PPI. In the case of children and people
with learning disabilities involved in studies, we had planned to review and modify data collection
tools in collaboration with a reference group of people with learning disabilities, and a reference group
of younger people with CF and their parents. However, all participants in this research were over the
age of 18 years and, as seen below, a few participants with IDDs were recruited to the RAPPORT study.
The only interviewee with a learning disability was high functioning and had experience of media
interviews. Participants received an ethics committee-approved information sheet (see Appendix 3) and
signed a consent form (see Appendix 4). All scheduled interviews were audio-recorded and professionally
transcribed for analysis, and researchers checked them for accuracy and anonymised them upon receipt.
Tracking
Ongoing case studies were tracked over an 18-month period to identify public involvement processes.
In negotiation with the study team this was expected to be a regular focused (telephone or occasionally
face-to-face) interview with the lead investigator or other nominated member(s) of the research team but,
as shown below, more often we were able to track PPI processes more fully by interviewing more than
one researcher and/or a PPI member and supplement this data collection with e-mail exchanges/updates.
The frequency of this contact depended on study characteristics and PPI milestones within the project,
but occurred approximately every 12–16 weeks.
Semistructured interviews with research funders and research networks
To develop a fuller understanding of the dynamic and historical context of PPI, telephone interviews were
also conducted with research funders and research networks. Key informants here included those
professionals with responsibility for setting PPI policy and/or process for the funder/network and the
studies funded within their research grant programmes. Other key informants here also included those
with a PPI role within the funding body or network funding body – often as PPI representatives on research
priority-setting panels or funding panels.
Interview guides here again drew on NPT (see Appendix 2), participants received an ethics committee-approved
information sheet and signed a consent form (see Appendices 2 and 3) and interviews were audio-recorded
and professionally transcribed for analysis and anonymised upon receipt.
Response and case study characteristics
In total we recruited 23 case studies in accordance with our sampling strategy as shown in Table 8.
Considerable efforts were made to balance the recruitment of case studies according to region, topic area
and research design. Other factors considered were the range of PPI models, PPI approaches, the stage
the case study was at in its research process/cycle and the duration of the study. The cases we achieved
appeared remarkably balanced, especially since the body of research in progress at any one time cannot be
balanced according to our project’s specifications, but will be dictated by wider historical and political
trends, biases and service needs.
DOI: 10.3310/hsdr03380 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 38
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
25
Reflecting our emphasis on PPI processes and the tracking element of our research design, we over-recruited
case studies in order to compensate for any potential dropout from the study. Standard consent to participation
in research respects the right of individuals to withdraw from participation at any time, and for a variety of
reasons research projects can be stopped before completion. Although we started with 23 case studies, after
about 9 months into the RAPPORT study one withdrew from the study. There were two PPI representatives and
two researchers in this study. These data were destroyed and removed from the analysis presented here.
Case studies were at various stages of progress during our RAPPORT data collection period and were
tracked for between 8 and 18 months. Most case studies (17 of 22) had already begun before we started
data collection, and approximately half (12 of 22) continued after RAPPORT data collection ended.
Initial and ongoing correspondence with case study CIs or a nominated research colleague identified
potential documents and personnel (by role) to invite for interview for the RAPPORT study. In some cases it
was acknowledged that some PPI representatives, more often those who had taken part in a larger one-off
PPI event in the past, could no longer be identified or approached, as their contact details had been
TABLE 8 Sample recruited
Topic Region Study design Funder
Dementia North East Basic science involving humans NIHR
East of England CTIMP NIHR
Diabetes mellitus North East CTIMP NIHR
London Trial, cohort, qualitative NIHR
Mixed qualitative/quantitative NIHR
Process of care, qualitative Non-commercial
East of England RCT to compare intervention NIHR
South West Basic science involving humans Charity
Genetic epidemiology Charity
Intervention (mixed quantitative/qualitative) Charity
Arthritis London CTIMP Charity
Research database Research council/charity
East of England Cohort Charity
South West Qualitative methods Research council
Public health London RCT to compare intervention NIHR
East of England RCT to compare intervention NIHR
Survey admin questionnaires/interviews Charity
South West RCT NIHR
IDD London Questionnaire NIHR
East of England RCT to compare intervention NIHR
South West Qualitative NIHR
Systematic review NIHR
CF London CTIMP NIHR/research council
CTIMP, Clinical Trial of an Investigational Medicinal Product.
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destroyed in line with the Data Protection Act (1998).150 In addition, where studies in their development
had been put to PPI panels that advise on a wider portfolio of research proposals [e.g. case study 01
(CS01)], it was deemed that they would have little to say regarding one of many studies they had reviewed
in recent years.
Case studies were allocated to one of the three qualitative RAPPORT researchers at the University of
Hertfordshire (PW and EM) and the University of East Anglia (JK). PPI co-researchers on the RAPPORT study
(MC, DM and another PPI co-researcher) were affiliated to the University of Hertfordshire PPI group and
thus were involved in case studies allocated there.
In total 129 participants [64 researchers, 48 PPI representatives, 7 PPI co-ordinators (attached to six of
the case studies) and 10 funders/network representatives] were recruited for interview. The researchers
and PPI representatives from the case studies were interviewed a number of times over the course of
the study while the funders/network were interviewed only once; this gave a total of 206 interviews
comprising 119 initial interviews with researchers and PPI representatives and 77 tracking interviews.
The vast majority were conducted over the telephone. In accordance with participants’ preferences and
geographical proximity/convenience, 17 of these interviews were conducted face to face (by JK).
The majority of researchers interviewed were female, although the sexes of the CIs were evenly split.
Three-fifths of the CIs were over 50 years old whereas three-fifths of the other researchers were under
50 years. The majority (three-quarters) of PPI representatives were female and almost a quarter were
over 65 years old.
In addition, approximately half (46%) of those PPI respondents who provided information had at least a
degree and just under half of the PPI representatives interviewed were employed, full time or part time.
Of those not employed, many were doing voluntary work.
The 22 case studies had a range of funders, including NIHR (Research for Patient Benefit, Health
Technology Assessment, Efficacy and Mechanism Evaluation, Programme Grants for Applied Research),
Collaboration for Leadership in Applied Health Research and Care (CLAHRC), charities and research
councils. Eight representatives (both professional and lay) from various funding agencies were interviewed
towards the end of the data collection period to explore the funding body’s perspective on PPI, including
how this shaped the study context.
Overview of the analytic approach
Semistructured interview schedules for this study were informed by NPT, as was the initial coding frame,
but, in line with guidance given regarding coding data using NPT, this did not preclude us from exploring
other avenues in the data or limit our thinking.
If you are doing some form of coding via NPT constructs and components, you always need a code
that is ‘other’, as in, issues and topics that do not clearly fit within the NPT.151
Inductive codes were also developed.
Thematic content analysis was used first to identify key themes and common experiences as site specific
and then to make cross-case comparisons. This established how different contexts (e.g. topic area, type of
research and setting) affected processes (e.g. training and support), mechanisms (e.g. relationships and
communication) and outcomes of PPI (e.g. evidence of changes, responsiveness to PPI input and impact on
dissemination). Research team data analysis meetings provided a productive environment for generating
themes, collective sense-making and enriched understanding through all stages of the study.
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Utilising a similar approach to those of Schierhout et al.152 and Rycroft-Malone et al.,153 the analysis
involved the following steps:
1. A subset sample of initial interview transcripts of interviews with both researchers and PPI representatives
as conducted by various team members were coded independently (manually) by team members
(PW, EM, JK, MC and DM). This was done both deductively, using an initial adapted version of the
16 NPT components, and inductively, capturing unforeseen themes which emerged within the data
relating to our research questions.154
2. A meeting was then held to discuss the coding of each sample interview, to address inconsistencies
in the application of the coding categories and to refine collective understanding of them
(increasing inter-rater reliability). We added several subcategories; for example, under the category ‘7.
legitimation – participants do/do not buy in to the intervention (PPI)’ we added the subcodes ‘a) keen to
do the research’ and ‘b) keen to do PPI’ to reflect distinctions within the accounts given by participants.
We also further adapted the NPT coding frame to distinguish between where participants were
discussing potential (hypothetical) and actual outcomes of PPI within case studies. In addition, given
that NPT is an action theory, we ensured that coding categories captured where participants were
reported not to have something as well as where they did have it, and that such instances were not
labelled based on judgements or assumptions. Indeed, minor revisions were made throughout (e.g. the
addition of inductive codes such as ‘background to project’).
3. All data relating to the identified categories were highlighted within the first round of interview transcripts
and documents collated for each case study, using NVivo 9 (QSR International, Warrington, UK).
4. Data generated through interview were triangulated (including with study documents) to corroborate,
elaborate, contradict or complement other data,155 in order to interpret PPI processes.
5. An initial summary of the NPT analysis and a RE were then written for each case study and shared
within the team to check consistency in usage of the coding categories.
6. The Economic and Social Research Council-funded web-based NPT toolkit was then used151 to develop
radar plots for each case study. These plots provided a temporal snapshot: a visual representation of the
embeddedness of PPI within a case study within the four constructs and 16 domains. It must be noted
that the expression of embeddedness is, of course, a function of the PPI design on different projects:
the fuller the radar plots, the more fully embedded the PPI. Spikier plots illustrate internal variance in
the degree of embeddedness (Figure 6).







































FIGURE 6 Levels of PPI embeddedness illustrated through NPT radar plots.
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Radar plots supported our understanding of changes within case studies over time and ongoing
comparison between them. Both the RE summaries and radar plots acted as aides-memoires for the
research team throughout the research and also helped to maintain the specificity and wholeness of each
case study. Summaries were updated and radar plots were re-evaluated at 18 months or the end of that
study to capture/reflect any changes in PPI processes.
1. We repeatedly read, viewed and discussed and compared data from each case study at regular team
meetings to develop our analysis and to identify emerging features of CMO across case studies.
2. We then tested CMO configurations across the data set as a whole, accepting, rejecting or refining
CMO configurations through discussion.
3. Context, mechanism and outcome configurations were further refined through discussions with case
study respondents, the reference groups and the RAPPORT advisory group, and four regional events
conducted at the end of the study (see Appendix 5).
The steps above were initially undertaken in the order shown, although most were returned to repeatedly
and iteratively.
A finalised NPT coding frame was devised and subcodes were added to the NPT constructs outlined earlier,
and further inductive codes (such as PPI model description and personal narrative) were added. Analysis
was informed by the research questions and RE, with methodological triangulation occurring during
analysis and interpretation of results.156
Quality assurance during the analytic phase
To make the analytic phase both transparent and rigorous, to increase the validity and reliability of our
findings, transcripts were shared and coding was frequently and rigorously discussed and amended
as analysis proceeded, maintaining reflexivity. This system of checking and critiquing the analysis was
not merely to promote consensus but was a way of more deeply interrogating the data and exploring
alternative explanations.157 The co-researchers on the core research team were actively involved throughout
the analysis and emerging findings/analysis discussed with an advisory group, which included PPI
representatives, and with an IDDs reference group.
Research data management
Project-specific secure drives were set up at both the University of Hertfordshire and the University of East
Anglia; only the research team had access to them. Both drives were backed up centrally each day. All
interview data recorded on digital devices were uploaded onto university secure servers as soon as possible
after interviews and deleted from devices. A file-labelling system was developed to ensure good housekeeping
of data. Digital audio recordings for transcription were sent securely between the transcription agency and the
research team. Upon receipt, transcripts were checked for accuracy and anonymised to protect the identities
of the participating studies (personnel and place names, for example, were changed/removed).
Dissemination
Four regional dissemination events were held towards the end of the study. RAPPORT participants, local
PPI and research groups attended (see Appendix 5). Our provisional findings were presented, and
facilitated small group discussions were used as a means to confirm or refine CMO configurations.
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Presentation of data in subsequent chapters
The findings chapters, Chapters 5 and 6, draw extensively upon statistics and illustrative examples from the
data collected and analysed in order to describe six CMO configurations. In Chapter 7 we develop our
analysis further to generate insights regarding the current embeddedness of PPI in health research in
England. Excerpts from interview transcripts are included to bring findings alive and boxes are used to
present case studies exemplifying each CMO configuration. Data from all 22 case studies are presented in
the findings chapters. We have honoured our duty to respect confidentiality and protect research case
studies by avoiding presenting too much data, which could be overly revealing. In Chapters 5 and 6,
participants’ words are presented within embedded extracts or within speech marks within the text and
speakers are broadly identified as funders or research network PPI co-ordinators, or by case study (CS)
number and as being either paid academics on the research (Res) or PPI representatives (PPI). If there was
more than one interview with a participant, interview number follows the participant code.
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Chapter 4 Patient and public involvement in the
RAPPORT study
As the RAPPORT study is a research project investigating PPI in contemporary health research inEngland, in this short chapter we begin by detailing the approach to PPI within the project itself, and
then present an analysis of some of the reflections upon the experiences and processes of PPI.
This chapter was first drafted by one co-researcher and then expanded and elaborated with evidence by
the research team, with comments from lay co-researchers and representatives.
Background to the project
The University of Hertfordshire had an existing PPI group: the University of Hertfordshire Public Involvement
in Research Group (PIRG, established in 2005), with which the proposal to the Health Services and
Delivery Research (HSDR) programme/INVOLVE was originally developed. The application included two
coapplicants from PIRG, to be funded as co-researchers if successful. Additional expertise was added to
the research team from coapplicants from the University of East Anglia. Lay representatives on the
project advisory group were subsequently recruited from the Norfolk and Suffolk Patient and Public
Involvement in Research (PPIRes) panel (established 2003), and the main support for this input linked with
the University of East Anglia team. AH’s work with the Royal College of General Practitioners (RCGP)
also allowed recruitment of a lay representative with a national overview of PPI in clinical settings (Chuter,
then Chair of the RCGP Patient Partnership Group). The co-researchers, as members of the research
team, attended the advisory group, but their roles were different: they were ‘embedded’ in the research
project, where other lay contributors had episodic input. Finally, there were lay people linked with each
research topic area as a reference point for the conditions under scrutiny. The study team aimed for a
mixture of different PPI representatives: those who had worked together before (co-researchers from
PIRG) and those who had not worked together before (PPIRes and the University of Hertfordshire); and
experienced (> 10 years) PPI representatives and reference groups who had not worked with researchers
before. It was one co-researcher’s first research project.
Patient and public involvement design
Coapplicants
Two members of the University of Hertfordshire PIRG were coapplicants on the RAPPORT study.
Co-researchers
There were three co-researchers: the two coapplicants plus a mother of a child with CF. These three were
involved throughout the study, but were particularly involved in case study data collection (interviewing)
and analysis. The two lay coapplicants were members of the research team (out of a total of 11 members),
which met every 3–4 months. Team meetings were held face to face every 6 months, with a teleconference
in between. The research team commented on all study documents, findings and publications.
Reference groups and representation
The project had reference links who were consulted during the progress of the study to add insight on PPI
in each topic area. Some links were via the research team itself: one co-researcher had a child with CF,
one had diabetes, one had arthritis, and two had cared for a family member with dementia and had been
on other studies involved with dementia. Where links did not exist, reference groups were set up: an IDD
group and a CF group of young people. The IDD reference group met face to face during the project to
facilitate communication (including Easy Read materials); the CF reference group ran on a virtual basis.
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Project advisory group
The project advisory group (a total of 22 members) met in person every 6 months and was well attended
by the five lay representatives and the lay chair. The lay representatives consisted of two members from
PPIRes, the two co-researchers from the University of Hertfordshire PIRG and one lay representative
from the RCGP. In addition, the advisory panel included representatives linked to reference panels and lay
groups: the Learning Disabilities Research and Development Manager (NHS North Essex) and the National
Cancer Research Network Consumer Involvement Lead, who was later replaced by the Mental Health
Research Network PPI Lead.
As for all advisory group members, PPI representatives reviewed all documentation concerning the
research, and commented on emergent findings and study progress; meetings were minuted in detail
so PPI contributions were included. The topic of PPI in the RAPPORT study was also an additional standing
agenda item at each meeting, to ensure that feedback was welcomed and queries or concerns raised
openly; this added to the reflective material utilised to assess impact within the study itself.
Patient and public involvement activities
Research design
Four members of the University of Hertfordshire PIRG submitted initial ideas for the research proposal;
their contribution actively shaped and informed the proposal design. From the beginning, two research
team/PIRG members actively contributed to the development of the full proposal, which was also discussed
at regular PIRG meetings.
Data collection and data analysis
Three co-researchers were heavily involved in stage 3: case studies. The agreed main purpose of their
input was to enable engagement with those playing PPI roles in some of the case studies: a peer-to-peer
interview, as used in previous studies.88–90 This was expected to add value to the study by allowing
themes to emerge that were different from or additional to those captured by other means, even though
the co-researchers were also involved in reflective analysis of the whole data set, not just their
own interviews.
In recognition of the co-researchers’ needs, the whole research team developed a training session on
interview techniques and the use of digital recorders, and co-researchers also helped develop the interview
schedules. The peer interviews (with PPI representatives on case studies) were allocated according to
interest, availability and background, sampling a total of eight case studies. Co-researchers were supported in
carrying out the telephone interviews (the majority of interviews were by phone), either at the University of
Hertfordshire or in the co-researchers’ homes, and carried out a total of 14 first interviews and three tracking
interviews. The numbers of peer interviews were lower than originally planned because of difficulties in
finding mutually convenient times for co-researchers and respondents. In reality, co-researchers had less
availability and flexibility to accommodate interviews that other members of the research team.
Once the interviews were transcribed, 11 data analysis sessions (including training) were held with the
researchers and the co-researchers (either individually or as a team). Only one further data analysis meeting
was held without the co-researchers when they were unable to attend. The initial meetings were used to
agree on coding structures and the use of NPT and to compare individually coded transcripts. Subsequently,
data analysis meetings tested out the CMO configurations within and across the various case studies.
PPI co-researchers also individually coded interview transcripts.
PATIENT AND PUBLIC INVOLVEMENT IN THE RAPPORT STUDY




The co-researchers copresented findings at four conferences and meetings while the project progressed.
They were also fully involved in the RAPPORT national dissemination events, where the CI gave a formal
presentation and the intention was to have a lay copresenter on each occasion. However, health needs of
co-researchers prevented this from happening. One co-researcher attended two of the four dissemination
events, and the two PPI representatives on the advisory group attended their local dissemination event.
In addition to the roadshows, we have disseminated at key conferences including INVOLVE and the Higher
Education Academy PPI seminar series, where both co-researchers presented and one made a podcast.
Papers
Two PPI coauthors contributed to a scoping and survey paper published in the International Journal of
Consumer Studies (January 2014).158 One co-researcher also submitted a piece on RAPPORT to Balance
(Diabetes UK’s patient magazine) in August 2013; it was published in May/June 2014. Further publications
with PPI input are expected. The overall general findings of the RAPPORT study will be available in Easy
Read format once the report has been agreed.
Data sources for the analysis of patient and public involvement
in the RAPPORT study
The following have been used to review the PPI input to the RAPPORT study:
l documentation on the development of the original proposal (already submitted to INVOLVE as
‘Short report prepared for INVOLVE on public involvement in the development of a research proposal’,
November 2010)
l team minutes and field notes – these include audio recordings of discussions with the co-researchers,
and researcher personal diaries (voluntary and self-held, but used for recall)
l reference group discussions and notes of meetings
l formal research team and advisory group minutes
l all study documentation
l records of interview schedule development, interviews, coding and analysis
l formal ‘end of project’ reflective meetings, including individual notes from co-researchers, and two
meetings held to reflect on the PPI process in the RAPPORT study, one with the research team and one
with the advisory group.
Some quotes are shown here as evidence of different impacts in different phases.
Impacts of patient and public involvement in the
RAPPORT study
Two co-researchers made some overall comments about the study:
None of this [PPI] has been tokenistic and lay contributors were treated as colleagues making
contributions of equal value to that of the researchers throughout. Our comments and suggestions
have been discussed and acted on where it was agreed they were appropriate. This has been
made possible by ensuring we saw all relevant paperwork and were kept informed of issues as they
arose and about progress as it took place.
Co-researcher01, 21 December 2014
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I enjoyed everything about collaborating in the study but particularly participating in all the team and
advisory meetings, the discussion on methodological issues and theoretical approaches. I appreciated
being involved in all aspects and felt thoroughly involved and appreciated.
Co-researcher02, 15 January 2014
There were also reflections about specific stages of the research process.
Study development and protocol
Two quotes from the report of 2010 show that there was lay involvement as soon as the funding call
came out and in developing the proposal:
Details of the call [for funding] were circulated to the PIRG for comment and initial ideas; four
members responded. Responses were fed into the pool of initial ideas about the proposal. Ideas were
fed back to the PIRG as they developed and after two weeks of on-line discussion PIRG members
were asked what level of continuing activity they would like to undertake in the proposal
development. Two members volunteered as co-applicants, the other two wished to contribute
informally to the development. Additionally, the developing proposal was presented at the regular
PIRG meetings to enable the whole group to have an input.
Early drafts of the outline proposal were circulated to the 2 PIRG members as part of the co-applicant
team. They actively contributed to the development of the outline proposal by:
1. Emphasising service user experience (a term they preferred rather than expertise)
2. The importance of PIR benefiting the general public, not just the actual research.
3. Editing drafts and improving presentation.
Data collection
Interviews carried out by PPI representatives (peer interviews) had some additional perceived benefits.
PPI members often had more knowledge about a particular health condition than the researcher and could
better relate to the interviewees:
I felt her [PPI’s] warm personality and humour shone through, and this made it very easy to build up a
rapport with her quickly, and therefore make more effort to contribute. There was careful and gentle
questioning, never intrusive, and she encouraged me carefully to think of other things I might have
missed. Throughout the interviews I have had with her, I felt I was a real person and not an object
of research.
RAPPORT PPI respondent CS17PPI01, e-mail exchange with respondent
[I had a] lot in common with her . . . think the connection we made was important, both had daughter
with [health condition] . . . it felt more like you were having a chat as opposed to doing an interview.
Co-researcher03, 26 November 2012
The relationship between co-researcher and respondent also developed with time:
Yes, you know, it was like . . . she was asking about my daughter, I told her she might be going to
hospital, she asked how was she and she said you have my number if you want to call me.
Co-researcher03, 26 November 2012
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However, this benefit of peer interviewing was not considered to have the same impact across data
collection. Not all experiences are shared: ‘I’m not sure user involvement made much difference in this
interview as she was only [in her twenties] and not closely related to my experience’ (Co-researcher03,
18 October 2012).
One of the researchers commented that ‘re-designing the interview schedule so that it was more informal
and chatty, involving people with real experience in talking to PPI reps in similar positions, helped make
interviews more relaxed, open and reciprocal’ (reflections July 2014) (Box 4).
Data analysis
The RAPPORT team, including the co-researchers, used NPT as the candidate programme theory and also
used it to shape the interview schedule and data analysis. One co-researcher found framing data analysis
through NPT constructs ‘intellectually stimulating’ (Co-researcher02), while another found using interpretive
approaches more generally (and NPT’s abstractions in particular) to be very challenging. This co-researcher
devised her own set of inductive codes and analysed the transcripts using her own coding system. The use
of this separate coding process added to the rigour and validity of data analysis as similar themes emerged:
I also think that having co-researchers independently coding transcripts added rigour to the
process – I remember concerns from the 3 core researchers about whether there was data forcing
into the NPT constructs. [X] went off, did free inductive coding and when we compared the same
findings emerged – quite a relief!
Research team member reflections July 2014
Impact of patient and public involvement on representatives
As found within the RAPPORT study, the co-researchers gained personally from carrying out the research:
stimulating to get me back to using my brain a bit more and think about research.
Co-researcher03, 27 April 2012
However, this did not apply to the same extent to those who were not co-researchers:
I found this quite difficult to do, as I want to do more than you are asking me to do all the while.
Lay advisory group member, reflective meeting, 15 January 2014
Discussion of emergent findings
Patient and public involvement representatives on the research and advisory teams continually reminded
the researchers of what is important, such as the current debate around PPI and professionalisation.
The research team was able to test out the findings from the survey/scoping and case studies with PPI
representatives as stakeholders who are aware of the current climate of PPI.
BOX 4 Documentary analysis
Original interview schedule first question: can you tell me how long you have been involved in research?
How did your involvement come about?
Revised interview schedule first question: first we want to explore what do you understand by the
term patient and public involvement in research? (sometimes called service user involvement/patient
representation – other terms)
Before you were involved in xxx study what did PPI mean to you?
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Enablers and challenges for patient and public involvement
within the RAPPORT study
These were examined using the four NPT constructs:
Coherence
Roles and expectations of PPI representatives. The original project’s assumptions about the different roles,
expectations and capacities of the various PPI representatives within the RAPPORT study needed revisiting
over time: ‘Being on an advisory group I found quite limiting’. After a discussion at the end of a project
meeting about whether or not being a PPI member of an advisory group was superfluous, it was then
acknowledged that ‘they have a real role of accountability and PPI need to play a part in that’. There was
also positive feedback about the improvements over time: ‘advisory groups have a bad reputation in PPI as
having been tokenistic, this project did not feel like that’ (all three comments from the advisory group
reflective meeting, 15 January 2014).
One co-researcher (Co-researcher02) was ‘disappointed’ that she was not able to do more interviews and
had expectations of doing more than the research team were able to organise. However, she acknowledged
this was also because of her own problems with availability of dates and different topic areas. She also felt
she had ‘let the team down by not keeping to deadline’ (this was not seen as a problem by the research
team). This co-researcher also reflected on the ‘difficulty of keeping sometimes, a lay role and not getting
carried away with all the theoretical and methodological aspects . . . and a recognition of my own bias’. This
comment resonates with the debate about ‘professionalisation’ of lay participants, and perhaps shows that
there will not be one long-lasting ‘coherent’ view of PPI – rather a need for renegotiation and flexibility.
Participation
There was feedback that having support for personal and practical queries improved inclusiveness and
contribution. Having a local person to co-ordinate PPI travel, expenses and other practical matters
was found to be very important, as was accommodating preferences for written/hard copy materials
rather than electronic communications:
paying attendance makes me feel valued, my time feel valued and respected, it is a big thing for me,
not just paying me enough for the day, they are paying me, respecting me and my time.
Lay representative, advisory group reflective meeting, 15 January 2014
Collective action
Relationships. Replicating the findings from the RAPPORT study, the importance of relationships emerged
as central in this study. Two of the co-researchers had a history of working with the CI and the team
based at the University of Hertfordshire: there was prior shared understanding and trust, and this
developed during the time of the project. The two PPIRes members on the advisory group already had
relationships with coapplicants at the University of East Anglia but not with the University of Hertfordshire
or other research team members, and new relationships across institutions developed over time. All
advisory meetings started with lunch, allowing time to socialise. With hindsight, it was acknowledged that
more time for the RAPPORT team to meet informally would have been beneficial, but lengthy journeys and
budget constraints would have made this difficult. One co-researcher commented on:
the challenge of keeping everyone in PPI in ‘the loop’ being a task – with our other PPI colleagues
being at a distance, but there was continued involvement and commitment to keeping all in touch
and involved.
Co-researcher02,15 January 2014
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Relationships had to develop with new members of the advisory group and with the reference groups, and
these took time to establish. Explicit emphasis on this might have increased input and facilitated early
project processes:
Usually I am approaching people to be on the advisory group that I have already have some relationship
with or worked with before . . . it was quite different to have people recommended that I had not met
in depth before, I think I had been quite naive before . . . if you haven’t got that relationship . . .
Team researcher reflections, 15 January 2014
Flexible provision for access. Respect for and accommodation of PPI representatives’ different skill mixes
and requirements was an issue. For example, two of the co-researchers had different qualitative data
analysis skills, two of the PPI representatives did not use computers and preferred to receive and annotate
paper copies and one PPI representative on the advisory group asked for contact to be made by text.
Health/illness. Over a 2.5-year study, illness has meant that at times it was difficult for some PPI
representatives to travel long distances or into London and be as involved in the RAPPORT study as they
would have liked. Not all activities could be undertaken as expected, and the team worked around to find
solutions. Every effort was made to be inclusive, by holding meetings locally wherever possible, organising
convenient parking at the university, providing lifts, accompanying representatives on public transport,
paying for taxis and so on.
Reflexive monitoring
Both lay advisory group representatives and research team members were encouraged to record formative
reflections upon PPI and were provided with prompt questions and notebooks. However, as the study
progressed, this proved difficult to maintain, with lay representatives reporting they did not do it immediately
and then forgot to do it, so opportunities were instead created to prompt and audio-record reflections
informally as conversations before or after certain meetings throughout the study. Two of the co-researchers,
however, did provide the paper records of their formative thoughts at the end of the project.
A more formal summative reflective session on PPI in the RAPPORT study was conducted to capture the
impact of PPI within the study. Two face-to-face meetings were held towards the end of the project: the
first was with members of the research team (facilitated by two external facilitators) and a second for
members of the advisory group. Each session was recorded and summary notes produced. An ‘ALPS’
[Amander’s Levels of Patient and Public Involvement Significance, a reflective tool developed by A.
Wellings, a lay member of the advisory group, and reproduced with permission (Amander Wellings, PPIRes
panel, 2014, personal communication)] was sent to all members before the reflective session and provided
a stimulus for this discussion (see Appendix 6).
Summary
Overall, PPI has had a demonstrable impact on the RAPPORT study at all stages of the research cycle,
particularly during the case study stage. As one PPI representative wrote, ‘there has been a large amount of
public involvement across a range of roles within RAPPORT from its conception to its finish’ (Co-researcher01,
21 December 2014) – ‘Validating what themes are important, being there as a critical friend throughout
the project’ (reflections on report July 2014). The key findings reflect those of the study itself: that both
embedded PPI and periodic inputs can be valuable in different ways; and that relationships are key to making
people feel included, getting their fullest contributions and solving practical problems. Clarity about different
roles is important when there is more than one type of input from lay people into a project, and sufficient
flexibility is needed for people whose other work or health may not allow predictable inputs. A strong
emphasis on dialogue and feedback may assist both developing relationships and a sense of mutual respect
and engagement, and allow concerns to be aired early. Previous experiences of PPI work may colour ongoing
expectations, and may be worth exploring early on.
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Chapter 5 Findings from scoping and survey
The scoping and survey had three main purposes. First, to provide some sense of the current landscapeof PPI in terms of extent and types of models used. Second, to do some initial testing on enabling
contexts for the embedding of PPI. We hypothesised that there were five important enabling contexts for
PPI: funder requirements; topic area and design; resources; organisation of PPI; and the host organisation.
Third, the results of the scoping and survey were used to further develop our sampling frame for the case
studies, and to sharpen our questions and testing within them.
This chapter will present the main findings from the scoping and survey, drawing out implications for our
hypotheses and the enablers and barriers for the candidate programme theory: NPT (see Chapter 3).
The chapter commences with a summary of the key findings.
Summary of key findings
The scoping illustrated that there is a limited amount of publicly accessible information about PPI within
research documentation and most of the information we obtained was through e-mailed requests to the
study teams (see Chapter 3). Within the scoping we were unable to find evidence of any PPI in nearly half
of the studies. Although within the normal parameters of an electronic survey,158 the disappointing
response rate of 28% means that the results from the survey must be treated with caution (see Chapter 8,
Reflections on and limitations of the research).
In both the scoping and survey it was clear that some respondents did not distinguish between
involvement and study participation. There was also evidence of a dual role: study participants also acting
as advisors either concurrently with being a participant, or sequentially.
There were differences in how PPI was approached by research topic; IDD had evidence of PPI in the
highest percentage of studies. Basic science or tissue bank design studies appeared to have a limited role
for PPI, although there were examples in the survey where these designs had PPI present.
From the survey we found that nearly half of PPI representatives were already known to the study team
when it invited them to be lay advisers. Paradoxically, open-text responses in the survey emphasised the
challenge of representativeness.
Survey respondents suggested that PPI impact is greatest in the early stages of research, although there
were examples given of impact throughout the research process. With some noteworthy exceptions,
there was sparse evidence of systematic evaluation of PPI within studies.
Studies without patient and public involvement
Within the scoping we were unable to find evidence of PPI in 49% of studies. This does not necessarily
mean there was no PPI; rather, it may be indicative of the lack of accessible PPI-specific evidence.
For example, protocols obtained directly from research teams confirmed that there was little space or official
requirement to record PPI, with only one-third of protocols including any PPI information. Some respondents
explained that other forms, such as funding applications and IRAS forms, had more detail of PPI:
We are happy to share our information on PPI. As the protocol does not reflect the level of PPI
involvement in the design and conduct of the study I have highlighted fields from our original NIHR
RfPB [Research for Patient Benefit] application form which reflect our level of PPI – see below.
Scoping: arthritis: clinical trial: identification code (ID) 49
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Survey respondents were more likely than scoping respondents to report PPI within their study (79%),
but 17% reported they did not have PPI, and for a further 4% (n= 4) it was unclear whether or not
what was being described was PPI. In a short survey focused on gaining descriptive detail on the current
extent of PPI, it was not possible to identify any specific rationale for not having PPI within a study
(see Chapter 3). Although three out of seven tissue bank studies did not have PPI, studies with a basic
science or tissue bank design did provide evidence of embedded PPI. Study design alone was not a
predictor of engagement with PPI. However, there were some differences in how PPI was approached
by research topic and study design.
Differences in the reported presence of patient and
public involvement
Numbers of studies in some topic areas were very small (e.g. CF). In both the scoping and the survey,
IDD studies, compared with the other topic areas, had the highest percentage of studies with evidence of the
presence of PPI (scoping 91%; survey 100%) (Table 9). Second highest were arthritis (60%) in the scoping
and dementia in the survey (87%). However, in the survey there was an overall trend for much higher
levels of PPI across all topic areas than in the scoping.
Using the IRAS definitions of study design (which were collapsed into four categories plus ‘other’), studies
with mixed-methods designs (i.e. qualitative and quantitative) had the highest incidence of PPI (61% of
scoping studies with this design had PPI; survey 91%), followed by clinical trials (scoping 56%; survey
81%). Both of them had higher levels of PPI than basic science (scoping 21%, survey 67%), tissue bank
(scoping 33%, survey 43%) and other (observational studies and ‘cohort’) (scoping 0%, survey 71%).
Basic science or tissue bank design studies appear to have a limited role for PPI.
TABLE 9 Lay involvement in research studies by topic area and study design
Design
Topic area (n)




Clinical trial 1 8 19 7 2 6 43
Basic science 0 0 2 1 1 0 4
Qualitative and quantitative 1 8 9 4 6 8 36
Human tissue, data and
tissue bank
0 3 3 0 1 2 9
Other 0 0 0 0 0 0 0
Total 2 19 33 12 10 16 92
Survey studies
Clinical trial 0 11 5 6 3 9 34
Basic science 0 4 1 3 0 0 8
Qualitative and quantitative 0 6 3 15 2 4 30
Human tissue, data and
tissue bank
0 0 1 2 0 0 3
Other 0 1 1 1 0 2 5
Total 0 22 11 27 5 15 80
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However, the survey findings for the three topic areas of arthritis, dementia and public health showed
examples of all four types of study design, and in these topic areas even basic science and tissue bank
studies included some PPI elements. Written answers seemed to link this to the recognised need to build
and sustain good relationships with patient groups in order to identify priorities and gain the research
materials they needed:
all our work has been carried out in partnership with the families . . . often helps to focus what
patients with a condition find most urgent to improve.
Survey: diabetes mellitus: basic science study: ID05
In this project probably all stages, from literature aimed at recruiting potential brain donors to lay
people on the committee that gives ethical approval to researchers requesting tissue from the bank.
We also invite a potential donor/carer to speak about brain donation from a personal perspective at
our Ethics Training Days and this is always very highly rated by people contributing to brain donation,
especially those without participant contact, such as mortuary services and neuropath lab staff.
Survey: dementia: tissue bank research: ID54
Relational work is a key element of the collective action construct within NPT and, as illustrated above, was
perhaps even more important to focus on in research designs such as basic science, where there was an
inevitable distance between researcher and end beneficiary of the study. This NPT construct proved important
in our case studies (see Chapter 6). Furthermore, the survey showed that 50% of PPI representatives involved
in research projects were patients or service users known to the researcher/clinician and that very few were
recruited via their local NHS comprehensive local research network or RDS. PPI representatives were also
recruited via voluntary organisations (40%) or from an established service user group (35%), and a quarter
(25%) of survey respondents reported that their PPI representatives had replied to an open invitation
(respondents could choose more than one option).
Organisation and resources for patient and public involvement
Survey results indicated that 29% of studies had 21 or more individual patient or public representatives
involved. However, the PPI information in the scoping documents/e-mails was very limited and it was
difficult to access who the PPI members were, how many there were and how they had been recruited.
It was therefore not possible to make an accurate assessment about PPI models. Just over a one-third gave
any information about PPI recruitment and only around one-quarter of the studies gave any information
about the number of PPI representatives.
To elicit any embedded PPI organisation, the survey respondents with PPI in their studies were asked if
working with regional/local public involvement groups had altered their practice when writing proposals.
Seventy-nine per cent of researcher respondents said they knew of a local or regional and public group
that had supported research. Sixty-three per cent had used such a group and 36% said that this
group had altered their practice when writing the proposal. The main way in which the researchers said
they had altered their practice had been by consulting PPI at proposal writing stage to ‘define research
questions’ and making objectives ‘more realistic’ and ‘patient-orientated’.
The survey provided information on what roles and activities lay representatives were undertaking. The most
frequently represented PPI activities were being on an advisory/steering committee (65% in the scoping study)
and patient information leaflet development (73% in the survey). Low levels of involvement were reported
in data analysis, data collection and report writing in either the scoping study or the survey (Table 10).
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The possible activities were then totalled into a score and the survey revealed that IDD had the highest
median level of activities, followed by arthritis and dementia (4.0 for IDD and 3.0 for arthritis and dementia).
However, Figure 7 shows that there is little difference in the overall range of activities between each
topic area.
Topic area was therefore not predictive of the range of PPI roles within a study. However, simply knowing
ranges of roles does not provide an in-depth analysis of whether or not the roles were appropriately
allocated and supported. We found only 9% of studies from the scoping with any evidence of training,
whereas over one-quarter (28%) of studies with PPI in the survey had provided training for their PPI
members, and 43% had directly costed for training of PPI members in the grant application.
TABLE 10 Patient and public activities in research
PPI activities Scoping (%) Survey (%)
Advisory/steering committee 65 71
Development of participant information materials 35 73
Dissemination materials 16 49
Review of reports/lay summaries 8 48
Design of research methodology 62 45
Identification of research topic 17 21
Report writing 3 9
Data analysis 12 8




















































FIGURE 7 Survey: box plot of number of activities for those studies with PPI by topic (showing range of the
number of activities, 75th percentile, median and 25th percentile). a, maximum value; b, 75th percentile;
c, median; d, 25th percentile; e, minimum value. Note: the number of activities was calculated only for those
studies with PPI.
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Funder requirements
The influence of funders could also be seen in that higher levels of PPI were found in NIHR-funded studies
(scoping 75%; survey 89%) and charity-funded studies (scoping 58%; survey 78%). Researchers
acknowledged that PPI is a relatively recent expectation from funders, and for some studies the external
expectation was key to the development of PPI:
We have had no structured PPI for this study. There are a number of reasons for this: The study was
developed a while ago and there was less of an expectation for PPI.
Scoping: diabetes: mixed qualitative/quantitative: ID24
Alzheimer’s Society uses a PPI [representative] for peer review of grants and so these proposals are
written with this in mind.
Survey: dementia: basic science: ID73
Neither scoping nor survey found any relationship between sample size or geographical area and levels
of PPI. There were similar proportions of studies having PPI in the older studies (as measured by being
‘closed’ on the UKCRN portfolio) and in the open studies. However, evidence of PPI was further blurred
because of inconsistencies in how PPI was defined.
Defining patient and public involvement
Our analysis showed that various interpretations of PPI were apparent among researchers. As a reminder to
recipients, the scoping requests for information and survey highlighted the INVOLVE definition23 of PPI.
However, the survey results suggested that a minority of respondents were equating PPI with participation
in research:
Survey Question: in your opinion at what stage of the research does service user/public involvement
have the most impact?
patient completes questionnaires. Results help to understand/control disease in specific population
Survey: public health: case control study: ID81
We also found evidence in the survey and case studies that a dual role of being both participant and lay
representative was being undertaken. The four studies reporting this in the survey suggested the benefit
of this was the provision of direct feedback which could be used to improve research processes
and outcomes:
we are continually listening to the comments of our participants in relation to study material and
where possible modify accordingly. At the end of the sessions they are asked to complete a feedback
form with their comments.
Survey: public health:mixed qualitative/quantitative: ID93
Collective understanding is a distinct NPT construct and the survey highlighted this as an area to be tested
in the case studies, particularly how PPI was understood by respondents, and the extent to which the dual
role was present. A lack of coherence in understanding the purpose and positive impact of PPI could
potentially create a number of tensions.
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The challenges of patient and public involvement
Free-text responses in the survey identified challenges as recruitment, communicating the research to lay
people, extra resources needed, the potential for tokenism, bureaucracy, confidence of individuals
to participate, managing expectations of the PPI individuals and threats to long-term commitment
(such as illness). The most common theme that emerged was recruitment and how to gain access to
‘representative’ service users, mentioned by about one-third of respondents:
trying to get a representative sample and not just the usual suspects.
Survey: dementia: qualitative studies: ID50
The only challenge is in finding appropriate representatives, they need to be able to understand the
basics of the type of research that you’re doing but if they are all former academics and/or health
professionals it kind of defeats the purpose, we were fortunate to get a mixture.
Survey: dementia: mixed qualitative/quantitative: ID57
Finding suitable people to take part that are able to see the broader picture and aren’t solely focused
on their own personal issues. Cost.
Survey: arthritis: other clinical trial: ID83
These comments may suggest that some researchers feel that the PPI representatives currently volunteering for
research studies are not necessarily those they feel should be involved, are not authentically representing the
views of others or do not offer enough diversity. There was also some evidence of concern about PPI
representatives losing the service user perspective through a process of socialisation into the research world:
in some contexts, we are engaging with a cadre of service users/public that become ‘professionalised’,
that they are being repeatedly asked to speak for others.
Survey: arthritis: qualitative: ID37
In addition to recruitment issues, the next most common challenge highlighted by researchers was being
able to communicate their research (i.e. complex design) to lay people and the time (to comment and build
relationships) and resources required to make the research accessible and supportive of PPI. Researchers
were also aware of the challenge of involving the public in a meaningful and real way. The management
of expectations about what the study could deliver was mentioned by some researchers, as was reconciling
the sometimes competing priorities of researchers and PPI representatives. This is a particular issue in
research which might not bring benefits in the lifetime of the PPI representatives.
Mainly the wish of families to believe that the genetic, clinical or cell studies will provide rapid answers
and treatments.
Survey: diabetes: basic science: ID05
The research approach did appear to influence what particular aspects of PPI were highlighted by
respondents as challenging. Topic-specific issues were mentioned, with dementia studies identifying the
extra time needed for PPI and diabetes mellitus studies the need to clearly explain information about
the research. In terms of NPT, this highlights the construct of collective action where the necessary tasks
for PPI are performed; as per our hypothesis, the survey findings suggested that certain topic areas and
study designs have different influences on researchers when working with PPI representatives.
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Impact of patient and public involvement
More recently there has been a growing emphasis on making attempts to assess the impact of
PPI.19,29,31,32,159 While fairly limited in the amount of evidence this would elicit about the benefits of PPI in
research, the survey included an open question where respondents could write about at which stage they
felt PPI had the most impact. The most frequent type of answer given was ‘the design stage/at the
beginning/as early as possible’. Studies which were clinical trials had the highest proportion of respondents
naming PPI as having the most impact at the design stage. The next most frequent was ‘at every stage’,
and mixed methods had a higher proportion of respondents naming PPI as having the most impact at
all stages:
Think there is an impact at many different stages of the process, all of which have equal rating
in terms of importance: Design – improves the potential uptake to a trial as the impact has
been evaluated prior to recruitment commencing and what would be an acceptable level of
intervention/participation. Review of supporting documents improves clarity for patients and reduces
the requirement to alter the documents when they are reviewed by ethics committees – these aspects
improve the timescales of studies being given ethical approval and reduce the time delay before study
recruitment begins. On-going evaluation – this can be a very useful component if there is difficulty
recruiting to a study. Dissemination – this can be very useful to ensure that the correct members of
the public are informed of the results of the study to ensure that the results are getting back to the
relevant patient population.
Survey: dementia: other clinical trial: ID75
Beyond describing where PPI potentially has the most impact in research, we also found some limited
evidence of a systematic approach to evaluating PPI impact within research.
Systematic evaluation of patient and public involvement
Although we were provided with very few examples, documents submitted as part of the scoping exercise
did provide some evidence of thinking around systematically evaluating PPI:
The proposed trial provides an opportunity to develop user research capacity for future trials and the
opportunity for user voices to develop recommendations and tools to support clinical practice. It is
imperative to evaluate involvement in this trial from a multi-stakeholder (members of the project team
and the user advisory group) perspective. This will inform the design of future studies with significant
user involvement. A focus group consisting of all the stakeholders will be conducted at the end of the
project. An independent user researcher will facilitate this, as well as undertaking the analysis. Lessons
learned and future recommendations will be disseminated widely.
Scoping: public health: clinical trial: ID151
Reflexive monitoring in order to evaluate PPI systematically and, in the light of this appraisal, reconfigure
work in the future is the fourth major construct within NPT:
Another change we would make would be to encourage three user group members (rather than two)
to join the project management group. This would help to promote better continuity, as well as
provide additional support for users, for example on the occasions when one person was unable
to attend.
Scoping: public health: mixed qualitative/quantitative: ID160
However, there was relatively sparse evidence of systematic evaluation happening overall. This finding was
replicated in the case studies (see Chapter 6).
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Conclusion
An unexpected finding was the invisibility of publicly accessible information on PPI in research studies.
This lack of information has implications for transparency, evaluability and accountability (see Chapter 7).
We had hypothesised that topic area, study design and funder requirements would be significant influences
on the embedding of NPT. The findings from the scoping and survey suggest that funder requirements and
study design appear to be the biggest influences on the extent of PPI within a study. We also expected that
resources would also be an enabler of PPI and yet fewer than half of the survey studies had actually costed
for PPI in their proposals.
The scoping and survey did not provide enough information to give a clear sense of the organisation or
models of PPI, or what part the host organisation was playing in embedding PPI. However, in applying the
NPT framework to the findings there were indications of barriers to embedding PPI.
Coherence
A surprising finding was the existence of a dual role. It was not clear whether this role was deliberately
created or was due to a lack of understanding in the difference between participation and involvement.
Cognitive participation
Enthusiasm or buy-in to PPI was often evident in the free-text responses; however, the extent of this buy-in
must be questioned when 17% of studies from the survey reported having no PPI.
Collective action
It was also surprising that the relational work to embed PPI was so prominent. For basic science and tissue
banks reporting PPI, this work appeared particularly important in an area of research where PPI was less
commonly found. The necessary tasks for PPI did appear to have some slight differences in topic areas,
but the scoping and survey were unable to capture these nuances in detail.
Reflexive monitoring
Free-text responses clearly highlighted some positive appraisal of PPI. While there was some evidence of
systematic evaluation, overall evidence for this was sparse.
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Chapter 6 Findings from the case studies
In this chapter we present the findings from the 22 case studies. We provide a rationale for why NPT wasfound to be the most comprehensive and predictive programme theory for PPI and present the 16 NPT
informed mechanisms that were tested within the case studies. We then summarise the key findings and
list the contexts that enabled mechanisms. CMO tables are provided, illustrating salient actions within
the case studies, potential contexts, plausible mechanisms and potential outcomes. Organised under the
major case study actions, data are presented to illustrate how the CMO tables were arrived at. We draw
on specific case studies, including their NPT radar plots, to provide illustrative exemplars. The chapter
concludes with evidence of PPI impact and outcomes.
Normalisation Process Theory as the candidate programme
theory being tested
Our testing within case studies was framed by the 16 NPT mechanisms grouped under the four headings
(see Chapter 3) and presented in Table 11. When applied to the 22 case studies, NPT121,134 had sufficient
explanatory power to predict which case studies had PPI embedded as normal practice; therefore, it
predicted both policy outcomes and the processes and infrastructure required for effective PPI that had
positive outcomes both methodologically and morally. Using NPT as a MRT developed out of health service
research, we directly interpreted PPI as the complex intervention, which then shaped our data collection
tools and analytical framework (see Chapter 3).
TABLE 11 Mechanisms to embed PPI
Number Mechanism
Coherence (sense-making)
M1 Understanding PPI as a different way of working in research
M2 Collective agreement about the purpose of PPI
M3 Individuals understand what PPI requires of them
M4 Individuals construct the potential value of PPI for their work
Cognitive participation
M5 There is a key individual driving PPI forward
M6 There is individual agreement that PPI should be part of their work
M7 Researchers and lay people ‘buy in’ to PPI
M8 There is continued support for PPI
Collective action
M9 The necessary tasks for PPI are performed
M10 Trust in each other’s PPI work and expertise is maintained
M11 Allocation of PPI work to individuals is appropriate
M12 Appropriate support for PPI is provided by the host organisation
Reflexive monitoring
M13 Information about the impact and outcomes of PPI is systematically assessed
M14 PPI is collectively appraised as being worthwhile
M15 PPI is individually appraised as being worthwhile
M16 PPI approaches and work are changed in response to the appraisal
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Summary of key findings
This is one of the first studies to contribute significantly to our understanding of PPI as a concept, through
the analysis of a large number of case studies, selected to capture varying levels of PPI embeddedness,
in order to understand how it may change over time during the research process.
In testing whether or not topic area had an influence on the embedding of PPI, we found similarity
between the nature of the clinician–patient relationship and the way PPI was enacted. This was further
influenced by the topic area’s history of PPI and the tacit models that had evolved. For example, we found
PPI in IDD studies to be framed by an empowerment model and resonant of the long history of partnership
working between practitioners and service users. Well-established PPI structures in some topic areas such
as dementia provided a pragmatic source for the lay perspective, but we found unintended outcomes for
this model, including the outsourcing of PPI to external parties with little researcher engagement. It also
exemplified a ‘one-off’ model whereby PPI was limited to a single task.
Researcher perceptions of what lay representatives could be expected to understand or be interested in,
coupled with a lack of effort to communicate in an accessible way, sometimes led to limiting lay
involvement in parts of the research process, potentially limiting impact. However, we also found in areas
such as basic science and tissue banks, where PPI has traditionally been seen as having a limited role, that
research teams were enabling PPI, leading to improved relevance of research priorities and questions.
While still challenging for a number of studies and funders, recruiting a diverse range of lay people was
enhanced when the study setting interfaced with a diverse population. Particular PPI structures helped,
including an outreach model with either a specific lay person or a co-ordinator acting as a bridge to a
broader community. The quality of such connections was important to create the context for involvement.
The resulting impact was culturally sensitive, participant-focused research designs.
In contrast, researchers’ descriptions of ‘usual suspects’ as lay representatives reflected a perception of
concerns about the professionalisation of PPI. However, our findings suggested this was at odds with
reality and with the advantages of the experienced lay representative being able to develop a number of
skills that helped their role, and enabling a career trajectory for the lay person within PPI.
An important finding in both the survey and the case studies was the dual role, whereby the lay advisor
was also a study participant. Although this had the benefit of real-time feedback about the impact of the
research design and enhanced a sense of ownership of the study for lay respondents, there was also
evidence of conflicts of interest and a blurring of roles. In some case studies the dual role was a deliberate
PPI design; however, in others it clearly demonstrated that involvement was not understood as being
different from participation, and highlighted the level of PPI drift away from INVOLVE definitions. It was
also indicative of a lack of training or experience in PPI, particularly in novice researchers. Training or
on-the-job experience not only helped researchers to differentiate between involvement and participation,
but also enhanced an understanding of what both parties bought to the table. Development of positive
relationships underpinned by trust was the minimal requirement for any form of PPI; this led to improved
self-worth for lay people, and increased researchers’ confidence in their work. Breakdown in this
relationship had a profound effect on levels of PPI embeddedness over time.
It was clear from the case studies that PPI was most likely to be embedded when hosted in well-resourced
research centres with a dedicated budget and PPI co-ordinator. PPI groups and panels had continued
engagement with the research host organisation, were reimbursed equitably and had social interaction
with the research teams; these are crucial to the sustaining of positive relationships. Resourcing PPI in such
a way also enabled a fully entwined model of PPI, in which lay people and researchers worked seamlessly
together, with research priorities and research questions created by the lay people involved. This generated
some research programmes that would not have been run without lay involvement. However, embedding
PPI to this level required not only resources but also time to develop.
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We found that funder requirements played a key role in influencing levels of reimbursement. In addition,
how PPI was operationalised in individual studies could be traced back to the funder’s ethos of PPI. Within
funding organisations there was a growing interest in evaluating processes and outcomes of PPI within
studies. However, even with funder expectations, only a limited number of case studies were reflecting on
and evaluating PPI in an ongoing way to improve the quality of PPI processes and outcomes.
Enabling contexts
The findings suggested there were eight enabling contexts for the mechanisms (Box 5). Five of these
(funder, topic area and design, resources, organisation of PPI and research host) were expected, based on
the literature, and shaped our sampling framework to ensure a range of case studies as a test-bed. The
other three (training, positive relationships and positive experience) became visible during data collection
and analysis.
Context–mechanism–outcome configurations
As described in Chapter 3, through an iterative process we tested candidate CMO configurations within
each case study and discussed our findings with case study respondents in the tracking interviews,
with our reference groups and finally at the four regional events. We identified six CMO configurations that
explained salient case study actions, potential contexts, plausible mechanisms and potential outcomes, both
intended and unintended. CMO configurations focus on immediate outcomes within a study. It was not
possible to include longer-term outcomes of a study, as these evolve over a longer period of time. Tables of
each CMO are presented and then illustrated by data and case study exemplars. Within exemplars, NPT
radar plots will be shown, and any change in PPI embeddedness over time will be illustrated through
tracking radar plots.
BOX 5 Enabling contexts
C1 Funder requirements for PPI in research.
C2 Training of lay people or researchers.
C3 Topic area and study design.
C4 Resources supporting PPI.
C5 Positive relationships between researchers and lay people.
C6 Organisational structures that support PPI.
C7 Research host support for PPI.
C8 Positive experience of PPI, both researchers and lay people.
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Purpose, structure and role of patient and public involvement
Table 12 illustrates the CMO configuration for this action. Funder requirements were a significant enabling
context, and had resulted in a more structured approach to PPI. It was also facilitated by host organisations
with an established PPI infrastructure, such as an established group or panel, and access to training. At
the time of data collection, this enabling context was provided by some topic areas (dementia and diabetes
mellitus) with network support for PPI. Having adequate resources to maintain this group in terms of
administration and reimbursement was vital for sustained engagement with PPI in research.
For some case studies, the purpose, structure and role for PPI were an inherent part of the research
design. For example, CS03 (see Box 10) and CS23 (see Box 21) were funded to coproduce an intervention
(self-management website and mobile phone applications for young people with diabetes mellitus). Other
case studies sometimes had to craft a PPI structure from new because of the funder’s requirements.
Funder requirements
Researchers were particularly aware that when applying for specific grants there were even stronger
imperatives to have PPI as a funding requirement. PPI was recognised as a part of the contemporary
research landscape, and some reflected that having formalised PPI as a requirement was beneficial,
as experience of good PPI usually leads to more in the future:
more researchers are willing to engage, whether that’s because they want to or whether because they
have to because of the grant application, I think there’s a bit of both there, but then again, that’s fine
because those that . . . engage because they have to kind of start to begin to see the worth of it anyway.
CS07Res01-01
Overall, the funder respondents clearly asserted that PPI both in research and at funder and system level
had developed significantly over the previous 5 years, describing a journey along a continuum of learning
and understanding of PPI, despite noting that there was still some way to go until it was fully embedded
as normal practice:
I think organisationally that’s been a sea-change . . . Externally with researchers I sense there has
broadly been a change but there’s still a lot to do, but certainly the quality of the PPI anecdotally that
we’re getting in our applications is on the up, possibly to do with . . . everything being reviewed by a
public contributor.
Funder01
Structures and processes for PPI within funder organisations themselves inevitably varied and strongly
reflected the influence of their core funding source, mission, scale and length of service. PPI structures had
developed either quite systematically or more recently and organically as part of the overall PPI movement.
Working closely with INVOLVE, two overarching programme management organisations and two research
programmes that are funded by central government had, over a number of years, developed similar,
embedded structures for PPI within their organisations. However, the sheer volume of applications to
process could potentially result in the PPI representatives having to work with a conveyor belt approach.
The industrial scale of PPI as metaphor was also picked up by one of the lay representatives:
I think, having started from a low base, it’s [PPI] now in danger I think of almost becoming an industry;
that is that everybody concerned with health care has to have some public involvement, and that goes
for GP practices, hospitals, and very much in research, all areas of research . . . It sometimes strikes me
that it’s a kind of bandwagon. Don’t get me wrong, I think it’s one of the most useful things in the
health economy, but it seems to have made jobs for an awful lot of people, let’s put it that way.
Funder07(lay rep.)
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The other funding bodies taking part in the RAPPORT study had only recently started to implement PPI
strategies in their organisations. A government-funded research council had endorsed its PPI strategy only a
year before and there was now a strategic vision around PPI. The structure of this funding organisation was
less complex and was led by a member of staff responsible for both public involvement and engagement.
This organisation had a PPI panel of around 20 members who were offered the opportunity to be involved
in particular funded projects; alternatively, the organisation would ask specific medical charities to nominate
lay representatives for particular condition-specific projects. Another large national funder, financed
through endowments, had a different stance on PPI, focusing more on public engagement:
patient and public involvement doesn’t just have to be people in a focus group or a patient
representative on a steering committee, it can, you can use kind of more engagement approaches that
can still inform and can kind of be part of the research process . . . sometimes when I talk to people in
the patient and public involvement sphere there’s quite a narrow definition of how they see patient
and public involvement, and so yeah, I can see it a bit wider than that.
Funder08
Public engagement was seen as a key policy driver within this organisation, and strategically it focused on
facilitating research teams to improve its public engagement, with PPI being seen as operationalised at
research team level.
We also interviewed two representatives from condition-specific medical research charities. Their PPI
strategies had gradually developed over recent years:
we’re currently looking at expanding it, so it is something that’s definitely on the radar of people
within the charity, it’s just the technicalities. I think, you know, everyone’s definitely willing to
do it and I know that our Medical Director is very keen on PPI, and I think it is almost evolving
organically . . .
Funder01(CharityA)
A major finding from the interviews with funder representatives was that their stances or values (and thus
PPI structures and processes) were actively shaped by the origin of their funding and their histories. The
funding organisations that received government public funding as part of a national research agenda
clearly articulated the reasons for PPI in methodological terms:
It [PPI], you know, is likely to improve recruitment. It makes sure that it meets patient needs so that
when it gets out the other end if you like into the implementation phase that it can actually have a
possibility of having impact on an individual with a said condition.
Funder04
In contrast, the medical charities reliant on fundraising spoke of PPI in terms of an ethical rationale:
we get our money from the public, from people with the condition, so it’s really important that we
include viewpoints of people with the condition in our decision.
Funder02(CharityB)
Hence, funders influenced PPI in subtly different ways depending on their organisational values. Case
studies funded by NIHR funding streams were required to have PPI as a different way of working within
the actual research process because of the emphasis on the methodological importance of PPI. In contrast,
those funded by charities tended to have less focus on a requirement for PPI in the actual research process,
with structures in their organisation concentrated more on ensuring PPI in funding decisions.
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Structures for patient and public involvement
Host organisations, and in particular CLAHRCs, were instrumental in providing a PPI infrastructure. This
often involved having a designated lead for PPI. Six of the case studies had a dedicated PPI co-ordinator
who was separate from the research team, and a further case study had a research team member who
took on the role of the PPI co-ordinator as part of their duties. Case study 21 (Box 6) had a colocated
co-ordinator who, as a non-researcher, was seen to bridge the gap between researchers and the public:
she’s become a great interface between us and the families because she helps, she’s . . . she knows
enough about research to be able to explain what we do, but equally doesn’t know enough that she
can challenge me or others in the team to explain more clearly what we’re asking of families. And I
think that’s probably the greatest reason for our success has been the sort of creation of that role and
the development of it.
CS21Res01-01
Case study 21 exemplified fully embedded PPI which was enabled by all eight identified contexts. It also
demonstrated an ‘entwined’ model of PPI in which research and PPI were wrapped together much like a
double helix. It was hosted within a research centre primarily funded by a charity (C1) with a topic area
(children with severe cognitive disabilities) (C3) where active involvement of parents was seen as a prerequisite
of meaningful research. The study design (systematic review) (C3), compared with the ongoing qualitative
research being undertaken in the programme of work, required more effort from the research team to ensure
that parents were involved and the review was rigorous. The research centre (C7) had an established PPI
system (C6) including a funded co-ordinator who supported parents and undertook extensive outreach work.
The centre was also part of a CLAHRC with a vibrant PPI community and resources for PPI (C4), and parents
were reimbursed for their time and received training (C2) for their role. Resources also included the time
researchers needed to work with parents on the systematic review. This level of resources was necessary for
an entwined model of PPI (see Chapter 7). There was a strong focus on positive relationships (C5) that were
developed over time and enhanced by social activities. This led to a positive experience of PPI (C8) for all
involved and the sustaining of a virtuous cycle whereby PPI became increasingly embedded. At the start of
data collection PPI was already embedded in CS21, so there was no change in the tracking radar plots
over time.
The need for time to develop a PPI infrastructure that could support embedded PPI was also clear in CS22
(Box 7). The topic area of CF had little history of established PPI structures, and the study designs are more
commonly towards basic science. This case study captured the early days of study set-up and developing
PPI, so radar plots were less full. After a year and despite focused work by a PPI champion, the radar
plots remained unchanged, suggesting that embedding PPI requires a significant amount of time: at least
5 years. The limited impact of PPI may reflect the very early stages of a research study; however, as other
case studies show significant impact in the early stages of the research cycle, it may also be indicative of a
neophyte PPI structure which is not enabling a fuller impact.
Outsourcing patient and public involvement
For case studies not hosted by organisations with existing PPI structures, an alternative was to recruit
an ad hoc, project-specific group of people or individuals to support the study as PPI. However, another
possibility was for research teams to access external PPI groups or panels. Topic area (C3) was an enabling
factor and respondents from two national networks covering dementia and diabetes mellitus both held
a list of names of interested PPI representatives. One network had a formal registration process on its
website (which was updated annually and had around 3000 names) and the other spoke of a more
informal, dynamic list based on personal relationships. Both networks had ready access to around
150–250 regularly involved and engaged PPI representatives; had been approached by researchers (in this
topic area and beyond) for PPI in protocol development, funding before the application stage, help with
PPI budgets and recruitment; and often organised local focus groups to gather PPI views.
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BOX 6 Case study 21: IDDs
Evaluation of peer-led interventions for parents of children with intellectual and
developmental disabilities: systematic review
Description of patient and public involvement
The research centre hosts a large PPI group made up of parents.
A project-specific ‘expert reference group’ was established, made up of the PPI representatives, and reviewed
the data collected.
Normalisation Process Theory
Coherence: roles and expectations of PPI clearly defined by all. Coherence in describing the approach and
philosophy of PPI in the organisation and research team.
Participation: key person drives it forward. Model adapted from elsewhere and now underpins the entire
centre’s work.
Collective action: roles clearly described and training given. Relationships seen as key; trust and making it fun.
Reflexive monitoring: no formal evaluative tool used but it is actively piloting tools developed within the






































Month 18 (no change) 
Patient and public involvement impact and outcomes
Research question setting: the group are encouraged to put forward research questions and this idea
originated from one of the parents.
Design of the study: sensitivity of statements on questionnaires.
Recruitment: recruitment improved through postcard-size reminders.
Outcome measures: increased relevance of outcome measures; parents set the inclusion criteria for the
systematic review.
Dissemination: conference presentations by lay reps and lay summary.
Impact for PPI representatives: increased knowledge of health services (parents), increased self-worth (parents),
respite from caring (parents).
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BOX 7 Case study 22: CF
Randomised controlled clinical trial
Description of patient and public involvement
Parents of children with CF (one member of charity). Experience of committees.
Stages: steering committee, four afternoons a year. One PPI representative also gives up about 3 days a month,
as they sit on a monthly committee.
Recruitment of PPI: known to researchers (through clinic or other committees).
Normalisation Process Theory
Coherence: PPI has recently become a new way of working for PPI reps, researchers and PPI co-ordinators.
Those interviewed have similar ideas about PPI but report some of the scientists/researchers in the hospital are
not so supportive or understanding of PPI.
Participation: PPI should be part of work, but not all clinicians see it that way. PPI representative wants to find a
cure in their child’s lifetime. Disagreement between researchers that PPI could understand all the science (this is
reported evidence). PPI representative was unsure about research progress over time.
Collective action: training has been provided on research and governance, more recent training provided by
charity – researchers and PPI representatives trained together. There has been a PPI co-ordinator for 3 years.
There is a formal procedure to include PPI in research proposals.
Reflexive monitoring: PPI representatives get feedback that proposals have been successful, how their views
were taken on board and how their suggestions on the protocol have been taken up.
Radar plots





































Patient and public involvement impact and outcomes
Recruitment: improved patient leaflets.
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Panels were preferred by some because they were more focused on a specific question and were hoped to
consult with a wider population:
I think that the PPI, you get from a reference panel is potentially more focused on specific important
questions . . . for example a Trial Steering Committee which might only meet twice a year or, and if
the layperson can’t attend.
ResearchNetwork02
Panels were felt to be a very effective way of using PPI time and skills, and easy access to existing groups
made PPI feasible within the time line of a project. However, although convenient, recruiting solely
through local PPI networks with trained and prepared members of the public was seen as not always
appropriate for effective PPI. Researchers within some of our case studies expressed concern about the
difficulty of recruiting more than just the ‘usual suspects’:
one of the problems is ensuring that you actually are getting real and representative user involvement
and not just the people who happen to be around who always get signed up to these user
involvement things . . . actually it’s quite easy I think to get the usual suspects.
CS23Res04-01
There was also evidence that relying on an external group had led to a ‘one-off’ model of PPI in which
researchers had requested help for just one task and there was an absence of PPI throughout the rest of
the research process. This limited the potential impact of PPI and was characterised by a more ambivalent
view towards the value or impact of PPI. In a few case studies, the CI appeared unconvinced of the value
of PPI:
but where’s the evidence that it [PPI] does work, maybe there’s scientific management for a
programme that should just be done by scientists, internal, external and managers and maybe there
are other elements that really need a PPI input, I don’t think that’s terribly well worked out at
the moment.
CS01Res02-01
Case study 01 (Box 8) provides an example of this model.
Training
The evidence suggested that training around PPI for researchers was likely to be an enabling context, but
there were mixed and even polarised views on training for lay representatives. Nevertheless, even in case
studies with embedded PPI, researchers had not received formal training on PPI. Rather, they had learned
through experience within an environment supportive of PPI.
Understanding PPI as different from study participation was a prerequisite for the development of
appropriate structures, purposes and roles for PPI. Most researchers could articulate the difference;
however, it was significant that many junior researchers could not. This lack of understanding was
attributed by some to a lack of formal training:
there was no formal training, I just, you know, from what my colleagues and supervisors have just
briefly mentioned but nothing formal on it and I think it would be an important part early on for
trainees interested in research.
CS14Res02-01
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BOX 8 Case study 01: dementia
People undergoing routine brain imaging: comparison
Description of patient and public involvement
Panel: an established local research network panel with a paid co-ordinator, who has worked with CI before.
Panel asked for views on access to patient notes.
Normalisation Process Theory
Coherence: PPI co-ordinator feels PPI is about recruitment, researcher feels it is about better research and CI
feels it is good for PIS and ethics committees but not necessarily design of studies. Both CI and researcher see
dissemination to participants as PPI. A journal letter on patient involvement is focused on providing feedback
to participants.
Participation: low legitimisation/enrolment. CI reservations that PPI can delay research, good for ethics but not
for research design.
Collective action: CI prefers to deal with panel rather than having one or two potentially idiosyncratic views on
a committee. Newer studies now have more contact with research network and PPI co-ordinator. Little support
for PPI from researchers; this is provided through the research network.
Reflexive monitoring: CI’s view ‘maybe PPI does work, maybe it doesn’t, we are not really sure’. No systemic
appraisal at research network, although a spreadsheet is maintained of PPI reps’ activity but not impact. PPI
reps are becoming more involved, but it is not clear if researchers are using more PPI in further studies.
Radar plots





































Patient and public involvement impact and outcomes
Study design: research design is acceptable to patients.
Recruitment: increase recruitment to studies (PPI co-ordinator’s priority to increase recruitment to studies).
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Of those lay respondents in the case studies who had received training, the majority had been provided
by CLAHRCs, public involvement groups or research networks. However, the need for training for lay
representatives did not emerge so strongly from the data as for early-career researchers. Indeed, various
arguments were put forward against training, such as potentially compromising the lay perspective, or
skills already existing because of extensive PPI experience or transferable skills from work life:
I don’t think there was any necessity for training at all. There’s certainly obviously one or two people
have got good committee experience who are sitting round the table, on the lay side, so no, I don’t
think there was any necessity at all.
CS13PPI05-01
In stark contrast a minority of lay representatives suggested it was impossible to contribute meaningfully
without some understanding of research:
I don’t think that you can just so easily shove inexperienced patients in to a PPI role without them
being, having some training and having some support because there’s no question that, you know,
the whole research agenda is incredibly complicated and they talk in a language which is, you know,
if you’re not a researcher you sometimes have no idea what they are talking about when they’re
talking about face validity and constructs and confidence intervals and so on and so on.
CS14PPI02-01
However, the above quote suggests that this lay representative felt it was essential for the PPI
representative to be able to cope with the research world, rather than the research community needing to
make the effort to include the lay world in an accessible way. Making the effort also included working
towards recruiting lay representatives who reflected the diversity of a study population.
Recruiting lay representatives reflecting the diversity of a
study population
Table 13 illustrates the CMO configuration for this action. Formal training for researchers played a part in
helping them to identify the need for this action, but experience on the job of recruiting diverse lay
representatives was a more common enabling factor. It was easier to achieve this action when the research
setting interfaced with and had access to a diverse population. Particular topic areas such as IDD had
developed links with less-heard groups, and in a number of case studies these links were provided by a PPI
co-ordinator or a lay person within an outreach model. In a few case studies, recruiting lay members as
representative of the study population was actually operationalised through recruiting study participants to
also have advisory input: a dual role.
Strategies for recruiting lay representatives
Being able to understand the research through the viewpoint of a target population was seen as key:
I was sat on a table with speech and language therapist, physiotherapists, paediatricians, and a
handful of parents, all as equals, you know? . . . and I was just thinking ‘What does that mean to me
as a parent’, thinking of my child’s capabilities and all the other children that I knew.
CS21PPI01-01
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However, finding lay representatives who they felt could present the viewpoint of the research study’s
target population was often challenging for research teams. This was more frequently cited for BME
groups. We attempted to include case studies that were likely to have a target population from the
BME community. One case study specifically focused on the experiences of a particular ethnic group living
with arthritis (CS18). One of the study sites was located in an area with a high percentage of people from
this ethnic background, and the lay representative was recruited through that site:
I was going to the clinic, attending the clinic and the nurse actually asked me if it’s okay because I
speak different, three or four different languages.
CS18PPI02-01
This opportunistic recruitment meant that CS18 benefited from the input of a lay representative who
demonstrably understood the enablers of recruitment in far more depth than the research team:
what we had was an audio CD because a lot of people do not read the script, [specific language], so
some of our interviewees did not speak English so we got the information sheet translated and put
onto CD and she [PPI01] listened to that and gave feedback on that because there are different
dialects of [specific language], apparently some are deemed posher than others and there’s all sorts of
things that I was not aware of initially.
CS18Res01-01
While there was trust in this lay representative’s expertise demonstrated by the peak in the collective
action segment of the radar plot (bold outline) (Box 9), the construct as a whole was affected by one
major challenge: that the CI (who was effectively the PPI lead within this study) and the PPI representative
were located at a significant distance from each other.
BOX 9 Case study 18: arthritis
Treatment outcomes for ethnic group
Description of patient and public involvement
Patient and public involvement representatives normally recruited to each study via an established PPI group
based at the university. Only one took part in CS18. Expert by experience (has condition). This PPI
representative was recruited through second university user group.
Normalisation Process Theory
Coherence: PPI representative slightly hesitant about role and impact. Researcher clear that PPI helped and
provided reassurance. Another, more experienced, PPI withdrew through ill health. Both feel it important to
give patient view and experience.
Participation: arthritis – outcome measures about pain were introduced because a patient spoke up.
Collective action: paid PPI co-ordinator. Training is provided once a year and group meet together. Sometimes
difficult to commit, because of illness (flares).
Reflexive monitoring: PPI representative found it worthwhile for herself. CI found PPI input very valuable. In the
future would involve two representatives. If the CI moved to another institution they would definitely set up a
similar organisational PPI approach.
FINDINGS FROM THE CASE STUDIES
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We also included four case studies focused on type 2 diabetes mellitus with the expectation that these
would include a relatively high percentage of research participants from BME groups susceptible to this
condition. One of these case studies (CS03) (Box 10) had used strategies (advertising and interviewing
applicants) to recruit a diverse range of lay representatives:
Strategies used when recruiting individual PPI representatives reflected researchers’ attempts to involve
people who could bring both specific and broader perspectives. Recruitment of individual lay representatives
was from five main groups: general public; expert by experience; carer/parent; patient representative; study
participant. Individuals could take on multiple roles and represent their views at different levels. However,
relying on just one or two individuals also raised the issue of representativeness:
it’s impossible, you can’t expect one person to speak on behalf of everyone so I guess the question
would be what would be useful, or truly influential patient involvement? Is it enough to have just one
person or two people who will be very, very good and who will be enthusiastic, but the question is,
how representative are their opinions into their input?
CS03Res02-01
Radar plots






































Patient and public involvement impact and outcomes
Data analysis: ensured it was culturally sensitive.
Dissemination: published paper with PPI representative in acknowledgements.
Cultural reassurance for CI (from other researcher and PPI representative).
Outcomes for PPI: hearing and reading about other people’s situations helped PPI representative personally.
Enabling contexts
Funder requirements: NIHR (C1). Study design: qualitative (C3). Research host (C7): CI located in an
organisation with embedded ‘established system’; each research project is automatically assigned two patient
representatives. However, this context was significantly counteracted by the research site being at a distance.
BOX 9 Case study 18: arthritis (continued)
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BOX 10 Case study 03: diabetes mellitus
Design of a self-management website: intervention design followed by
randomised controlled trial
Description of patient and public involvement
Experts by experience, different levels:
1. Focus groups involving diabetic and health professionals.
2. Eight to ten people with diabetes mellitus were selected through interview. The PPI recruited mostly through
Diabetes UK magazine. Newly established group or panel meets once a month for a year.
3. Two patient representatives on steering committee (one PPI representative volunteers for local diabetes
support group and Diabetes UK network, is involved in another charity and was involved in a project at the
research centre before; second PPI representative not available for interview).
Normalisation Process Theory
Coherence: high. PPI representatives and researchers use the same language (everyday life, real-world
knowledge), pooling experiences, diversity of views. Value for PPI individuals: confidence, mental stimulation.
They value the importance of the research and website.
Participation: key person (one of the researchers) approachable, supportive, interested; trust is strong, all voices
heard, researcher says ‘you have to take a back seat’ and that PPI have ownership.
Collective action: PPI representatives are a selected subgroup from a larger group. They know exactly what they
have to do, they are given clear instructions and they are set appropriate tasks as homework, which is made
clear at the beginning of each meeting. They are supported in terms of parking and venue. PPI embedded
within department but not whole university. Some underestimation about what PPI representatives can do
(by researchers).
Reflexive monitoring: PPI representatives know that their ideas have been used. Homework set each month and
representatives given feedback on why their ideas have been incorporated into the website or why not.
Comments clearly written up. Collectively think it is worthwhile, users shaping the intervention, broader
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Nevertheless, one model of using a single lay representative as a conduit to a broader constituency
appeared to work well. The outreach model, as exemplified by CS02 (Box 11), involved one representative
from a charity who then linked with 20 members of the support group in an iterative way to inform the
study design and recruitment materials. An unforeseen impact from this PPI was to raise concerns over the
safety of the study, resulting in extra study visits and a questionnaire (see Impact and outcomes of patient
and public involvement).
Some case studies also bought together project-specific panels. Case study 12 (Box 12) was particularly
enabled by being located in a teaching hospital with relatively good resources for research (C4), which
were sufficient for PPI honoraria.
Patient and public involvement impact and outcomes
Recruitment: two PPI representatives on steering group involved in suggesting changes to documents.
Design of intervention: self-management tool.
Outcomes for PPI: PPI representatives feel valued, sense of worth, benefits for society.
we wanted a really representative mix of people with diabetes . . . we wanted to be quite diverse in sort of
the sociodemographic, those variables so we got a really nice ethnicity mix and age mix and gender and so
that’s what formed our regular groups . . . Because sort of in the population, diabetes is more prevalent
in sort of the Afro-Caribbean, South East Asian population, . . . it was one of the things that sort of
influenced our decision as well.
CS03Res03-01
BOX 10 Case study 03: diabetes mellitus (continued)
BOX 11 Case study 02: diabetes mellitus
To test whether or not older people benefit from lower doses of a particular drug
Description of patient and public involvement
Steering committee: national representative. One PPI representative (senior position in charity) sits on trial steering
committee. PPI representative then consults the (20) panel members, invites feedback, collates answers and
then sends it back to research study team. Provided study with letter of support from charity. Involved at a
number of stages during the research study. At second interview PPI was in a lull while trial up and running.
PPI representative wanted to write something for charity newsletter. PPI representative leads and initiates
involvement when appropriate.
Recruitment of PPI: PPI representative known to CI; charity recruits to panel.
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Normalisation Process Theory
Coherence: high. CI and one researcher new to PPI, other researcher 2–3 years’ experience. Recognition that
funding agencies now require PPI. Agreed PPI was about patient views, perspective, real life, everyday life.
Overall, in agreement that PPI does bring value for research.
Participation: medium. PPI representative now gets approached by lots of people for PPI. One researcher had
had negative experience of PPI, unsure about benefits and CI feels PPI might not be involved in research
applications (PPI might not agree with what clinicians feel is an important research question). ‘Involvement
might not be in the best interests of a partnership’ (CI).
Collective action: skills of PPI representative are put to good use, collating views, information more patient-
friendly. Communication appears to be good. PPI representative is supported by her charity, not really by the
research institution.
Reflexive monitoring: PPI representative believes PPI should be from the beginning and early involvement
should be assessed by funding bodies. However, recognition that PPI does take more time. CI thinks PPI
representatives not so useful at commenting on research design but great at commenting on how patients
might feel to take part, adding questionnaire about safety and reassuring patients with an extra visit. PPI
representative can see their ideas have been taken on board.
Radar plots





































Patient and public involvement impact and outcomes
Design of study: protocol changed to include extra visit.
Safety of study: PPI suggested adding in a 3-month visit for patient reassurance. Patient concerns about safety
so a safety questionnaire was added.
Recruitment: changed language of documents (more readable/PIS altered); designed a small card (with hospital
telephone number, emergency number and information on); suggested avoiding the word ‘mortality’.
BOX 11 Case study 02: diabetes mellitus (continued)
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BOX 12 Case study 12: diabetes mellitus
Lifestyle intervention
Description of patient and public involvement
Newly formed panel: experts by experience, participants on the trial, mentors on the trial. Less PPI at the early
stages of the research, became involved with study documents. One lay representative had already worked
with the CI, others were new.
Normalisation Process Theory
Coherence: researcher and PPI representative agree an outsider’s view is needed especially when testing a
service which will be eventually used by pre-diabetics. Value of the psychological support for coming to terms
with having diabetes mellitus (PPI). Good for ethics.
Participation: PPI representatives and researchers agree it should be part of their work. Wider than just the
research project.
Collective action: PPI representatives do perform activities asked of them; relationships not a strong focus, but
PPI representatives do not articulate this as a need, being very experienced working on committees (feel they
do not need the support); skill set seems appropriate.
Reflexive monitoring: do not formally evaluate PPI, although meetings minuted; all feel PPI is worthwhile.
Radar plots





































Patient and public involvement impact and outcomes
Ethics: enhanced approvals process as materials reviewed by PPI representatives before submission.
Recruitment: increase recruitment to study by clarifying paperwork. PPI looking at reasons for withdrawals
from study.
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Challenges in ensuring diversity
Researchers acknowledged there was much work to be done to ensure diversity in PPI. The fact that only
a very few of our PPI respondents were not from a white British background exemplifies the common
problem as described by one of the funders:
we have as much of a problem as anyone about, you know, diversity and all those issues are still
issues which we need to explore further. I think often public, people who get involved with PPI are a
self-selecting group and it’s really difficult to bring in groups wider and that’s a usual excuse and I
hate it, and I hate it when researchers say it. But I, it, you know, for example if somebody couldn’t
read and write how would we include them in this process? If someone wasn’t, we do manage to
include people who are not computer literate but then these days how are they going to even find
out about us if they don’t have a computer? How are they going to know who to ring?
Funder01
Difficulties in accessing ‘representative’ PPI were particularly marked for public health studies when the
focus was on healthy or ‘at-risk’ populations with particular lifestyles. The difficulties for public health
studies was also linked to the setting (e.g. broad communities) in which they took place. Those studies
taking place in settings with ready access to patients obviously had greater potential for recruiting both
participants and PPI representatives onto their studies:
the problem at the university is that those researchers that aren’t clinical or don’t have good links
into the clinical setting, it becomes very difficult to identify service users to sit on a panel like that so we’re
in quite a privileged position because we’re right next to the outpatients clinic and that makes our life a lot
easier for maintaining that model.
CS18Res01-01
The dual role
Clinicians who were also researchers had the added advantage of having ready access to patients as
potential PPI representatives. For example, one case study (CS14) (see Box 26) hosted by a district general
hospital with few embedded PPI structures was able to involve patients through an active condition-
specific support group facilitated by clinical department staff. However, the distinction between being
involved and being a research participant was often blurred in this case study, with PPI being understood
by many of the respondents as a dual role. This dual role was overt in another arthritis-related study
(CS08) (Box 13), where the PPI respondent was also a study participant. While there are potential ethical
conflicts here, this lay representative actively recruited participants through her own network and had a
strong sense of purpose. This action-orientated approach to PPI resulted in a fuller quadrant in the radar
plot denoting a positive appraisal of the PPI within CS08 (see bold outline in box figure).
BOX 13 Case study 08: arthritis
Differences in joint functioning between those with and without osteoarthritis
Description of patient and public involvement
Dual role: PPI representative already known to CI through being on funding committee but also has joint issues
so is participating in the research as well as acting as an advisor.
FINDINGS FROM THE CASE STUDIES
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Normalisation Process Theory
Coherence: there is a general understanding of what PPI means but also some confusion and acknowledgement
that this is not a typical example of PPI. PPI representative has particularly strong views on the limitations of PPI
whereas the CI appears to be increasingly converted to its possibilities.
Participation: the CI is fully enrolled, but the other two respondents have some doubts over whether or not the
value of PPI outweighs the effort required. There is no key leader for PPI.
Collective action: the roles of involvement and participation are blurred. However, the relationship between CI and
PPI representative is key and characterised by continuity and reciprocity. Both CI and PPI representative agree that
there is the ‘right sort of person’ for PPI. There is mixed acknowledgement of reimbursement for time and travel,
as some members of the research team see PPI as a voluntary role not requiring reimbursement for time.
Reflexive monitoring: CI can identify the impact of PPI in the study and to a lesser extent so can the PPI
representative. However, the CI is concerned about the difficulties in evaluating PPI formally and talks of
needing numbers for an evaluation. CI has clearly learned from this study and would have earlier and fuller
PPI; all seem to think dual role is useful, particularly in terms of ongoing feedback during a study.
Radar plots





































Patient and public involvement impact and outcomes
Design of study: changes in the way the study was run (subtle touches such as introducing staff, cups of tea).
Recruitment: actual recruitment by PPI representative to study, changes to PIS.
Enabling contexts
Study design: low-risk observational study so lay rep. comfortable recruiting others (C3). Research host (C7):
study being conducted in labs with little interface with the public; CI relying on existing contacts for lay
representation but this established relationship also enabled trust (C5).
BOX 13 Case study 08: arthritis (continued)
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Although respondents in CS08 were comfortable with this dual role, it was operationalised in an ad hoc
manner that was unlikely to lead to any embedding of PPI. In contrast, this dual role was carefully
constructed and managed in a longitudinal cohort study (CS13, see Box 16). A rolling PPI panel was drawn
from study participants and the role was clearly defined and separated. The impact of this role included
both increased public engagement with the study and improved participant retention. This model of PPI
was enabled by topic area (public health with healthy participants) and the longitudinal design, which
allowed relationships to be developed and sustained over time. This was a well-resourced study with
dedicated PPI staff and good organisation, and was run from community hospitals at the heart of local
populations. For the public undertaking this dual role, there was a sense of ownership of the study, with
subsequent sustained engagement. Two tissue bank studies also had lay representatives who advised
but also had donated samples. In CS17 (see Box 23), engagement was sustained, but for the other
(CS16, see Box 20) the sense of ownership became a cause of conflict, which is presented in Enablers
and barriers to trust.
If this dual role was to have a positive impact, then the purpose, structure and clear role boundaries
needed to be defined.
Whole research team is engaged with patient and
public involvement
A distinct action of case studies where PPI was embedded was engagement of the whole team with PPI,
and having the skill set to do this. Funder requirements (C1) for plain English summaries were bringing into
sharp focus the need to be able to explain technical aspects of the research in an accessible way, and the
most effective way of doing this was to work in partnership with lay representatives (C5). This needed time
to achieve (C4) and could also be helped through specific training (C2). It was particularly evident as an
action in the IDD topic area (C3). The CMO configuration for this action is shown in Table 14.
Relying on one person to lead patient and public involvement
As described in Purpose, structure and role of patient and public involvement, having someone to lead and
co-ordinate was important in embedding PPI. If there was not a designated co-ordinator, this role was
often carried out in addition to a junior researcher role and was not part of the original job description.
Different levels of commitment to this role were found and PPI representatives spoke of often not having
one ‘designated person’. Continuity of personnel with responsibility for PPI was an issue. For example, one
PPI representative reported seeing someone different at each meeting (CS05) (Box 14) and another said
the enthusiastic support ‘gradually dwindled’ (CS14). If the whole team was not engaged with PPI, the loss
of the PPI champion had a detrimental impact.
FINDINGS FROM THE CASE STUDIES
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BOX 14 Case study 05: arthritis
Reduced dosage of medication for people with arthritis, clinical trial of an
investigational medicinal product
Description of patient and public involvement
Steering committee: one expert by experience, recruited through national arthritis body, who was a patient of
the CI. Was asked to change consultants. Nursing background and interested in research. Understands some of
the medical terminology.
Stages: PPI representative on steering committee throughout the project. Steering committee meets every
6 months.
Normalisation Process Theory
Coherence: PPI representative is ‘patient voice’. Mixed views from the research team about PPI processes within
the study. PPI representative believes PPI can be bridge between clinical decision and actual opinion. CI thinks
PPI is ‘neutral’ in terms of recruitment.
Participation: PPI seen by some as just another change in the research landscape. Qualitative researcher within
department (not involved with this research) very keen on PPI. PPI representative keen to take part.
Collective action: steering committee every 6 months and few e-mails in between. Not much work for PPI
representative to do in between times. Lack of continuity with change of study managers (hard for PPI to
maintain a relationship), PPI representative accepts she will not understand everything, she communicates the
patient perspective. Researcher agrees that PPI representative might not be able to be involved in clinical
practice. CI says PPI support needs to be tackled centrally, not at individual study level.
Appraisal: no feedback to PPI representative. PPI representative has some doubt about how much impact PPI
has. PPI representative made comments on protocol, concern regarding radiography and reducing medication.
PPI rep. feels views taken on board, but less evidence that research team evaluate these as changes.
Radar plots





































Patient and public involvement impact and outcomes
Protocol: PPI suggested changes to protocol; concern regarding radiography and impact of reducing medication.
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Patient and public involvement as a collective action
Case studies demonstrating agreement of all individuals in the team that PPI should be part of their work
were particularly strong within the IDD topic area, where there is an acknowledged history and strong
investment in PPI. The CI from CS11 (Box 15) clearly articulated this:
in order to understand and develop theory effectively, you need to really have a conversation with
service users and probably somebody who has the problem with the condition, and that is how
psychological theory develops. You know, it is that, ‘Are you doing something to people or are you
doing it with people?’ and doing it to people, you know, there’s such a power imbalance, and given
the backdrop and the history associated with people with disabilities internationally, that’s not
politically palatable to me personally and to, you know, society, I suppose.
CS11Res01
BOX 15 Case study 11: IDD
Group intervention to reduce anxiety of (age-range) people with
specific condition
Description of patient and public involvement
Two PPI representatives are new to PPI in research (one voluntary worker, one carer) and one more experienced
(expert patient). Preference for PPI recruitment from established condition-specific networks (built on previous
relationships and personal recommendations) rather than local (generalised) PPI networks.
Normalisation Process Theory
Coherence: CI (clinician) has much more of an overview of PPI in the project (and its genesis) and deeper
understanding of politics/history of PPI in this area than other (less experienced) researchers interviewed.
PPI representatives have a good understanding of role/purpose of PPI in this study.
Cognitive participation: strong investment in PPI in this research topic, and on this project. CI drives
participation. PPI members see participation as (1) part of their job, (2) their only job, (3) a voluntary role with
potential benefits for those affected, including family members.
Collective action: PPI members feel valued and identify importance of being assertive. One PPI representative
feels that research team could use that representative’s skills more. Interpersonal aspects of PPI: a few examples
of issues which have arisen and been managed well are given, which stem from health condition and
professional boundary issues. The word ‘mindful’ is used a couple of times in respect of this. Effective chairing
of meetings very important.
Reflexive monitoring: nothing systematic in place, but some clear contributions outlined in minutes and
interviews and lots of important small changes made, in line with PPI recommendations.
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Although the NIHR funding (C1) was used to pay out-of-pocket expenses, this case study was hosted by a
medical school, with the CI reporting limited engagement with PPI. However, it is the topic area (C3) that
is the strongest enabling feature, suggesting a culture where ‘nothing about me without me’ shaped
research practice. This CI also framed the challenge to explain technicalities more clearly to lay audiences
positively, as good practice for communicating ideas to the public:
saying things like, ‘Oh, this is a stepped wedge design,’ and ‘We’re randomising,’ . . . you can use that
language, but people aren’t going to understand it. So, you’re going to spend all your time explaining
what you mean, so you might as well just use simpler language to start with, and perhaps really as a
researcher or scientist, that’s a good thing because it helps improve your communication skills with lay
people and the general public.
CS11Res01-01
This whole team engagement was not unique to IDD as a topic area. For example, in CS13 (public health)
(Box 16) although a project-specific PPI panel was facilitated by a lead person, all senior researchers took
it in turns to attend panel meetings. The embedding of PPI in this study was enabled through access to resources
from grant monies (C4) and a longitudinal design (C3) that enabled relationships to be sustained (C5).
Radar plots





































Patient and public involvement impact and outcomes
Intervention: refining intervention and testing acceptability of intervention.
Recruitment: better recruitment/retention of participants to trial.
Outcome measures: more meaningful.
PPI outcomes: taking part improves curriculum vitae to get more work of this nature, including
consultant/trainer work.
BOX 15 Case study 11: IDD (continued)
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BOX 16 Case study 13: public health
Relationships between dietary intake and cancer incidence: prospective
cohort study
Description of patient and public involvement
‘Consultation’ panel hybrid model, built upon earlier, less formalised (mass consultation, participant feedback)
PPI panel drawn from large cohort study (now mostly retirement age). Panel meet quarterly with an annual
general meeting with a rolling membership of 15.
Patient and public involvement in all research stages apart from data collection and analysis.
Normalisation Process Theory
Coherence: PPI approach (roles and purpose) of consultation type panel clearly understood across team with
strong leadership; other historical PPI mechanisms have been utilised in cohort study, for example to identify
study priorities.
Cognitive participation: run by dedicated and respected member of team. Strong buy-in communicated from
outset/CIs: verified from researchers and PPI panel members interviewed. Lots of thought put into planning:
how to set up the panel, following best-practice principles.
Collective action: All very satisfied with the way the PPI is run and managed. Shared decision-making regarding
panel name, frequency of meetings, level of commitment, when/where meeting and level of input required.
Light touch, structured but engaging, elements of fun. Panel only more recently being asked to help set the
agenda of meetings, but do feel comfortable to challenge any points put to them for consideration.
Reflexive monitoring: panel are given clear, itemised feedback on why all suggestions are/are not taken on
board. All queries are reported back on. They can clearly see their impact in before/after versions of documents.
They enjoy taking part and feel highly valued. Annual general meeting reviews PPI contribution and model.
Radar plots
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Mutual understanding and trust
While formal training (C2) had a part to play in helping both researchers and the public to understand
each other’s roles in research, positive relationships (C5) sustained over time led to PPI as a positive
experience (C8) and the development of trust, which was key for this action. Reimbursement of out-of-pocket
expenses and time contributed to maintaining trust. If clearly articulated, funders’ expectations (C1) of
reimbursement were an enabling context, as was the topic area (C3) if reimbursement was normal practice.
Host organisations (C7) had a key role in providing resources (C4) for reimbursement and ensuring payment
was smooth. The CMO configuration for this action is shown in Table 15.
Coherence in understanding the contribution of patient and
public involvement
As the bedrock for trust, lay representatives and researchers needed to have a shared understanding of the
purpose of PPI. Novice researchers were more likely to be unable to fully distinguish PPI as separate from
research participation. For example, a registrar in CS14 defined PPI as:
patients contributing to research and enrolling into research studies, whether they had portfolio status
or not.
CS14Res02-01
While this impeded an understanding of what PPI could offer to the research process, other researchers
and PPI representatives provided a variety of reasons for carrying out PPI including gaining insight into the
lived experience of a particular health condition, and to provide reassurance for researchers that their
research question resonates with the patient community. This was exemplified in CS07 (Box 17).
Case study 07 was enabled through an established diabetes (C3) network group (C6) housed in the host
organisation (C7). The study focus on processes of care (C3) also enabled coherence. PPI members met
regularly and were involved in a number of projects which helped promote sustained engagement (C5).
However, lay representatives were not reimbursed for their time because of bureaucratic difficulties; rather,
they were taken out for a social meal.
Patient and public involvement impact and outcomes
Research priority setting: helping identify research questions.
Design of the study: testing acceptability (refining) of data collection tools of proposed phases.
Recruitment: redesigning website to be more user friendly.
Design of intervention: testing acceptability of future intervention studies.
Standardise outcome measures: patient-focused outcome measures.
Dissemination: presentation to an audience of researchers on PPI and being a panel member. PPI representatives
involved in public engagement work. Newsletters.
Other: improved participant retention.
BOX 16 Case study 13: public health (continued)
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BOX 17 Case study 07: diabetes mellitus
Consultation between the practice nurse and the person with diabetes mellitus:
randomised controlled trial and qualitative
Description of patient and public involvement
Experts by experience panel (≥ 10 patients who have lived with diabetes mellitus for over 5 years). Recruited
from diabetes research network panel. Members of the CS07 panel are on their own Diabetes UK voluntary
group (access to another level of PPI). There is also an online panel. Involved in different stages (involved at
beginning and in recruitment and CI hopes they will be involved in dissemination).
Normalisation Process Theory
Coherence: CI says ‘patients are the experts’, ‘find it incomprehensible that you wouldn’t ask patients first’.
Researcher had been involved with PPI in service redesign before – ‘it’s the way forward’. Involve people from
the concept and design through to dissemination. ‘PPI runs throughout the study’. Ethics committee had been
very positive. PPI representative believes PPI to ‘humanise research’, ‘white coat jargon – words of one syllable’.
Participation: researchers buy into PPI as does the PPI representative.
Collective action: meetings set up only when needed. Training through research network, not sure PPI
representative wants any more technical training as providing lay perspective. PPI representatives distributed
questionnaires to their own Diabetes UK groups, so got lots of feedback. PPI representative accepts limitations
of specialist knowledge and terminology. CI feels PPI is embedded within her organisation. Taxi organised for
PPI representative as has mobility problems.
Reflexive monitoring: involved in protocol (randomisation), PIS, design of questionnaire, video used when
recruiting practices to the trial. PPI representative intends to be involved in dissemination (not analysis).
Researchers listen, PPI representative feels contribution is valued. Researchers recognise importance of feedback
(it is an agenda item). PPI representative says feedback very complimentary on the video. Dissemination so far:
PPI poster designed for UK annual conference, newsletters.
Radar plots
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Whereas the experience of established panels was seen by many researchers as a bonus, others spoke of
the tension between wanting someone who was ‘outside’ the research environment and wanting
someone who was also able to engage with research studies (possessing some research skills) and thus
perceived as being able to perform the necessary PPI tasks. This notion of wanting the right person with a
short distance between direct experience and its interpretation but who also can feel comfortable in a
research environment is maybe a contradiction in itself. There was evidence of an ongoing debate about
whether or not the experience of a condition (direct or indirect) was seen as less legitimate because of that
person’s professional background, experience or training in research or health care:
we’re all patients . . . yeah, and some of us have PhDs and some of us don’t, so it’s quite difficult to
kind of define what is a lay representative . . . they’re really just people who, actually, through their
qualifications, they should be research assistants but don’t happen to have a job in research but are
on a lay panel. And I kind of think ‘what . . . are you really a lay person? You’re just an unpaid
researcher’, but I’m not entirely sure whether that’s right . . .
CS17Res01-01
Our findings suggested that defining PPI as a discrete and commonly understood component of research
was difficult but the range of PPI representatives can be summarised through a fourfold typology based
on an insider/outsider perspective (on one axis) and a range of research skills (on the other) (Figure 8).
Research studies can be placed along these axes; however, within one research study there may be a
mixture of individuals with varying skills and perspectives.
While the insider/outsider debate was articulated in a number of case studies, those that had embedded
PPI were likely to have sustained engagement with the same group of PPI representatives over a long time.
Patient and public involvement impact and outcomes
Design of study: psychological element (scale has been shortened), whether to do partial or full RCT. Panel
commented on proposal of this study at the beginning. Introduction, how to phrase the study.
Design of intervention: refined – changed the questionnaire six times, eight pages to three. Validated the
questionnaire (panel sent out to their user groups and through diabetes database).
Recruitment: through video – PPI representatives took part.
BOX 17 Case study 07: diabetes mellitus (continued)
Insider perspective (linked into research team)
No research skills High research skills
Outsider perspective (apart/separate from research team)
FIGURE 8 Insider/outsider perspective.
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Building relationships over time
We found that the relationship between the researchers and PPI representatives was a key factor for
successful PPI. Relationships took time to establish, which was particularly difficult at the beginning of
research (or even before the proposal is written). One finding from the case studies was that the majority
of PPI representatives had a previous working relationship with the research team. Of the 51 PPI
representatives, 33 (64.7%) had some prior working relationship with either the CI or members of the
research team (three were patients of the CI and also members of a service user group, so had worked
together before), nine (17.6%) had a more distant acquaintance (but described themselves as being within
the same loose network) and nine (17.6%) PPI representatives were completely new to the research team
(recruited from outside existing structures). The obvious advantage of having a previous relationship meant
that PPI could start as soon as possible within the research project, whereas more time was needed to
establish relationships through informal small meetings if the lay representatives and researchers had not
previously met.
Research teams spoke of initial meetings where everyone got to know each other and having these times
of informality before starting on the ‘academic’ business. The benefits of PPI representatives having the
opportunity to get to know each other also provided support later in the project. Social elements were
important in encouraging and maintaining continual engagement in the research study and should not be
underestimated by researchers. Some of the case studies also ran social events outside the research, which
again helped to build and maintain relationships:
We do these family fun days as well, which we get together once a year, just to get together at the
zoo or something. [PPI co-ordinator] works phenomenally hard to build relationships with the families
that . . . So, it’s a partnership really.
CS21Res01-01
In more formal advisory or steering committee meetings, PPI representatives spoke of being specifically
welcomed into the meeting (sometimes being met beforehand). Most importantly, during the meeting,
successful PPI was being ‘genuinely’ listened to and their comments taken on board. The relationship
between the researchers and the PPI representatives was key to fully embedding PPI within the research
study. The researchers needed certain social skills, which included being approachable, good listening
skills and group work skills:
initially facilitating and always presented a positive, welcoming, friendly, supportive space to you.
CS17PPI01-02
Patient and public involvement representatives reported that meetings needed to have a ‘flat structure’
where PPI representatives felt free and at ease to speak.
Relationships could change over time, either through loss of trust or as trust developed, as illustrated in
CS19 (Box 18). Although only subtly different, the radar plots show a change in all quadrants but
particularly in collective action (bold box), where M10 (trust in each other’s PPI work and expertise is
maintained) is included as a mechanism. This reflects clarification of roles and the improving relationship
and trust in the PPI work:
I don’t know what they want me to prepare for, I don’t know what they want me to do, and I don’t
know if the confusion is because of my professional role [. . .] and I don’t know if they’re waiting for
me to take the lead, and I’m waiting for them to treat me as a patient. . . . I’m a little bit disappointed.
It feels almost tokenistic.
CS19PPI02-01
FINDINGS FROM THE CASE STUDIES
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BOX 18 Case study 19: public health
Comparison of obesity treatments: randomised controlled trial
Description of patient and public involvement
Committees: two representatives (one a coapplicant) on trial steering committee (meet twice a year). Two PPI
representatives on trial management group (meet once/twice a year).
PPI in all but data collection and analysis stages of research.
Recruitment of PPI representatives: two research-related professionals already known to CI who had had
experience of the intervention.
Normalisation Process Theory
Coherence: mixed understandings and tensions about the purpose and role of PPI in general and specifically
on this project. CI sees PPI as normalised and indistinct from other research partnerships.
Cognitive participation: CI drives the PPI. Qualitative researchers unsure how PPI will impact. PPI coapplicant
bought in from the start. Agreement on commitment to PPI but mixed views on how it needs developing
further in the study.
Collective action: PPI coapplicant very effective to begin with but has had to step down. Other PPI
representative feels that team need to think about patient experience and is unsure whether or not the team
is responding to the PPI representative’s message. PPI representative feels both she and the other PPI
representatives could be more involved.
Reflexive monitoring: no systematic process for appraising PPI in place, but clear, if weak, examples given
of contributions of PPI to the study after initial protocol development; some reflections on how PPI could
be strengthened.
Radar plots
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Conflict between roles resolved . . . CS19PPI02 feels happier now that they are no longer post-surgery,
less vulnerable. They had a long chat with a rheumatology person in department who had done a lot of
PPI work who reassured CS19PPI02 that one PPI voice is better than none, more confidence to feel you
don’t have to represent all patients, can just give your own experience. Different way of looking at the
value of their contribution.
CS19PPI02, notes of tracking interview 6 months later
Trust as the foundation for patient and public involvement
A relationship framed by trust was the minimum requirement for PPI to have a positive impact. Although
PPI was not embedded within CS14 (see Box 26), the relationship between lay representatives and the
clinician was based on trust built up from a clinician–patient relationship with continuity over time:
there’s a trust there, I trust them that they wouldn’t ask me to do something that wouldn’t be, you
know, it would be difficult or wouldn’t necessarily be appropriate or whatever.
CS14PPI01-01
Some researchers also trusted their lay representatives to undertake the work in a way that was workable
for the researcher:
It’s always good, you know, on research it’s you need good people you can work with and that’s what
I would be looking for, to set up some relationship of trust and mutual respect . . . Without thinking of
them as a hindrance.
CS15Res03-01
Patient and public involvement impact and outcomes
Marketing of study: awareness that study logo might be inappropriate/insensitive.
Design of study: timing of nutrition questionnaire; PPI representative felt this is too invasive.
Design of intervention: testing acceptability of intervention; asking too much of patients in each visit.
Recruitment: recruitment pack, information.
Dissemination: PPI representative invited to coauthor a paper.
BOX 18 Case study 19: public health (continued)
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Case study 15 (Box 19) exemplified how, even when resources were minimal for PPI, the very existence of
mutual trust resulted in positive PPI impact. This study was housed in an organisation with no PPI infrastructure
and with minimal resources for PPI despite the study being funded by the NIHR. The research setting [intensive
care unit (ICU)] provided particular challenges: consent and recruitment difficulties in a high-stress environment;
difficulty in recruiting lay representatives, as they were often traumatised by their time in ICU; and lack of
resources, as there was no large charitable funder. The lay representative in CS15 had an impact on recruitment
processes for the study and provided a valid argument to present to the ethics committee for this approach:
we put a thing here saying in the consent ‘to continue information now you’ve regained
consciousness, we would like your permission to continue in the research’, now [PPI01 has] written
‘I realise this might not be possible but in my own experience of delirium I was regarded as having
capacity long before I was in my right mind or capable of rational decision making. I appreciate this
may be beyond the scope of the study but if there were any way to change the emphasis for the
patient remaining in the study unless they chose to opt out, I think that would be much better’.
CS15Res03-01
It can be clearly seen how M10 appears as a peak in the collective action section of the radar plot (bold square).
BOX 19 Case study 15: dementia
Prevention of delirium in intensive care: clinical trial of an investigational
medicinal product
Description of patient and public involvement
One national representative. PPI role confined to trial steering group.
Activities include review of PIS before ethical approval, project management. Involvement in
dissemination expected.
A topic area with particular challenges in recruiting lay representatives.
Normalisation Process Theory
Coherence: lay representative very experienced in different PPI roles (although first clinical trial of an
investigational medicinal product) but all research team very new to PPI and some find it hard to differentiate
from obtaining feedback from participants. Despite some difficulties in clearly defining PPI and describing their
own role in PPI, all the research team articulated potential value of PPI including bringing patient perspective,
advising on consent process, improving recruitment and dissemination and raising awareness of the research.
Participation: CI sees role to drive PPI forward as a requirement of funders, whereas the research nurse feels
this is something that could be developed in her role. There is no resistance to the idea of PPI and there is
evidence that the team are likely to continue supporting PPI.
Collective action: some acknowledgement by the team that regular communication is a requirement for PPI.
Trust is a key feature but unlike many of the other case studies it is trust in the PPI representative that is more
articulated. Research team trust the PPI representative. This will make dealing with PPI representative easier,
and representative will feed back appropriately and not mind if they do not take up PPI suggestions. The PPI
representative sees the relationship with the CI as key.
Reflexive monitoring: minimal – had not thought of systematically evaluating PPI impact. CI evaluates PPI input
as useful to date, but no evidence of any reconfiguration.
DOI: 10.3310/hsdr03380 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 38
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
81
Enablers and barriers to trust
Sustained feedback to PPI representatives was a clear enabler of trust and continued engagement:
and they’re always thanking us for our participation. All the time. Always saying, you know, I get it in
e-mail messages, we get it at the meetings and they always say how valuable our input is, you know,
they make us feel worthwhile and that is good.
CS13PPI03-04
This feedback was recognised by many researchers as being important:
I think it’s important, what I’ve learnt is that if you are going to ask them things you need to feed
back to them so that it’s terrible to actually ask their opinion and they never hear again, so I’m quite
good now, it’s an agenda item that you know, I feed back what I’ve heard from different people,
because they’re left wondering . . .
CS07Res01-01
The forum in which researchers and lay representatives came together was also an important enabling
context for trust. The majority of our case studies had PPI representatives as members of steering
committees (one or more lay representatives per study) which met every 3 or 6 months to advise the
research team but did not necessarily have a ‘hands-on’ role with the research. However, different research
teams made different uses of their steering committee members, with some members making comments
only during the meeting and others who were asked to comment on documents throughout the study.
As shown in CS04 (see Box 22), there was a varying sense of equality within the committee:
it wasn’t run by the Professor from the top down in sort of military fashion, it was a round table
discussion where anybody could contribute . . . whilst it could have been intimidating actually it was
very welcoming, and the person who chaired the meeting was very sensitive to that.
CS04PPI02-01
Radar plots





































Patient and public involvement impact and outcomes
Recruitment: too early to tell but is seen mainly in terms of improving recruitment because of refinement of PIS,
in particular making the wording more sensitive to relatives who will be consenting.
BOX 19 Case study 15: dementia (continued)
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However, the formal term ‘steering committee’ put some PPI representatives off: ‘if they said someone to
be on the Steering Group I mean I would never, I would have just thought well that wouldn’t be . . . that
sounds too high powered for me’ (CS04PPI01-01).
Despite it often being seen as good practice, there was little evidence that this relational integration was
being formalised through job descriptions or contracts for the PPI representatives. However, at the start of
the study researchers often clarified expected commitments to attending meetings; other PPI input was
often less formalised. Those case studies which had high levels of PPI activity could achieve this through
flexibility and allowing PPI representatives to ‘dip in and out’ as their other commitments also varied:
parents will stick with the programme because they know that they can step in and out if needs be,
and the team also think about how they can include people that might not be able to travel, so
whether it’s joining in a meeting by phoning in to it and participating over the phone or sending
responses or comments and feedback in an e-mail, so it’s made it available and it’s made accessible.
CS21PPI02-01
However, trust in CS16 (Box 20) was lost because of a lack of formal agreements about access and
ownership of a database. This issue appeared midway through data collection and the impact can be
quite clearly seen on the radar plots tracked over time. The impact can also be seen in the way the PPI
was appraised (hatched box); because of this experience the charity would get legal documents drawn up
before working with researchers again.
BOX 20 Case study 16: diabetes mellitus
Genetic and cell culture: tissue bank database
Description of patient and public involvement
National expert network: charity. Dual role (participants and representatives).
Patients meet once a year but charity has ongoing contact.
Recruitment of PPI: through charity.
Normalisation Process Theory
Coherence: CI has worked with patients with a particular rare condition (which is related to diabetes mellitus)
since the 1980s. CI received money to fund a clinic (but not the research). With parents of children with the
condition, PPI and charity reps, the CI developed a grant application which was awarded by the charity. CI very
committed to PPI. PPI representatives believe in patient voice. All three PPI reps work for charity, very involved.
PPI representatives feel clinicians/researchers do not fully understand the condition as a whole. Come together
for conference once a year.
Participation: PPI seen as essential, as patients/parents are in unique position to understand experience
of condition.
Collective action: CI believes PPI not appropriate for all areas and sometimes realistically there is no time to
involve patients – depends on the study. Scientists having an open mind to be challenged and be able to
explain things simply. CI thinks funders should make PPI compulsory but the sponsor also needs to be signed
up to PPI. The charity owns the database and wants to access it but there are research governance issues.
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Virtual patient and public involvement
There has been a recent move towards the increasing use of technology and teleconferences being used
as a means to include lay representatives who might otherwise not be able to attend meetings. However,
this move towards ‘virtual’ contact as opposed to ‘face to face’ has implications for the establishment of
relationships. One lay representative said that they always wanted an initial face-to-face meeting to make
any following (virtual) meetings easier. As presented in Strategies for recruiting lay representatives, being
unable to meet in person also caused problems in CS18, where the CI and lay representative were in
different regions. The challenges of building and sustaining relationships through virtual contact were also
raised by a funder. Maintaining arm’s length relationships was acknowledged to be difficult for the army
of remote lay reviewers, and they found it difficult to sustain any more active involvement. Case study 23
(Box 21) provided an example of virtual PPI with young adults, and also demonstrated how this medium
provided an outreach model (see Discussion).
Reflexive monitoring: PPI representative keeps an events log of conferences, events. As study progressed,
ownership of database became contested. PPI work will be reconfigured in future studies to include a
formal contract.
Radar plots





































Patient and public involvement impact and outcomes
Study design: sensitive research tools, how to undertake procedures and examinations.
Recruitment: changing the wording of PIS. Language: employ people at the charity who speak Urdu or Punjabi
so not just relying on interpreter from the hospital – so can have open discussion.
Dissemination: will be from the charity, which is hoped will be more effective coming from patients.
BOX 20 Case study 16: diabetes mellitus (continued)
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BOX 21 Case study 23: diabetes mellitus
Mobile phone applications for diabetes service users: mixed-methods intervention
feasibility study
Description of patient and public involvement
Four YPD as advisory group.
One local community volunteer (experienced in PPI) also a coapplicant.
Another PPI coapplicant was meant to be a co-researcher but dropped out. A third coapplicant was an expert
by experience.
Involved in developing initial idea, bid writing, design of study, giving feedback on mobile phone applications
(apps), contribution to e-mail discussions.
Recruitment of PPI: coapplicant PPI through previous research contact, and local voluntary representative.
Normalisation Process Theory
Coherence: divergent understanding within the team regarding the PPI model, as research is user led. Concerns
that the YPD on PPI advisory panel may not fully represent the (hard to reach) service users. Strong belief in
value of PPI for more effective, relevant research/service development.
Cognitive participation: PPI in study has assigned co-ordinator from HEI cluster who runs YPD advisory group
with research assistant. Strong buy-in across research team – allied to study being user-led research, but YPD
have to be prompted to do their PPI tasks. Continued PPI has been a challenge to maintain here because of
other demands on time and geographical remoteness. Coapplicant also dropped out.
Collective action: ‘virtual PPI’; never had a full team meeting – lots of e-mail discussion. YPD advisory group run
separately (at their request) but mechanisms for feeding their input back to researchers unclear. Payment for
PPI well handled – some flexible use of the project’s PPI budget to support participation. PPI on steering group
believes they have challenged the team.
Reflexive monitoring: strong interest in evaluating PPI within the HEI cluster, but very little in evidence on
this project. No minutes of meetings; mechanisms by which PPI informs study clear at bid development
phase, but not always so in running of the project. Mixed assessments of the value of impact of PPI YPD
advisory group.
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The benefit of this virtual form of PPI was obvious:
I’ve got a main informant on Twitter . . . asked her if she could work with me on developing a paper
and she’s a young person . . . and so she basically threw some question out to Twitter to her one and
a half thousand followers . . . and we sort of put some questions to them and we’d written a paper
within 3 weeks.
CS23Res04-01
Case study 23 also had an advisory PPI group made up of four young people with the condition. At their
request, this group was hosted separately from the research team meetings and deliberately had an
‘informal feel’. These separate meetings were envisaged to be a series of evening, face-to-face meetings
with monies allocated to cover travel expenses. However, in reality, as a result of competing demands
placed on the attention of this age group, the group did PPI ‘virtually’. Co-ordinating such involvement
was a significant workload, which was difficult to predict and cost for. However, as this was adapted to
over time, the tracking radar plot became fuller.
Radar plots





































Patient and public involvement impact and outcomes
Research priority setting: original research idea builds on PPI coapplicant’s website.
Study design: research question and design confirmed as relevant but more clearly defined by diabetes service
users ‘expert patients’ panel; split original proposal into two target populations and approaches.
Recruitment: research web pages more younger person-friendly and language less clinical in style. Young
person with diabetes mellitus helped to recruit participants to test apps via social media.
Dissemination: researcher and a main participant/informant on Twitter coauthored an invited journal paper.
YPD, young people with diabetes mellitus.
BOX 21 Case study 23: diabetes mellitus (continued)
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Reimbursement
Reimbursing lay representatives for their time is intuitively an enabler of trust and seen as normal good
practice, yet payment for time was surprisingly rare in the case studies, although all were paid for out-of-
pocket expenses. This was not only because of financial restraints but also reflected a continuing debate
from a minority of respondents on how payment fitted with the notion of volunteerism. For example, in
CS08 (see Box 13) PPI was felt to be more of a voluntary role, which payment would then ‘professionalise’:
No, I think it should be voluntary . . . because you’ll be paying for services for like, I guess, advice or
public feedback, if you’re paying them then it’s, I don’t think, it’s more official, I guess . . .
CS08Res02-01
This was rejected by many lay representatives:
It is and part of the problem is that people just kind of make an assumption, oh they’re patients, we
won’t need to pay them. And you know our time in our life is just as . . . important as a researcher’s or
a doctor’s.
CS14PPI02-01
Among the five case studies reimbursing for time, the amounts ranged from £25 per meeting to £75. This
was often enabled by the host organisation, such as a CLAHRC or research centre. However, even within
well-funded host organisations such as HEIs, researchers related institutional barriers to paying lay
representatives within institutional systems reliant upon inappropriate standardised status classifications
(such as lay people having to be classed as visiting lecturers), electronic forms and difficulties dealing with
cash refunds, as well as payments affecting lay volunteers’ benefit payments and tax arrangements. Hence,
the host organisations that managed reimbursement and arrangements seamlessly made lay representatives
feel a collegial partner with the organisation.
National charity representatives reported that they were being asked to be involved with an increasing
number of research studies, which is not necessarily the main part of their work. One PPI representative
called for there to be some recognition of cost to the organisation and the consequences:
there must be other charities like me in other therapeutic areas who are getting the same issues . . . So
I would have thought that we should be looking at this at a national level to say if patients are going
to be involved in research in a way that they have not been previously then they need support to do
that and it should not, all of the cost of doing that, should not fall solely on the third sector. We
should be getting some kind of NHS/government DH [Department of Health] support for this.
CS14PPI02-01
One paid charity representative said her workload was such that she did PPI work in her own time. Perhaps
in acknowledgement of this, another charity representative in a PPI role was contracted (part time) by the
research project – yet further blurring the lines between PPI and researcher. It could also be argued that
paid employment also introduces different obligations and commitments to involvement, although it has
the potential to clarify an otherwise open-ended commitment.
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Opportunities for patient and public involvement throughout
the research process
A characteristic of studies with fully embedded PPI was that opportunities for PPI in all parts of the
research process were fully exploited. The CMO configuration for this action is shown in Table 16. As an
enabling context for embeddedness, it was not necessarily how the PPI was organised but how much
PPI representatives were encouraged to be involved and were exposed to different areas of the study
throughout its stages where they could have an impact. There were reservations from some researchers
on the potential for PPI in the early work of basic science designs (C3). However, we found that, with
appropriate training (C2) and experience, lay representatives were effectively contributing to funding
decisions for basic science studies, and prioritisation for tissue bank studies. This was further enabled by
having a pool of lay representatives (C6) with sufficient interest and expertise to contribute effectively at all
stages of the research.
Patient and public involvement and the research cycle
Performing the necessary tasks for PPI appeared limited to certain stages of the research cycle. Some
researchers recognised the importance of having PPI before studies were funded but acknowledged the
difficulty of finding appropriate PPI representatives in a short time frame. Many researchers felt comfortable
involving PPI representatives in the general review of study documents but not so certain about involvement
in other parts of the research process. In most case studies there was significant PPI during study set-up,
but this often decreased as the research progressed, for example when patient recruitment or data collection
started. Researchers often reported that the pressure to recruit research participants (during data collection)
resulted in less capacity to enable involvement of PPI representatives. This impacted most on relational
aspects, with changes evident in this sector of the NPT radar plots.
The distinctive characteristic of case studies that enabled involvement at all stages of the research process
was the presence of a dedicated individual facilitating PPI (e.g. CS21, see Box 6). A complementary or
alternative approach was having a lay coapplicant who was fully involved from the inception of the design,
and sometimes undertook an outreach role, or worked as an integral part of the research team. Case
study 04 (Box 22) had one experienced lay member as coapplicant; this was enabled by the research topic
being focused on a patient evaluation tool, and by having an established PPI group with experienced
lay members.
Patient and public involvement in different research designs
Funders and some researchers espoused stereotypical assumptions about the limitations of PPI in certain
research designs, such as basic science, which has traditionally been an area with little PPI. A PPI co-ordinator
working in a medical setting and talking about CTIMP (clinical trial of an investigational medicinal product)
research observed that, because some researchers believed patients have difficulty in understanding the
science and bench side of research, they find it hard to engage and have meaningful PPI. Similarly, one
funder suggested PPI was more compatible with applied science:
I think it comes down to the complexity of science and the type of research that you’re talking about,
some studies: when it’s very kind of lab based and it’s very molecular, doesn’t really lend itself to
being able to involve the public or patient, you know, at a very kind of technical level. But there are a
lot of opportunities in medical research where it is viable and it is possible to do it.
Funder03
FINDINGS FROM THE CASE STUDIES
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BOX 22 Case study 04: diabetes mellitus
Questionnaire development: evaluation of self-management programme,
mixed methods
Description of patient and public involvement
Experts by experience.
Number of levels: focus group, consensus event (10 people) (not consented so counted as public involvement);
two lay representatives on steering committee (one of the lay representatives is also on the research team and
is particularly experienced; has been on diabetes user group for 3–4 years and been involved in other
research projects).
Stages: involved throughout, as one PPI representative is on research team.
Recruitment of PPI: diabetes user group and known to CI.
Normalisation Process Theory
Coherence: both researchers new to PPI, but both felt PPI essential to research: ‘seems ridiculous . . . without’.
Consensus event considered to be PPI. Researchers and PPI representatives agree on purpose of PPI; real
situations, bigger picture, quality of life, well-being and sense of worth.
Participation: CI is approachable, in contact a lot; ‘invaluable to have someone with the condition involved’.
PPI representatives view ‘amazing piece of research’.
Collective action: CI felt PPI not embedded within institution. PPI rep. talks of flat structure (relationship),
managing expectations, welcomed, included, round table discussion, not intimidating. Other PPI rep. had
thought she would not be sort of person for steering committee, as sounds too high powered, but persuaded
through personal contact. Travel, support organised.
Reflexive monitoring: comments given on questionnaire are recorded. Second PPI representative does not
consider self to have contributed very much. The end result is that questionnaire is unrecognisable from original
form (so can see impact of PPI input). Felt to increase validity of research, more balanced. PPI representative
suggested changing area of country when researching the education courses (national coverage). Questions
were ambiguous and section on pumps changed.
Radar plots





































FINDINGS FROM THE CASE STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
Other researchers also felt that involving PPI representatives in ‘technical’ discussions about certain research
designs was tokenistic, as they were able to contribute very little:
I mean we’re doing a review of reviews . . . so it’s methodologically very challenging, it’s conceptually
quite challenging, half the academics feel out of their depth, intellectually and conceptually. The PPI
feel . . . that’s not to denigrate them or to put them down in any way at all, it’s not what PPI is about,
. . . No, they come to the steering group and then they feel a bit left out and I think it’s a shame, I
think it’s, you know I think it’s disrespectful in a way that not having, I mean I think, for that project
it would be more respectful not to have PPI, does that make sense?
CS03Res04-01
There was also some evidence that researchers felt concerned that some PPI representatives who lacked
scientific understanding could jeopardise a study at the design stage. However, another funder challenged
assumptions about the ability of experienced PPI to review less applied, more basic science applications:
when we set up these committees, there was a fear or a worry that they would have trouble reviewing
basic science applications and therefore they would be more drawn towards the clinical ones, but
actually what happens is, it’s quite funny really, it’s almost the other way round. I think they can see
the pipedream or the hope at the end, and almost they’re more critical about clinical studies, I think
maybe because it’s closer to the patient benefit.
Funder01
Indeed CS17 (Box 23) successfully involved PPI in approving bench research proposals in genetic
epidemiology through a panel model whereby the PPI representatives are presented with lay protocols
written specifically for the panel.
Patient and public involvement impact and outcomes
Protocol: input into proposal (keep the patient in mind).
Design of intervention: questionnaire, issues added not thought of by researcher.
Dissemination: two papers written, one submitted to journal with PPI representative’s name as coauthor.
Outcomes of PPI: rewarding for PPI reps.
BOX 22 Case study 04: diabetes mellitus (continued)
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BOX 23 Case study 17: diabetes mellitus
Tissue bank database
Description of patient and public involvement
Established panel for over 10 years; about 30 on panel and two attend each monthly meeting (usually invite
four). Meeting and reviewing papers. PPI mixture of research-naive and ‘professional lay people’. PPI work more
widely than just the panel – work with primary care research network. Some of the PPI representatives do have
samples in the biobank (therefore participants as well).
Stages: involved at the beginning at proposal stage, sometimes PIS.
Recruitment of PPI: diabetes mellitus research network, county shows, shop staff, researchers go out to recruit.
Members decide which researchers should have access to database. Some members also from diabetes mellitus
research network.
Normalisation Process Theory
Coherence: new way of working for CI (was a tick box previously). Panel running some time (PPI now formal),
previously PPI more ad hoc. PPI representatives had not realised how powerful PPI could be before being
involved (changing the way studies go, outcomes relevant to patients). Researcher and PPI representatives
seem to be in agreement about the purpose of PPI and the value of it. PPI to help other people,
intellectual stimulation.
Participation: PPI representatives have sense of ownership. PPI representatives write articles for newsletters and
magazines encouraging people to take part in the research. CI committed to PPI and is the main contact. All
feel it should be part of their work. The CI uses the database budget to fund PPI.
Collective action: workload is manageable. PPI representatives know what they have to do, including
commenting on proposals, PIS and consent forms; ensuring more accessibility to lay people. Direct feedback in
the meetings, for example intervention is too onerous for people, information from own experience and own
health background. The panel votes on whether or not they think proposed research is a good use of the
database and samples. PPI representatives feel welcomed, communication is good. CI says group has to be
managed well. CI would like to offer the panel some training in the future (governance processes and ethics).
PPI representatives feel supported.
Reflexive monitoring: PPI representatives feel valued. PPI representatives suggested a toolkit for when you start
on a project (time commitment, travel expenses for different research networks). Feedback all the time – PPI
representatives know what happens after the meeting – whether proposals are approved or not.
FINDINGS FROM THE CASE STUDIES
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Levels of involvement
Beyond stages of research, respondents identified themselves as working at different ‘levels’ or degrees
of consultation and collaboration. Rather than being polarised, these approaches could be used
interchangeably throughout the project:
I mean research is knocking a billiard ball gently down a table to the other end and the role of the
public bit is to just have to influence and push it to the left, push it to the right, give the researchers,
oh it’s difficult to describe, isn’t it? Because it’s not, I understand entirely it’s not complete consultation
and on some occasions it’s taken seriously. I think, put it this way, to keep the researchers in touch.
CS03PPI02-01
To me, I mean, I think there are different levels at which you can involve people through the standard
three levels. I mean, to me, we like to work with people as collaboratively as possible. I realise there is
a role for consultative involvement in research but, for me, it’s being able to work in partnership really
with members of the public to help design and to have ideas for research really.
CS21Res02-01
Radar plots





































Patient and public involvement impact and outcomes
Research priority setting: PPI representatives decide on which researchers have access to database/biobank.
Ethics: PPI adds strength to ethics committee submissions.
Recruitment: PPI representatives involved in writing articles to involve patients. PPI representatives tell friends
about a new study. Research more patient friendly (PIS).
Outcomes for PPI: PPI provides intellectual stimulation; socially, meet like-minded people.
BOX 23 Case study 17: diabetes mellitus (continued)
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Although none of our case studies was user-led, as described in the previous section some did have lay
representatives as coapplicants or co-researchers (CS04, CS19, CS21 and CS23), although levels of
involvement also varied. Although CS17 (see previous section) did involve lay representatives at all stages,
researchers also raised as an issue the move towards lay representatives as coapplicants. There were
concerns that this was becoming the ‘gold-standard’ of PPI and people questioned if all study designs are
suited to having PPI representatives as coapplicants:
it is difficult to have coapplicants on the kind of research we do, because of the nature of it, you
know, if a member of the public came up and said I think you should compare the level of HbA1C
[glycated haemoglobin] compared to glucose, they wouldn’t be a member of the public, they would
be a scientist, to even know what the question was . . . because I think there is the idea that being
coapplicants, and making videos is a measure of doing good PPI.
CS17Res01-04
Nevertheless, some felt that funding was more likely with a PPI representative as coapplicant; but this was
not confirmed by any of our funder respondents. However, there was clearly a lack of reflection on
whether or not having lay coapplicants made any particular impact on the research process and outcomes.
Reflection, appraisal and evaluation
Only two of the case studies provided any evidence of systematically appraising the PPI contribution to their
study. However, funders’ requirements (C1) for an evaluation of PPI in the final report were beginning to
have an influence, but any evaluative work was less commonly a collaborative endeavour for a research
team. In contrast, host organisations (C7) that had embedded PPI infrastructures were more likely to
evaluate and fine-tune PPI processes in a collaborative way. Having developed over time, embedded PPI
infrastructures also enabled positive relationships (C5) in which researchers and lay members could reflect
honestly on what and what had not worked well. Table 17 illustrates the CMO configuration for this action.
Systematic appraisal of patient and public involvement
Of the two case studies with systematic appraisal, CS13 (see Box 16) had an annual evaluation, with a
review of the PPI contribution and model at the panel annual general meeting. The researcher co-ordinating
PPI ‘measures’ the extent of PPI against published best practice guides to assess if PPI can be of use in further
phases of the research:
The NIHR, five or six points in the research cycle in which people should be involved, I’ve always
bought into that notion, so we try and use that as a template for judging how we’re doing internally.
CS13Res05-01
Case study 21 provided the RAPPORT study with numerous documents which recorded PPI activities and
impact but currently did not formally evaluate PPI. However, the case study site was actively involved in
piloting an evaluative framework for PPI with clear intentions to change its PPI practices in future to
include systematic appraisal.
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However, researchers often did not have the time or resources to record PPI activities and reflect on PPI
input, and some did not see it as something they should be doing. Respondents from CS06 (Box 24)
saw PPI as an implicit part of the research process and hence not requiring discrete evaluation:
I wouldn’t say it has added value, I think it’s actually fundamental to, to the research inquiry . . . it’s
not just added value, it’s intrinsic to the inquiry.
CS06PPI01-01
However, as the NPT radar plots illustrate (bold box), although there was no systematic evaluation of PPI,
respondents did individually appraise PPI as worthwhile in the study.
Other researchers struggled to evaluate PPI because there was little guidance or knowledge on how to
carry out this task and recognised: ‘it’s quite hard to evaluate I would have thought’ (CS08Res01-02).
Despite the lack of systematic evaluation, some research projects did record PPI activities, providing a
baseline to document PPI input.
BOX 24 Case study 06: public health
Physical activity in older people in primary care: randomised controlled trial
Description of patient and public involvement
Hybrid model consisting of one-off events for less experienced PPI, and an advisory group including a more
experienced PPI with more commitment/ongoing responsibility required. Member of the general public. Three
development focus groups (approximately 60 people) held with participants from earlier pilot.
One PPI focus group (nine people) to look at project participant paperwork, before ethics committee approval.
One PPI member on advisory group from local community voluntary service.
Chief investigator also got feedback on dissemination materials from three older people: one trial participant
and relatives of researcher.
Stages: in all stages, apart from data collection/analysis.
Recruitment of PPI: participants in pilot study and local (recommended) voluntary representative.
Normalisation Process Theory
Coherence: CI less experienced at using PPI, so takes steer from highly experienced coapplicant (has a deep
working knowledge of PPI in this field and at HEI, where PPI is strongly embedded). Other research team
members see PPI as closely linked to trial participation. PPI representative on advisory group sees PPI in wider
context of community voluntary service participation in service/policy consultation.
Cognitive participation: all research team very keen, PPI members in focus groups strongly perceived to have
been very keen too – there was a waiting list.
FINDINGS FROM THE CASE STUDIES
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Collective action: coapplicant is highly attuned to power dynamics of PPI. Research team employ their different
professional skills/relationships with PPI to good effect. Previous/ongoing relationship of research nurse with
PPI (part of GP practice) highly significant. Providing food/refreshments significant in light of no payment. PPI
representative on advisory group has a lot of trust in team and their professionalism. Pacing of implementation
focus group was perhaps too intense according to CI. No training offered or requested.
Reflexive monitoring: clear contributions systematically recorded, with implications, but changes not necessarily
fed back to those involved in focus groups. PPI representative on advisory group sees the endeavour of PPI as
intrinsic to research.
Radar plots





































Patient and public involvement impact and outcomes
Marketing the study: changed project logo and images used on PISs.
Design of study: participants on previous (pilot) study ‘came up with’ study design for this RCT.
Design of intervention: refined participant intervention – time taken to complete, better tailored to older
‘healthy volunteers’.
Recruitment: changed language used to identify participants, not ‘seniors’ or ‘elderly’ but age range. Clarity of
invitation letters, PIS, trial handbook improved. Include images of older people from different ethnic groups and
both single and couples, and specify exactly what the intervention group and control group did in the trial.
BOX 24 Case study 06: public health (continued)
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For some researchers a lack of robust evidence on the value of PPI was a problem. In CS10 (Box 25) it was
explicitly recognised that what was seen as ‘worthwhile’ by the general public might not be seen in the
same way by researchers:
especially not to researchers. To people outside the world of research, I can reason very happily [on
the value of PPI]. But researchers want evidence and that’s the holy grail, and I haven’t seen it yet.
CS10Res04-01
The rather mixed view on the value of PPI within CS10 can be seen in the radar plot in the case study summary.
Within the tracking radar plot, the impact of questioning the value of the PPI in this study is marked.
BOX 25 Case study 10: public health
Trial of self-help materials for the prevention of smoking relapse: randomised
controlled trial with parallel qualitative study
Description of patient and public involvement
Experts by experience, using a ‘consultation’ approach.
Two PPI representatives on trial steering committee (one could not attend meetings and did not comment
on materials).
One PPI representative (ex-smoker) gave one-off feedback on intervention booklets.
Local PPI patient involvement group provided (one-off) feedback on PIS, for further linked qualitative study.
PPI co-ordinator attached to this patient involvement group, little input.
New PPI representatives 2013: one person to take on the trial steering committee role (replacement) and
another interested in the qualitative study (both have academic backgrounds).
Stages: development and developing study materials, refining intervention and on committee.
Recruitment of PPI: local PPI group and CI recruited other ‘lay’ representative. Mixture of smokers
and ex-smokers.
Normalisation Process Theory
Coherence: research team less clear on purpose of PPI in this project, or its potential further application. PPI
contribution as mostly collaborating to redesign booklets and giving feedback on additional qualitative study
bid. PPI representative recruited by CI was not aware of PPI as a broader ‘movement’.
Cognitive participation: CI less experienced in using PPI and not clear on validity of PPI, especially when
recruited via PPI networks. Researchers: normal practice to them; see the PPI in this study as relatively
straightforward, unproblematic. PPI representatives have mixed views on the value of PPI in this study.
Collective action: researchers understand the importance of PPI in tailoring process to suit volunteers, although
they question costs associated with local PPI group model. Secretarial aspects of checking project materials for
clarity suited PPI representative but less confident about commenting on research design (although has had
training). Lay PPI representative happy to help, would have done it for free (convenient, interesting, local).
FINDINGS FROM THE CASE STUDIES
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Enabling contexts for evaluating patient and public involvement
Funders’ requirements (C1) were a strong enabling context for evaluation. For example, the requirement to
report on PPI when NIHR-funded projects were completed was a major incentive for researchers to review
processes and benefits of PPI in the project. Indeed, some case studies agreed to be part of the RAPPORT
study as an aid to meet this requirement. However, approaches to evaluating the outcomes and impact
of PPI were shaped by the funding organisation’s stance towards PPI. The data from the programme
management organisations strongly resonated with the methodological argument for PPI; hence, the
organisations were actively seeking ways of evaluating the impact of PPI on research outcomes. Approaches
cited, however systematic, seemed descriptive and biased towards ‘good news’: the collection of illustrative
case studies and the specific identification of PPI in the final research report, as described below.
I ask that all the monitoring programme managers, if they spot something really interesting or good
or unusual or positive, that they just let me know. And then I keep a spreadsheet of all of those for
posterity, for, you know, when I start doing, we’re doing a lot of work on impact here . . . we’ll have
more ability to really get in and look at good examples of PPI.
Funder04
Reflexive monitoring: CI and lay PPI question the contribution PPI actually has to project. Very little supporting
documentary evidence, not clear what specific changes PPI made to intervention booklets or PIS for qualitative
study. No PPI in minutes from first two committee meetings (did not attend or send comments), in final
committee no comments attributed to new PPI person. PPI rep. feels they made a minor contribution.
Radar plots




































Patient and public involvement impact and outcomes
Design of study: PPI representative on trial steering committee (along with other local panel members) provided
timely feedback on lay summary for additional qualitative bid. Two new PPI members have input into the
interview topic guide.
Intervention: refine self-help booklets – better tailored to population targeted. Clarity of PIS improved.
BOX 25 Case study 10: public health (continued)
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There was evidence that this focus on evaluation, although not fully assessing and comparing impact,
was resulting in some modification to the funder’s PPI work, for example developing advice to support lay
representatives on trial steering committees.
For the funding organisations framing PPI more in the engagement paradigm, evaluation was focused on
the impact of public engagement activities, and a web-based tool was used for researchers to record their
public engagement activities and outcomes. For the condition-specific medical charities, again perhaps
shaped by their moral stance on PPI, there was anecdotal evidence of where PPI has had an observable
impact: ‘I think that they [grant applicants] have an increased awareness of the fact that they have to write
a good lay summary’ (Funder01). However, there was no systematic appraisal of this.
For lay representatives, a positive appraisal of PPI was shaped not only by a positive experience (C8), but
also by personal outcomes. Described further later, these outcomes included increased understanding of
their health condition:
I read some of the interviews from other patients . . . it really helped me because personally . . . reading
about how people are suffering from it and I’m not the only one, other people are also going through
the same sort of problems, yeah. So some people do get better, people still live a happy life.
CS18PPI02-01
For others it was a sense of giving something back to the health-care system:
I then felt well if I can do anything, you know for the greater good, I was happy to do it and so I get
out of it the feeling I’m making a contribution towards the research and the further development of
treatment for patients with rheumatoid.
CS14PPI01-01
A number of researchers also felt PPI was worthwhile to them personally beyond impact just on the
research process and outcomes. Researchers spoke of PPI bringing them closer to patients or service users,
and reminding the researcher about the real aim of the research:
remind you a bit why you’re doing it because sitting in front of a load of numbers you sort of think,
you know you’re doing it for those people. Because that’s the population you’re working with.
CS13Res01-01
A positive experience of PPI was often the start of the process to establish PPI as normal practice:
she’s really been the one that’s been my epiphany for understanding patient involvement more
than anyone.
CS08Res01-01
Equally, a negative experience of PPI could hold up this process for some time:
I did an informal questionnaire amongst patients who we saw in the secondary care clinic, research
patients, asking them to identify, you know, suitable research topics. However, I didn’t find it was very
useful, patients mainly said that research should be concentrating on identifying a cure for diabetes,
and that’s not completely helpful as that’s like a very long-term goal in research . . . then that sort of
coloured my views of PPI for a little while afterwards thinking, hmm, I’m not sure really what patients
want to get out of it or whether they have enough knowledge about the research process and
personnel involved to be able to contribute effectively.
CS02Res02-01
FINDINGS FROM THE CASE STUDIES
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Modifying future work
The majority of the case studies reflected on their PPI approaches only informally towards the end of the
study, so there was minimal evidence of any changes within actual case studies. However, in a longitudinal
cohort study (CS14) there was also evidence that being a case study within the RAPPORT study provided
the opportunity for participants to reflect on PPI and plan things differently for the future:
you’re making me think [interviewer], maybe I should do a little leaflet to send out to show them all
what we are doing with their information. So as I’ve been talking to you that’s something I will be
doing differently and I’ll bring it up at the meeting that we should be sending them an update
or feedback.
CS14Res03-03
This case study (Box 26) was supported by minimal PPI infrastructure but the impact of reflection can be
seen in the tracking radar plots (bold box).
For the majority of case studies, either modifications to PPI approaches would be operationalised in future
studies, or the influence of that particular case study was affecting PPI approaches within other studies:
What is great now, lots and lots of studies are coming through . . . other departments who weren’t
doing any PPI or patients, it is forcing them, I have access to a group of volunteers, pre-screened; you
need to do PPI to get them! . . . we are getting sport scientists, oncologist, all sorts of people; the
meetings are becoming more and more interesting . . . now the meeting [panel] has such a wide
diversity of studies that are being discussed.
CS17Res01-03
BOX 26 Case study 14: arthritis
Prognostic factors in early arthritis: cohort observational study
Description of patient and public involvement
Hybrid: national representative, local service user group and expert by experience. However, these components
did not come together and hence there was no cross-fertilisation. The national representative has advised
nationally (multicentre) but the other lay representatives are just asked to be involved when needed, for
example in the training of research nurses.
Recruitment of PPI: the national representative was formally recruited but the service user reps and expert
patient were invited as CI’s patients. Service users also undertook dual role as study participants.
Age of study: started well before PPI in research movement, so rather ad hoc.
Normalisation Process Theory
Coherence: Less evidence of a shared understanding of the purpose and definition of PPI.
Participation: different levels of buy-in and some hesitation over recruiting PPI representatives who do not just
talk to a personal agenda.
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Hence, while the CS17 (see Box 23) tracking radar plot showed minimal change in the reflexive monitoring
segment, if expanded to the research environment in which it was hosted then a far more significant
change could be noted.
Nevertheless, extensive future changes to PPI approaches could be inhibited by a lack of understanding of
what is possible, as exemplified by CS09 (Box 27):
I don’t know how you go about involving patient and public in planning research, that maybe sounds
a bit silly; in my mind I have a big question mark about how it works: before you recruit anyone to the
study you need ethical approval, and to me asking patients potentially what they want research to
entail, is in a way recruiting them to a mini study before the main study.
CS09Res02-01
While the radar plots indicate a comparatively embedded level of PPI, future potential impact of PPI is
constrained by researchers’ beliefs. This reinforces findings presented earlier where potential PPI impact
was inhibited by boundaries set by the research team.
Collective action: relationship key and is underpinned by a long-term clinician–patient relationship. The national
representative is finding the workload of being involved in a number of studies challenging. The lack of
reimbursement of their time is a problem and has consequences for the national charity. Limited PPI infrastructure
means ad hoc approaches. Blurring of PPI in service delivery and PPI in research.
Reflexive monitoring: more how it has impacted on research process rather than outcome. Lots of personal
benefit for PPI representatives. Using a service user group was seen as having benefits but may require a









































Patient and public involvement impact and outcomes
Design of study: PPI representative on trial steering committee (along with other local panel members) provided
timely feedback on lay summary for additional qualitative bid. Two new PPI members have input into the
interview topic guide.
Intervention: refine self-help booklets – better tailored to population targeted. Clarity of PIS improved.
BOX 26 Case study 14: arthritis (continued)
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BOX 27 Case study 09: IDD
Diagnostic testing during pregnancy: questionnaire
Description of patient and public involvement
Two national representatives of two different support groups. Both PPI representatives sit on project advisory
group; one of them carries out much of the qualitative analysis.
Normalisation Process Theory
Coherence: PPI representatives have seen an increase in PPI activity over the years. PPI rep. believes formal
structures for PPI are a good thing. PPI believed to be important, valuable and worthwhile. Agreement among PPI
representatives and researchers. PPI representatives feel listened to and not just because they have to have PPI.
Participation: can make medical ideas understandable for users; PPI is extra work but not a negative.
Researchers will definitely use PPI in future (and one PPI representative is now a coapplicant on next grant).
Collective action: PPI representatives are confident to put views across, PPI representative doing qualitative
analysis (skills), other PPI representative commenting on main themes (sees her lack of research skills as
advantage), reassurance for researcher in a sensitive topic. One PPI representative and researcher know each
other personally.
Reflexive monitoring: talk of track changes to documents but back copies not routinely collated. PPI
representative has led on documents and views taken on board. Suggests a PPI mentor for less experienced
PPI representatives. Research paper changed because of comments made by PPI representative. Researcher
would like to work with individual women also but not sure how to go about it, unless through the charity.
Radar plots





































Patient and public involvement impact and outcomes
Design of study: PPI representative on trial steering committee (along with other local panel members) provided
timely feedback on lay summary for additional qualitative bid. Two new PPI members have input into the
interview topic guide.
Intervention: refine self-help booklets – better tailored to population targeted. Clarity of PIS improved.
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Impact and outcomes of patient and public involvement
As presented in each CMO configuration, case study actions led to a number of methodological and moral
impacts and outcomes. This section draws on the interview and documentary data to provide evidence of
the methodological impacts and outcomes of PPI within the case studies. Here we define impact as the
immediate effects of PPI, which may be intended as part of the objective for PPI within each study, or
unintended. Outcomes are longer-term effects of PPI in relation to the overall goal for PPI in each study.160
Eight of the 22 case studies concluded during the RAPPORT data collection period, so participants could
provide summative assessments of the impact and also possible longer-term outcomes of PPI. However, it
should be recognised that there are likely to be longer-term outcomes of studies that were not possible to
capture within the time scale of the RAPPORT study.
Impact and/or outcomes were described within 13 stages of the research cycle/process and there were a
range of topic areas with evidence of impact and outcomes (Table 18). The following section provides
evidence of PPI methodological impact and outcomes with specific examples from the 22 case studies.
Impact and outcomes are applicable only to certain research designs and, of course, are a function of the
original PPI objectives and overall goal.
TABLE 18 Methodological impact of PPI by topic area
Stage of involvement
Number of studies reporting impact/outcomes by topic area
Ar De Di IDD PH CF Total
Research priority setting 1 0 3 0 1 0 5
Identifying research questions 1 0 0 1 0 0 2
Linking to the wider community 1 0 2 1 0 0 4
Recruitment of research staff 0 0 0 1 0 0 1
Marketing the study 0 0 0 0 2 0 2
Study design 1 1 6 1 4 0 13
Study safety 0 0 1 0 0 0 1
Intervention design 0 0 2 1 4 0 7
Ethics submission 0 0 2 0 0 0 2
Recruitment (documents and direct recruitment) 2 2 8 2 3 1 18
Standardising outcome measures 1 0 1 1 1 0 4
Data collection/analysis 1 0 1 1 0 0 3
Dissemination 1 0 4 1 1 0 7
Ar, arthritis; De, dementia; Di, diabetes mellitus; PH, public health.
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Research priority and question setting
Five of the case studies reported that PPI representatives had been involved in research priority setting. For
example, the panel in CS17 had input into deciding which research should be funded, although we
received no documentary evidence to show the impact on decision-making. We were provided evidence of
PPI impact in identifying research questions. For example, the research centre hosting CS21 has a large PPI
group who are encouraged to put forward research questions, and this particular case study originated
from one of the parents. The structure of the research centre and the priority that this organisation gives
to PPI ensure that the ideas relevant to service users are carried out:
Because the very idea of the whole thing came from a parent, it’s been a very natural process to have
families involved in it all of the time, and I think that’s the beauty of getting the idea from the family.
You don’t have to then try and shoehorn PPI in, it’s already there. So, it’s just been from the word go.
CS21Res01-01
Linking to the wider community
Four case studies utilised PPI to provide links to the wider community. Case study 02 exemplified this
approach, with the single lay representative on the steering committee consulting with wider range of
people from the study target population. A newsletter to this group provides evidence of the impact of
this approach (Box 28).
In CS23, this PPI bridging role to the wider population (in this case younger people) was done via social
media and was an effective way of getting one-off input from an often less-heard group. This input was
used as a basis for a practice-focused article and also informed the development of the study (Box 29).
BOX 28 Documentary evidence: case study 02
Excerpt from patient organisation newsletter
[Patient organisation] members recommended changes to the draft proposal and these were incorporated into
the final version and into the current protocol. The suggestions included:
l the type of quality of life questionnaires given to patients to complete;
l the option that follow-up visits can also be conducted at the patient’s home;
l the assurance that as far as possible the same researcher will carry out all assessments for home visits to
ensure continuity of care;
l and the request for additional laboratory safety tests midway during the study.
BOX 29 Documentary evidence: case study 23
Excerpt from a published article
. . . what apps and websites are YPD [young people with diabetes] using? In order to review the use of apps
and other online resources by YPDs, one of the authors (PPI rep.) discussed the use of apps with her followers
on Twitter and friends on Facebook, asking three questions. 1. What apps/sites do you use in relation to your
diabetes? 2. What do you like about apps/sites and what don’t you like? 3. If your DSN [diabetes specialist
nurse] needs to know one thing about diabetes apps/sites what is it? At least 30 respondents posted responses.
DOI: 10.3310/hsdr03380 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 38
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Wilson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
105
Lay representatives were also used as a link to recruit study participants. Examples included writing articles
for newsletters to encourage participants to take part, being filmed as part of the recruitment video, using
social media or approaching people directly through their networks (support groups).
Such connections with other groups of members of the public or service users proved to be valuable in
recruitment, and in harnessing a wider range of (less accessible) PPI representatives/experiences, reassuring
researchers who were concerned about the PPI representatives not being a ‘typical’ lay person.
Marketing the study
Two of the studies had PPI input regarding study logos, and in the first study the logo was changed (Box 30).
However, in CS19 PPI advice was not taken on board, as the logo had been already commissioned and
developed by the team (and PPI coapplicant), but it was later criticised as being potentially insensitive by
steering group PPI representatives:
it was about their logo [. . .] I just hated it on sight, and their response to that was, ‘But we paid
someone to do it and . . . maybe . . . [other] people wouldn’t feel like that.’
CS19PPI02
Design of study
Patient and public involvement representatives made comments on the protocol and design of the study in
13 of the case studies, particularly regarding lay summaries, data collection instruments and study information
(Box 31). In other case studies PPI representatives were consulted over study design; for example, they were
asked whether a RCT or partial randomised control design should be used, and PPI representatives’ suggestion
of a RCT design (CS07) was accepted. In another case study the PPI representatives were asked if they
approved of particular methods of accessing patients’ notes (CS01). Data collection tools such as
questionnaires were ‘softened’ by PPI representatives in terms of language and sensitivity (CS09, CS21).
BOX 30 Documentary evidence: case study 06
Action log after meeting with 10 patient and public involvement representatives
There was a lot of discussion about the photographs used. They preferred the picture of the couple walking in
the wood, as this looked active and upbeat. However, they felt that there was also value in the older woman
with a walking stick, as there would be patients recruited who used walking sticks and this might appeal to
them. They suggested having the picture of the couple on the front and the older woman with a walking stick
and possibly a similar one of an older man walking on his own, on the back of the leaflet.
Action taken: We will stick to the idea of giving out the leaflet when participants come to see the research
assistant. We will use the picture of the couple on the front of the leaflet and the older woman with the stick
and a picture of an older man on the back of the leaflet.
FINDINGS FROM THE CASE STUDIES
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Safety of study
Involving patients’ groups in the governance of a study had evidence of potentially improving patient
safety. In the original proposal of CS02, the researcher conceded that the research study was presented in
a very clinical fashion and, because it was asking people to reduce the amount of a particular drug that
they were taking, the safety element (from the patient’s point of view) had not been considered. PPI views
(through a national charity panel) changed the application to include a safety questionnaire:
when I put together the original application, it didn’t really have much in terms of the safety element
because I had taken it for granted that people are already on [x drug], reducing the dose wouldn’t
make a big difference and I would have seen it in a clinical fashion, but as soon as we got the patients
on board and had their comments coming through, one of the things that seemed to be coming
through was a concern, or a potential concern from the patients that would it make them feel unwell
or would it do anything to them? So therefore we then added an extra element asking patients about
how they felt, safety questionnaires.
CS02Res01-01
The outcome of PPI here was reassurance for patients in terms of safety and also improved recruitment
rates, and a 3-month visit (for reassurance) was added to the study design for participants.
Design of intervention
In those studies which contained an intervention as part of their study design, PPI representatives helped to
design or make suggestions to existing interventions to make them more acceptable/feasible. In CS03 one
PPI representative suggested there should be more content on pre-pregnancy and diabetes mellitus, and
the documentation confirmed that more was added into the resource intervention (Box 32).
BOX 31 Documentary evidence: case study 13
Meeting notes
It was suggested at the last meeting that the third health-check webpage is too heavy on text and if the big
paragraphs could be reduced with the option to expand if someone is interested in reading more information.
The ‘read more’ function is tricky technically. [XX] has adjusted image and text so it fits better.
BOX 32 Documentary evidence: case study 03
Patient and public involvement workbook excerpt
I fully understand that you don’t want to go into the complexities of pregnancy with diabetes but I feel more is
needed to inform women of the importance of pre-pregnancy planning and quick action once they suspect
they are pregnant. Asian and Afro-Caribbean women are developing Type 2 at younger ages than the general
population and also the increase in obesity is likely to see an increase in younger women with type 2 . . .
[She goes on to explain about her personal experience of pregnancy and diabetes].
Action: to include more information pre-pregnancy.
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When the intervention was a questionnaire (CS04, CS07) the questionnaire was altered to include items
not previously considered by the researcher:
I’m sort of embarrassed to admit it, but I went to that meeting thinking, ‘I know everything that
should go in this questionnaire’, but I so didn’t, and loads of stuff came out in that meeting that I
just never would have thought of.
CS04Res01-01
In another case study (CS07) PPI representatives were involved in the validation of 260 pre- and
post-questionnaires (which were used as part of the intervention). The PPI representatives took the
questionnaire back to their local user groups and asked them to complete the questionnaire as
a pilot. However, there was also evidence that researchers perceived an unintended outcome of PPI.
In CS23 the CI (who was also a clinician) felt that the PPI representatives had steered the project
off course, and that the interventions developed were neither innovative nor adequately focused on
the research question.
Research ethics submission
Two of the case studies felt that having PPI helped their ethics submission by saying that materials had
been viewed and approved by PPI representatives:
they [research ethics committee] take note it, of course the committees have their own lay people and
I mean the one thing about lay people is they’re individuals like all of us, it’s a bit like a peer review
and you might get lay members of the panel who don’t really agree but they take note of it and I
think it carries quite a bit of weight, doesn’t always carry the day though.
CS01Res02-01
Recruitment
One of the most frequently stated outcomes for PPI in our case studies was a perceived increase in
recruitment rates to the research study (18 of the 22 case studies). Researchers commonly attributed
recruitment success to the PPI input to materials (suggestions on layout, size, language, colour, length,
readability, clarity and design; evidenced by tracked changes/before and after versions of documents) used
for recruitment (PIS, invitation letters, consent forms). Suggested changes were made either directly by the
PPI representatives themselves or by taking materials back to wider reference groups for further comments;
for example parents showing the PIS to their children. PPI representatives made changes to language such
as taking out the word ‘mortality’ or explaining technical words such as ‘lung function’. They introduced a
summary section at the start of the PIS and produced information in a small, credit card-sized, format for
people to carry in their wallets. Changes also included images of actual people wearing equipment or lying
on scanners, and extra information about the length of procedure and the weight and size of any
equipment was added (CS13 PIS).
One researcher felt able to quantify the increase in recruitment because of such PPI changes. A number of
different versions of the PIS and invitation letter had been submitted to ethics committees:
we changed a few things but we did [a] stage [at a] time so we could see what had an impact, and
that certainly did increase recruitment by, only you know, 1 or 2%, but 1 or 2% when you’re sending
out thousands a month . . .
CS12Res02-01
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Outcome measures
Research teams advocated the use of PPI for outcome measures that were relevant to patients; this was
particularly relevant to one arthritis study:
it was appreciated that there were certain things that we were measuring that we thought were really
important, these patients actually weren’t interested in at all and didn’t deem relevant, whereas other
issues we didn’t think were . . . well, we thought they were important, obviously, otherwise we
wouldn’t measure them, but we didn’t realise how important they were to patients.
CS14Res01-01
There was qualifying evidence here that the outcome measures had been changed or added to in the
research design. Respondents also reported that this change of emphasis was fed into clinical guidelines,
which may have an impact on patient experience.
Data analysis and collection
Two studies had PPI representatives involved directly in data collection. The PPI representative in CS18 was
involved in data analysis; she was asked because of her cultural knowledge and to reassure the researchers
that the analysis resonated with her experience of the ethnic ‘community’:
I want to check with the community that I’m not sort of completely going way off track here so I
guess in some ways that was her main role, more than in this situation the experience of living with
the illness really, it was actually her cultural knowledge that was most helpful.
CS18Res01-01
In one case study where this PPI role could have been applicable but was not utilised (CS21), this was a
deliberate restriction because of ethical considerations; many of the study participants would have been
known to the PPI representatives.
Patient and public involvement representatives also made a contribution to data analysis (Box 33).
The impact of this was clearly described by the researcher:
When I initially did a straight comparison women’s views versus health professional’s views, [PPI02]
suggested I break down the women, into those that had experience with [xxx] or [xxxx], compared
them to women who haven’t had any problem [xxxx] and we found quite big differences between
the two groups.
CS09Res01-02
BOX 33 Documentary evidence: case study 09
E-mail correspondence between lay representative and researcher
As you say, the difference in preference is interesting. What I could really do with – if you ever have five
minutes – is for you just to talk me through one or two of the tables as I am rubbish at interpreting
graphic info. And then you could also help me with understanding things like ‘conditional logit model’.
Was there any difference in responses from the [xxx] sample? I was just wondering whether they would
value accuracy fairly highly as they were painfully aware . . .
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Dissemination
Two of the case studies (CS17 and CS21) mentioned that the PPI representatives had presented the study
findings at conferences, and six examples of academic papers with PPI representatives as coauthors were
submitted to the RAPPORT study. One of the PPI representatives, who was working as an academic
researcher 3 days a week on the project, was first author of a paper (and her organisation was the charity
mentioned in the paper). Other representatives were mentioned in the acknowledgements at the end of
the paper. Some case studies in the RAPPORT study had not yet reached dissemination phases; however,
our tracking interviews suggested that, in a number of cases where it had been planned that PPI
representatives would be involved in dissemination, this had not happened.
Moral impact and outcomes
In addition to the outcomes which were identified in terms of the research project, the researchers and PPI
representatives also identified personal outcomes associated with their PPI role. The personal benefits of
PPI have been well documented, and those reported here echo previous studies. These included increased
self-confidence and mental challenge. The PPI role helped people to keep mentally active in retirement or
unemployment and provided the possibility of leading to other roles or responsibilities:
. . . enriches our research but also enriches their lives.
CS21Res01
. . . it just opens up a world of opportunities.
CS21PPI01
Interestingly, some PPI representatives spoke of the benefits of their involvement to the wider society:
‘maybe it’ll change the world a little bit’ (CS11PPI02-01). In CS03, the PPI representatives felt that they
could pass back information to their wider network and again be ‘boundary spanners’ (which Williams161
describes as ‘individuals who have a dedicated job role or responsibility to work in collaborative
environments’) between the academic world and the patient community:
I have met since my diagnosis other people who’ve had [condition] for many many years who haven’t
necessarily had access to much information or they haven’t, or they have had access to information
and services but it’s been a bit sporadic and I always wanted to kind of pass that information along or
back to people that I’d met, so . . . I’ve kind of been a lay tutor.
CS03PPI04-01
Longer-term outcomes
The RAPPORT study was designed to include studies that concluded during our data collection period,
with the expectation that outcomes of PPI could be summatively assessed. Among the eight that were
completed, we found no evidence of any immediate outcomes of PPI for the research findings. However,
out of these eight studies, five had demonstrated clear embedding of PPI and interestingly it was these
studies that clearly identified the outcome as developing further grant applications, as more research
was required. These five case studies were continuing to work with their lay representatives to generate
further research questions. Out of the remaining three, one was in follow-up, we could find no evidence
from the other two case studies of any particular outcome, and from a dissemination perspective there
was nothing publicly accessible providing results or outcomes of the studies. It is clear that, as in all
evaluation of research impact, longer-term outcomes influenced by PPI need an extensive time to detect.
FINDINGS FROM THE CASE STUDIES
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Conclusion
Collective understanding about the purpose and role of PPI was an important mechanism leading to
positive outcomes, and was enabled by training and certain topics and study designs. Values quite clearly
shaped this understanding, and there was some questioning of whether or not PPI was appropriate in all
study designs. Three main models of PPI were identified: a bounded, one-off model, an outreach model
and a fully intertwined model. Even in research settings with minimal PPI infrastructure, there was clear
evidence that establishing and maintaining relationships was crucial and required time. PPI as a dynamic
process was significantly compromised when relationships broke down. It was also clear that a dual role
(participant/involvee) was relatively common, and that an unintended consequence of the evolving national
and regional PPI structure was an outsourcing of PPI, with associated researcher disengagement. These key
areas will now be explored further in the discussion.
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W ithin the scoping, survey and case studies we tested what contexts were required to enable themechanisms informed by NPT to embed PPI in UK health research as normal practice. We have presented
six CMO configurations detailing the NPT mechanisms, enabling contexts and outcomes of salient actions
for PPI. These actions were focused on:
l the purpose, role and structure of PPI
l recruiting lay representatives likely to have an understanding of the diverse viewpoints of the target
study population
l engagement of the whole research team with PPI
l mutual understanding and trust between researchers and lay representatives
l opportunities for PPI in all parts of the research process
l reflection, appraisal and evaluation of PPI.
This chapter discusses the implications of the findings, and explores in more depth those results which
were unexpected. These include:
l lack of transparency, publicly accessible information and ongoing evaluation of PPI
l a lack of coherence in understanding and defining PPI
l within the national research infrastructure, the nuanced shaping of PPI through values
l frameworks and models of PPI
l enabling contexts for PPI, in particular the importance of relationships
l the impact of PPI.
How embedded is patient and public involvement within a
national research infrastructure?
Despite the limitations of the survey, it did provide some evidence that the proportion of studies which
included PPI has increased over recent years. Two surveys conducted in 2000162 and 2003163 attempted to
quantitatively capture the extent of PPI in English health research. The survey by Telford et al.162 of 66 NHS
research and development leads had a 73% response rate but fewer than 25% reported any PPI in research
activity within their respective NHS organisations. The survey by Barber et al.,163 conducted 2 years later,
comprised a randomly selected sample of 900 researchers from the National Research Register and had a
response rate of 58%. This indicated even less PPI activity in research, with only 17% reporting PPI in
their research studies. In comparison, our survey findings, with 79% of respondents reporting PPI in their
research study, show a notable increase in the extent of PPI activity. This is unsurprising in the light of the
flow of successive national policies aimed at increasing and embedding PPI in research.1,5,6,164 Major research
funders now expect to see details of PPI in their grant application and this was reflected in our results, where
NIHR-funded studies (which require PPI details) were more likely to confirm the presence of PPI.
Despite these encouraging findings indicating that PPI in research is becoming more widespread in
England, a number of limitations persist. A major finding from the scoping was the limited amount of
publicly accessible information about PPI contained in research documents, despite PPI having become a
requirement of many funding agencies. While the expectations of the funder were identified as a key
influence on PPI within grant applications and study designs, not only was there a lack of transparency
within documentation about how PPI would be operationalised, but there was equally a lack of
follow-through. This reflected the overall low quality of reporting PPI in studies.21 Paradoxically, while
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PPI processes may be articulated within grant applications, there is no corresponding documentation
providing evidence of monitoring or how the PPI strategy within a study may have changed as the research
developed. This contrasts starkly with the usual reporting of other amendments in study protocols, which
routinely undergo rigorous and transparent external monitoring and research governance auditing.
Furthermore, some responses received in the scoping, survey and case studies indicated that, although the
UK has one of the most extensive PPI research infrastructures in the world,165 there was evidence of a
persisting lack of coherence in understanding and defining PPI.
Coherence: how was patient and public involvement understood?
Echoing the earlier survey of Barber et al.,163 the RAPPORT survey findings suggested that some researchers
still have difficulty in distinguishing between research participation and PPI activities. There was some
evidence of this, albeit minimal, in the case studies. As described in the first two CMO tables, understanding
PPI as a different way of working was needed particularly to enable a clear role, purpose and structure
for PPI, and to ensure lay representatives were recruited who would have an understanding of the diverse
viewpoints of the study population.
The respondents most likely to confuse these terms were those less involved in submitting grant
applications, such as research assistants or research nurses. In the case of the latter, this may be caused by
less uptake of research training.166 Many of our senior researcher respondents were also unlikely to have
received any formal preparation for PPI, but the actual process of submitting bids (particularly for NIHR
funding applications) requires increasingly detailed descriptions of proposed PPI, potentially encouraging
more clarity in defining PPI.
Engagement, feedback or involvement?
While confusion between participation and involvement still persists among some junior and indeed some
senior staff, the boundaries between ‘engagement’ and ‘involvement’ were sometimes even less firmly
defined. In differentiating between engagement and involvement, we draw on definitions offered by
INVOLVE167 and National Voices168 which view involvement as a deliberative activity characterised in various
two-way processes such as collaboration or partnership. Our findings suggested that, in a minority of case
studies, simply providing feedback on, for example, the study results, despite being one-way information
giving, was seen by some participants as active involvement.
A recent study exploring PPI in commissioning services for long-term conditions57 suggested a model of
involvement as the product of engagement plus experience. Peckham et al.57 defined engagement as a
commitment to respond or interact. In terms of PPI in research this could mean the public attending
dissemination sessions, reading research summaries or going to engagement events. One of our
respondents from a funding organisation very clearly defined PPI in terms of this kind of engagement,
discussed in more depth later in this chapter. Our PPI respondents’ experiences were varied and included
public service, experience of a health condition as patient or carer and being a research participant.
If PPI is limited to engagement, this precludes the full potential of involvement. The model of partnership
synergy proposed by Lasker et al.105 illustrates the full potential of involvement where the sum of the
whole (PPI and researcher working together) is greater than the sum of its parts. Synergistic collaboration
leads to thinking that is comprehensive and holistic, creative, practical and transforming.
In one RAPPORT case study (CS10), a PPI representative was identified as such because he had the
appropriate experience of the public health issue being researched, but not of prior engagement with
the research process. His involvement in this study was limited to a one-off event and the data suggested
he was unlikely to actively seek to be involved in any future studies.
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The study of Peckham et al.57 also identified the impact of failing to maintain a two-way interactive
process, which leads to disengagement. Some of our PPI respondents reported feeling disengaged from
projects because of long periods of silence, and, if results of studies were not fed back, disenchanted with
research overall.
The dual role
While some researchers appear not to understand the differences between involvement, engagement and
participation in research,167 there is also developmental evidence of some explicit merging of research
participant and PPI roles, in which patients undertake a dual role as participants and also as lay
representatives. With the current focus on increasing patient participation in research trials169,170 and given
that involvement and participation are listed alongside each other in the NIHR’s aims for patient and public
awareness of research, the time may now be appropriate to examine the potential advantages and
implications of this dual role further. In particular, the ethical implications and the robustness of
knowledge gained in this way need to be explored further.
We found little evidence within the literature of the dual role, and discussions at our dissemination events
also suggested that this was seen as very unusual, if not ‘bad’ practice. However, Goodman et al.171
describe the benefits of involving young people in a study on transport and health as advisors, co-
researchers and study participants. While they acknowledge it is more in the research team’s interests to
recruit study participants, there were notable outcomes for the same young people in acting as advisors:
increasing self-worth and understanding of research, and having enjoyable work experiences. While aware
of potential ethical issues, the authors describe a reciprocal win–win situation for the young people,
schools and research team. Where managed carefully, such experience for both research teams and lay
representatives was also evidenced in the RAPPORT study.
Patient and public involvement: is it always needed?
While the majority of our survey respondents and case studies did report having some form of PPI, they
varied considerably in how many research stages and which levels of PPI activity this involved, with a few
case studies showing PPI as entailing only minimal, one-off activity. Not everyone believed that PPI was
essential to each stage of a study or was persuaded that benefits far outweighed potential risks,
particularly for studies nearer the laboratory end of the ‘bench to bedside continuum’.172 Arguments for
seeing PPI as less essential or more risky included there being a lack of evidence of PPI effectiveness in this
type of research. However, our analysis suggested that underpinning this assertion were several researcher
beliefs, including that lay representatives would not be comfortable with the more basic science and that
they lack the knowledge to understand it. A small number of researchers appeared to minimise the
general ability and skills of PPI representatives to contribute to research. Some respondents, including a
funder, had changed their view on this, and after initial surprise reported now seeing their lay
representatives as being able to understand and offer more than originally envisaged.27
Narratives also included researchers’ stories of lay representatives being seen as overstepping boundaries
and dabbling in science. A few researchers perceived a threat of the lay person taking over, an anxiety
reported in other studies.28 The supposed menace of experiential, subjective knowledge overturning
scientific notions of neutrality, objectivity and distance173 has been described in terms of a clash of two
worlds.130 However, McKevitt et al.,16 in reflecting on PPI in a stroke research study, argue that the moral
status of PPI balances out any asymmetry between these two worlds. Some of our case studies at the basic
science end of the research continuum did bear out the sustainability of such a viewpoint, with researchers
making great efforts to ensure active involvement.
In terms of amount of activities, PPI was most likely to be limited in basic science studies, where lay
knowledge was generally seen by researchers as less useful in this kind of research.39 Callard et al.172 argue
that failing to have PPI in the early stages of translational research may result in failing to capitalise on the
potential contributions lay representatives could make, including ensuring that the end product of bench
research must be appropriately designed for the end-user, and that ethical issues arising between any
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academic and commercial interests are challenged. The basic science studies in the RAPPORT study that did
have a firm PPI underpinning adopted a partnership approach,105 even though at times this partnership
came under strain, particularly over issues of who had more say in decisions about the use of data.
Conflict or tension, while posing difficulties to resolve, is not necessarily undesirable and, indeed, is
evidence of engagement,105,174 so much so that where it was managed well, through, for example, clear
guidelines, dialogue and consensus, it was seen to add to the strength of the case study in terms of how
embedded PPI was.
Values shaping patient and public involvement approaches
Two main stances, methodological and moral, appeared to shape the ways in which our respondents
viewed and operationalised PPI. A third stance (policy) described in Chapter 2, was the initial trigger for
many of the researchers and the centrally funded funders to engage with PPI. Analysis of the data from
these respondents suggested three pathways (see Figures 9 and 10).
A frequently found narrative, illustrated in Figure 9, was of researchers ‘having to do’ PPI because of
revised governance requirements.5 However, this often shifted to a subsequent ‘conversion’ to PPI when
they appraised outcomes of PPI as having had a benefit on the research outcomes. Policy was then no
longer required as the main trigger, so PPI activity became a self-sustaining virtuous cycle. A variation
found in this pathway, also demonstrated in our analysis, identified not only a ‘conversion’ in terms of
the methodological benefits of PPI, but also a move towards the moral value set whereby PPI became a
process that one should do because it is ‘right’. Of course, some respondents were embedded in this
moral paradigm and their pathways can be depicted in Figure 10. In particular, the funder representatives
from condition-specific charities articulated PPI as a moral imperative and, perhaps paradoxically, had
given little to no thought to if and how their PPI strategies should be evaluated as appropriate or
successful. In contrast, some case studies from the IDD topic area clearly presented a strongly coherent
moral stance on PPI. However, as well as seeing PPI as a given, the approach taken by researchers
from these case studies was an open one, actively seeking to explore ways of capturing the impact of










FIGURE 9 ‘Virtuous cycle’ of PPI triggered by policy.
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That values should have such a profound impact on shaping PPI processes is unsurprising and will be discussed
further in other sections. A project running at the same time as the RAPPORT study explored values in more
depth and suggested three value sets: normative (which we have termed ‘moral’), substantive (which we have
termed ‘methodological’) and process.25,175 Its process value set included concepts such as partnership and
equality, respect, trust and honesty, which we have mostly subsumed under our ‘moral’, ‘methodological’ and
‘policy’ value sets. However, whichever labels are used to define value sets, it is clear that different value sets
are seen to lead to diverse constructions of PPI,28,174 and can affect whether or not and how PPI is evaluated.52
It was specifically notable that values could be seen to shape the way PPI was organised within funding
bodies, with impact on how they evaluated PPI within their funded projects. The centrally funded programme
management organisations placed a clear focus on developing ways of capturing the methodological impact of
PPI, in contrast to the condition-specific charities, which followed a clear moral imperative to involve the people
who put coins into the tin. The influence of values on funders was further highlighted by the approach of the
large national funding body funded through endowments, for which the obligation was one of engagement
rather than any moral imperative to involve. An earlier study on funders also suggested that charities and
centrally funded organisations adopted different approaches and rationales for PPI.176 It should also be noted
that O’Donnell and Entwistle176 and van Bekkum and Hilton177 suggest that funders had many anxieties about
PPI such as its ‘distorting’ the research agenda. This was not reflected in the RAPPORT findings on current views
of funder organisations; the main concern from our data was the potential to overload lay representatives
with reviews.
The metaphor of an ‘industrialised’ scale of research suggested by our data echoes the similar argument of
Ward et al.39 that the trend towards consumerism has shaped the commodification of research. Although
we had no evidence of any of our lay respondents ‘shopping around’ for research projects to be involved
in, it could also be seen that one of the condition-specific charities had framed the end-user of the research
as being the consumer, and consequently including both patient and clinician as their ‘user representatives’.
Kreindler27 also argues that the consumer paradigm is predicated on consumer satisfaction, so that methods
for implementing PPI will centre on feedback. Our case studies offered examples of PPI approaches adopting
such methods, such as focus groups.
Moral value set regarding PPI influenced by
• individual’s belief set
• research topic PPI norms (researcher and lay
   representatives)
• funding body mission and funding source (funder
   respondents) 






FIGURE 10 Pathways triggered by moral value set.
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Models and commitment to patient and public involvement
While values were seen to have a major influential role in all our data, narratives also offered evidence that
values can and do change over time. One influence on such shifts was from the model of PPI used, which,
as seen earlier, is often triggered by one value set and then either the model is reinforced over time or a
subsequent shift in values leads to a new model being adopted.
Dynamic framework for patient and public involvement
The RAPPORT data supported a typology of PPI in research based on:
l who the PPI representatives were
l what the forums for the PPI representative–researcher interface were
l the approaches used.
This typology is not dissimilar to the conceptual framework suggested by Oliver et al.132 However, the
RAPPORT data suggested a far more dynamic framework (Figure 11) than that of Oliver et al.,132
recognising subtle changes over time. Within this more dynamic framework, the PPI approaches, forums
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FIGURE 11 Dynamic framework of PPI.
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forums may run throughout the life of a study. In contrast to previous observations18 that PPI
conceptualisations have not addressed the dynamic nature of PPI within research, our analysis, and the
framework that it underpins, is able to take into account a dynamic concept of PPI within a research study.
Value sets greatly influence PPI processes within a study; and relatedly, in turn, the model of PPI in each
study was seen to be influenced by the CI’s desired outcomes from the PPI input.18 For example, one
case study (CS01) recorded only a one-off narrowly defined PPI input, which reflected the CI’s reservations
about any benefits of PPI.
Patient and public involvement within a study was also partially shaped by the lay recruitment method.
Varying the methods of PPI recruitment was one means by which researchers tried to address the issue
of PPI representativeness, an often-questioned issue. The quest to find a person (or a group) with
characteristics as close as possible to a target study population173 was particularly challenging for research
teams in public health studies, where the target population would not necessarily see themselves as having
a health condition or need. Interestingly, those of our case studies which involved marginalised groups,
such as those with learning disabilities and IDDs, did not have particular problems in recruiting PPI
representatives thanks to the existing infrastructure for PPI developed in these areas. As argued by Barnes
et al.,178 representativeness in providing perspectives was achieved by merit of the lay representative’s
personal experience, particular characteristics (e.g. being an older person) or links with other networks
(e.g. representatives from local or national charities). However, what particularly vexed some researchers was
the perceived repeated recruitment of the same group of lay people, rather than of those able to bring a fresh
outsider perspective (discussed in Impact of involvement on patient and public representatives).
Our data also suggested that existing groups or panels were a pragmatic source of recruitment for many
researchers, and had benefits such as PPI members having some basic knowledge about the research
process, providing more than one voice and having support mechanisms in place. Many of these groups
were also able to reimburse lay members for work in developing grant applications, a particularly
challenging issue raised by many17 that could then be addressed. However, the PPI costs required in a
grant application proved a surprise to a minority of researchers, suggesting that further work needs to be
done in helping researchers understand the resource implications of supporting PPI. How often PPI
representatives were involved in successive research stages in our case studies could be presented as a
decreasing double bell shape, with activity focused on project set-up and to a lesser extent the
dissemination phase.
The forums in which PPI representatives and researchers came together provided similarly contrasting data.
The most common forum in our case studies was some form of study management committee. In many of
these committees lay representatives felt well supported and that their voice was heard, often primarily
enabled by relational work (discussed in Contextual enablers for patient and public involvement:
relationships). However, in some committees, other PPI representatives reported feeling lost by language,
procedures and lack of support, and unable to contribute effectively to these committees.
Scott179 suggests a number of rules and norms that govern such forums:
l regulative – the system of rules that shape and monitor actions
l normative – the rules for appropriate behaviour in that particular forum
l cultural-cognitive – the shared meanings that lead to unwritten agendas of ‘how we do things here’.
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Regulative rules may be written and formalised, for example in research governance frameworks, but
may not be understandable to lay representatives even if documents are provided. However, it is the other
two sets of norms that can cause most problems, as they may be unwritten and therefore not visible
to a PPI representative who is working with a research team for the first time, or is new to the work of
study management committees. Barnes et al.178 argue that these rules and norms have specific effects on
such forums. First, proscribing groups with which studies engage may affect access to such committees.
So, for example, certain lay representatives such as those with poor literacy or lacking access to a
computer may not be invited to be part of the committee. Second, rules and norms can define agenda
setting, including which items are included and who can take part in the discussion. Some of our data
suggested that some lay representatives felt unable to contribute to any item on the agenda, and certainly
had no say in adding any agenda item. Finally, the normative and cultural-cognitive rules and norms guide
the way the deliberation proceeds and is conducted. So, for example, some lay representatives sitting
on committees alongside eminent scientists followed unspoken rules that the scientists be allowed more
talk-time than other members of the committee. Effective chairing could often ameliorate this, and several
PPI respondents articulated the role of the chair in moving key PPI contributions beyond only tokenistic
membership of a committee.
Models of patient and public involvement
While we found different forums, approaches and people involved in a dynamic framework of PPI, and
traditional models of PPI with two or more representatives fully involved as part of a steering committee,
our findings also suggested three specific models of PPI which resulted in different levels of PPI impact.
The one-off model of patient and public involvement
We found evidence of a model with one-off, limited PPI input into the study with boundaries set by the CI
(Figure 12). While such involvement did achieve its purpose from the CI’s perspective, it also precluded any
further potential positive impact of PPI.
As this model was indicative of a CI who had reservations about PPI, it was unsurprising that we had few
case studies that exemplified this model, as we would expect that those agreeing to take part in the
RAPPORT study would be more engaged with PPI. Therefore, it is likely that this model may be rather more
common in the wider research community and so merits further exploration. It is also an interesting model,
as our analysis suggests that an unintended outcome was commodification, whereby PPI was ‘bought’ by
the CI for a specific task.
We can draw on Habermas’s theory of communicative action180,181 to illuminate this further. Habermas
suggests that the modern capitalist society comprises a ‘lifeworld’ where public and private experiences
and values are culturally and socially integrated, sustained and reproduced. Here, for example, we could
see how people living with dementia exist in a ‘lifeworld’ where experiences can be shaped by stigmatising
processes182 that are sustained and reproduced. One rationale for PPI in dementia research is therefore to
be able to gain understandings of these experiences from the perspective of service user and carer, and
how these experiences inform research priorities and design.
Research process
FIGURE 12 Model 1: the ‘one-off’ PPI.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
120
Alongside the ‘lifeworld’, Habermas argues, is the ‘system’ made up of bureaucracies, markets and policies;129
for example, this would include the bureaucratic and policy processes, and economic drivers of health research.
A key mechanism within the ‘lifeworld’ is communicative action, a consensual process whereby people
understand and share experiences. Within the RAPPORT study we can see communicative action within one
particular case study with families of children with disabilities (CS21), where they shared experiences which
were translated into research priorities. In contrast to the ‘lifeworld’, the ‘system’ is sustained by strategic
action, which may be conscious or unconscious. Therefore, the requirement for PPI as a condition for research
funding could be seen as a conscious strategic action. However, the tacit shaping of PPI through a process of
commodification would, through the Habermas perspective, be seen as the colonisation of the ‘lifeworld’ by
the bureaucratic and market interests of the scientific-technical system,183,184 which will then influence and
rationalise the ‘lifeworld’. In the case study with more limited PPI, PPI was bought in by the CI as a commodity
to demonstrate that those representing the target population would find the accessing of medical notes
acceptable. Because there was no sustained engagement with the PPI representatives, we were unable to
interview any of them, but our interviews with other PPI representatives suggested it would be unlikely that this
one-off activity could lead to engagement with the research study, or therefore any connection with PPI
representatives’ ‘lifeworld’.
The fully intertwined model of patient and public involvement
Seven of our case studies (CS03, CS04, CS07, CS09, CS13, CS17 and CS21) demonstrated a fully
entwined model (Figure 13), in which PPI was integral and ongoing within the research study. This model
demanded more resourcing, including a discrete co-ordination role, reimbursement of larger numbers of
PPI representatives, ongoing and proactive communication and building and sustaining relationships
between the research team, centre or host organisation and lay representatives. However, this model
produced greater impact than the one-off model and, without exception, had the fullest NPT radar plots,
indicating that PPI was embedded as normal practice.
This model was particularly exemplified in two case studies (CS13 and CS21), which had the most embedded
PPI as shown in the radar plots (see Chapter 6). The context for both was research being conducted in a
well-resourced research centre, jointly or totally hosted by a university. However, they differed in research
design, topic area (IDD and public health) and, hence, their tradition and history of PPI. They also differed in
PPI approaches, with CS21 tending more to user-led research in that the research question had been identified
by service users, but the actual research itself was conducted in partnership with researchers. In CS13, the
approach was characterised by a collaborative approach, with the panel an integral part of the research process
but as collaborators, not co-researchers. The key enablers for this model appeared to be the ‘work’ described in
all four NPT constructs and, in particular, values, PPI co-ordination role and relationships. Both studies also had
time, core funding and stability to develop a fully entwined model of involvement, where PPI was integral to
the research process. Therefore, this model was not possible for all our case studies even when actively sought,
because of limited resources.
FIGURE 13 Model 2: fully intertwined PPI.
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The outreach model of patient and public involvement
A third model was identified, which we termed the outreach model. This still entailed entwinement but
was looser and generally involved fewer PPI representatives: just one in some cases. The key feature of this
model was that this small number of PPI representatives provided a conduit to and from a wider population
from which they would bring back perspectives and views (Figure 14).
Recent literature has also promoted this model if the PPI representative is well connected to and has
credibility with the target population.185 Although this appeared to be an effective model which required
fewer resources, the resource implications are from the research team’s perspective and we had evidence
that this model increasingly relied on charities to perform the outreach function. This escalation of demand
on charities without associated funding to support this work has significant implications for sustainability,
and is discussed further later. Van Bekkum and Hilton’s study on funding bodies177 also suggests that this
model is being adopted by some funders, seeking representatives who could act as a ‘middle-man’
between the worlds of research and the public. While CS02 demonstrated a collaborative approach, it also
showed the potential for tokenism in this model if the individual is operating just to provide endorsement
of the study by the target population.
Contextual enablers: organisation of patient and public involvement
We wished to test out in our case studies and survey whether or not the principles identified for
successful PPI,137 or architecture for PPI in research,29 would be found to be prerequisites for effective and
embedded PPI. The PIRICOM study architecture for PPI included the principles gained through consensus
by Telford et al.,133,137 grouped here under three headings: processes (PPI activities/research interface),
resources and relationships (see Figure 15).
As reported in Chapter 6, having a clear purpose, role and structure for PPI was a salient action
undertaken by case studies with embedded PPI. As illustrated in Figure 15, we found that adequate
resources and the development of relationships over time were important enabling contexts, and these will
be discussed in Contextual enablers for patient and public involvement: resources and Contextual enablers
for patient and public involvement: relationships. However, what is not so explicit within the Brett et al.29
architecture is the need for someone to lead, and in particular co-ordinate PPI.
FIGURE 14 Model 3: outreach PPI.
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Processes
Early as possible PPI
Roles defined for PPI and
researchers 
Involve PPI reps in
developing participant
information literature 
Involve PPI reps in
decisions on participant
recruitment 
With training, PPI reps
can be involved with
data collection
PPI reps can identify
patient-important
themes in data 
Report how PPI was
conducted 




reimbursement for time 
Build in additional time
for PPI activities into
time scales 
Provide PPI reps with
appropriate training 
Provide PPI reps with
additional knowledge
of the condition/disease
to be able to contribute
effectively 
Provide researchers with
training for PPI 
Relationships
Establish good
relationships over time 
Encourage researchers
to have a positive












and avoid isolation 
FIGURE 15 Architecture for PPI (adapted from Brett et al.131).
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The co-ordinator role
A major feature of the case studies where PPI was strongly embedded was the presence of a person with
designated responsibility for co-ordinating and facilitating PPI within the research study. In some case
studies this was undertaken by a paid co-ordinator with general responsibility for a research centre’s
programme of work, for a UKCRN network or for a public involvement group serving a geographical area.
In other case studies this role was undertaken by the CI or assigned to another researcher in the team.
For the paid co-ordinators and assigned researchers, the role comprised various components (Figure 16).
Some of these components were also evident in the work of the CIs and the funding bodies’ PPI leads, and all
could be described as providing a bridge between two worlds: research and lay. This idea of bridging fits well
with the social network theory-derived definition of ‘boundary spanner’161 (see Chapter 6). Further exploration
of the specific features of this bridging role helps tease out the different approaches of these co-ordinators.











FIGURE 16 Components of PPI co-ordination work.
TABLE 19 Three aspects to the bridging role
Aspect Actions RAPPORT findings
Cognitive translation Bringing insights in from the public and
translating them into research questions
Case studies 21 and 23 had forums specifically
designed to do this, with members of the public
facilitated in turning needs into research
questions
Strategic translation Circulating and translating information
derived from research and public perspectives.
Establishing committees and procedures.
Clarification of expectations
Case study 17 PPI co-ordination was facilitated by
the CI. Panels and structures plus effective lines of
communication were a feature (see also CS13)
Logistic practices The practical work and time required to
enable both translations
Well-resourced case studies had discrete
administrative support for PPI, or researchers
would take the time and make the effort to carry
out these tasks
Source: adapted from Clavier et al. (2012).186
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One of our case studies (CS21) exemplified cognitive translation by bringing the public and service users
into the research centre and helping them translate their perceived needs into research questions. Strategic
translation was often undertaken by CIs who facilitated PPI within their study. They emphasised ensuring
good communication and feedback, and setting up structures for PPI within their study. For both aspects
of translation to work well, various logistical practices were required to ensure that PPI ran smoothly,
usually in the administrative tasks such as payment of expenses. In some case studies the dedicated
co-ordinator also carried out these tasks; in others this work had to be absorbed by the research team.
Our interviews evidenced respondents carrying out the PPI co-ordination role as displaying certain traits
reflecting Williams’s boundary spanners’ skills requirements187 (Figure 17), focused on managing
complexities through negotiation and building sustainable relationships. The nature, development and
facilitation of such relationships will be discussed more in Contextual enablers for patient and public
involvement: relationships, but our findings made clear that effective PPI co-ordination, whether within
research teams or funding bodies, depended heavily on the ability to build and sustain relations.
However, to see PPI co-ordination simply as a bridge between two worlds disguises its complexity. As
illustrated in Figure 11, within each case study, PPI was not static and boundaries between the research
and lay world were dynamic, constantly shifting. For example, over time, PPI representatives may become
less research naive and the nature of relationships and the boundary dividing the research and lay worlds
may subtly shift. Equally, researchers’ assumptions regarding PPI may change with time and again affect
the nature and permeability of the boundary. The evaluation of knowledge translation processes within
CLAHRCs by Evans and Scarborough188 suggested that the bridging model described above may keep the
two worlds apart. They argue that a ‘blurring’ approach is more effective in creating transformation.
Rather than rely on a single PPI co-ordinator to perform the boundary-spanning role, the blurring approach
requires both researchers and PPI representatives to adapt the skills they have to accommodate new ways
of working. This theory may partly explain why in the case studies with minimal PPI co-ordination there
could still be positive outcomes from PPI, and why in one case study with formal PPI co-ordination there
was minimal PPI impact: the worlds of research and lay had remained separated by a boundary that only
the co-ordinator could cross.














FIGURE 17 Skills for PPI co-ordination (adapted from Williams187).
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Patient and public involvement role descriptions and expectations
A pertinent finding in the RAPPORT study was the lack of formalised PPI role descriptions and expectations
in the majority of case studies. Indeed, in some case studies, it was seen as an explicit requirement that
roles and expectations were left as open as possible. The logic given was that, if a research team wanted
PPI representatives because of their personal experience of complex needs, then the role needed to be
flexible enough to accommodate these complex needs. Indeed, as CMO Table 12 illustrated, tightly bound
work specification for PPI representatives could limit their potential impact.
However, there was also evidence that a lack of clarity around role expectations could lead to a
breakdown of trust, with a negative impact on relationships and outcomes for PPI. Hence, it would seem
that some careful balancing between flexibility and clarity around expectations was required to enable
sustained embedding of PPI within a research study.
Contextual enablers for patient and public involvement: resources
As seen in the findings, some of our case studies did include PPI during the grant development phase, but
most exhibited an intense ‘PPI phase’, usually when developing ethics applications, and to a lesser extent
when findings including the development of a lay summary were disseminated. Surprisingly, and in
contrast to best practice,189 whereas all case studies reimbursed PPI representatives for their out-of-pocket
expenses, only around a quarter of case studies reimbursed for time. As discussed earlier, there was
evidence that this was becoming a very contentious issue, particularly for PPI representatives from relatively
small charities. There were five such representatives. One was a representative from the charity partially
funding the study so did not expect any remuneration. The second was being paid as a part-time
researcher, and a third took an altruistic stance, giving time free in the interests of those she represented.
However, two respondents who ran national organisations expressed doubts that it was sustainable for
them to undertake this PPI work with no recompense, as their absence had implications for the work of
the charity. They also called into question the idea that it was morally defensible to expect them to
undertake an increasing workload of PPI requests without some significant financial reimbursement. There
was evidence that both these charities were putting in place consultancy procedures and costs that would
need to be met in future grant applications.
Interestingly, PPI respondents also rarely mentioned the need for training. Although some had received
appropriate training, many lay representatives did not feel they required any particular training. However,
there was some evidence that researchers (particularly those relatively new to research) did want more
training and preparation for PPI.
The strongest theme to emerge from our data was the centrality of relationships to PPI. Whereas previous
work has highlighted the importance of the researcher–lay relationship, the RAPPORT findings illuminate
this further by teasing out the components that result in relationships being one of the most important
enabling contexts in leading to positive PPI outcomes.
Contextual enablers for patient and public involvement: relationships
Truman and Raine190 suggested that ‘the creation of evidence in health research is shaped by the social
relations of the research process as well as by the methodologies used’ (p. 215). This was very evident in
the RAPPORT case studies, with several clearly recognising the importance of emotional as well as rational
deliberation (cf. Martin 2011191). There were four components in enabling relationships: time, reciprocity,
arenas and skills.
Time for relationships to develop
Our data showed that meaningful relationships took time to develop, and this need had been reduced
within the great majority of case studies by having PPI representatives already known to the research team;
only 6% of lay representatives were completely new to the team. This may be a reflection of our sampling,
as CIs with UKCRN portfolio studies tend to be more experienced. Generally, PPI representatives were
known to the researchers through being involved in previous studies, being part of an established PPI
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group attached to the research centre or being a patient or acquaintance. The temporal aspect of
relationship building supported the development of trust.192 For researchers this could mean trusting the
PPI representative to not derail the project, behave according to the rules and norms of that context179
and/or make a positive contribution to the study. For PPI representatives, trust was a sense of security at
meetings that they would not be made to look foolish and their comments would be listened to; this was
always enhanced when research teams provided feedback on their response to lay comments. For PPI
representatives in a governance role, there was also a sense of trust that the research team would alert
them if there were any safety issues with the study. Time also allowed PPI representatives to develop their
skills192 to enable them to contribute to the study; many saw this ‘learning on the job’ as equally effective
as formalised training, if not more effective.
Reciprocity
To enable PPI, reciprocal trust and relationships needed to be built.101,193 Reciprocity is often defined as a
co-operative or mutual exchange of gifts or privileges.194 Criticisms of PPI include tokenism and power
asymmetries between researcher and lay representative.27,52,173 However, Ben-Ari and Enosh194 suggest that
focusing on such exchanges is too simplistic and that, within health research, reciprocity between
researcher and the lay representative occurs less through the exchange of gifts and privileges, but more
through sharing an issue of common concern or interest, reflecting the notion of mutual gain.195 This was
certainly evident in some of our case studies: PPI representatives willingly gave up their time to contribute
to a project for which they could see longer-term benefits. However, our data suggested that there was
another form of reciprocity, although not necessarily exclusive to the shared and vested interest in
the research topic. PPI respondents often reported an increased sense of self-worth and confidence as
an outcome of their PPI activity.196 Others stated that, if they gained knowledge of a specific condition or
services available for it, this was of personal benefit to them. There were others for whom the reciprocal
favour was either access to services or perceived maintenance of good services. For example, patients of
clinical researchers would often agree to undertake PPI as something to ‘give back’ for the quality care
they had received. Finally, for a minority, the reciprocal gift was monetary.
Arenas for relationships
Those case studies with embedded PPI, or that were particularly strong in relational integration, both used
arenas outside the formal research structures, where relationships could develop and flourish. Examples
ranged from entire days devoted to an exclusively social activity to, more commonly, the provision of food
and meals outside a research meeting. Although our research was not designed to observe such arenas
ethnographically, the interview data did suggest that the arenas were explicitly being used to nurture
relationships. This included sharing personal narratives, which Barnes197 argues is important in ensuring
mutual recognition, and allows the researcher to understand where the PPI representative is ‘coming
from’.193 In the theoretical conceptualisation of PPI by Gibson et al.,130 there is a call for a ‘plurality of
arenas’ where the different voices (lay and professional/researcher) can be heard. Many of the RAPPORT
case studies suggested that different arenas were created to enable the emotive and rational voices to be
heard and to contribute to the research study. Conversely, this may also imply that the formal arenas such
as trial steering committees were unlikely to provide much space for personal narratives. Rather, our data
suggest that prevailing norms and rationalistic discourse continued to dominate these arenas.
Our findings pinpoint specific issues if PPI is to be conducted solely through virtual media. Having an arena
where relationships could flourish was a shared characteristic of the case studies with strongly embedded
PPI. As relationships are created through, for example, social networking, blogs, followers and tweets,
there is no reason why virtual PPI could not work within plural arenas. This area merits further research.
Skills for enabling relationships
Whatever arena within which relationships developed, there were discrete skills and traits needed by
those facilitating relationships. Others have highlighted the challenge of encouraging and maintaining
relationships in PPI,193 and the need for training to do this.29,101
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As discussed earlier, knowledge about boundary spanners helps illuminate the skills and traits that enable
this work. Williams187 describes four aspects to building sustainable relationships (Figure 18), and these skills
and traits were described within our data. Some of these aspects are amenable to development through
training; others may be seen as personality traits. The RAPPORT data gave a sense of the PPI co-ordinator or
person leading on PPI being that kind of person: approachable, sensitive, tolerant and open.
Impact and outcomes of patient and public involvement
The findings from the RAPPORT case studies identified the impact and outcomes of PPI, which were
overwhelmingly articulated by our respondents as positive, although some negative experiences were also
described. The case for evaluating PPI impact draws upon the methodological case for the need to
know what is working and what does not work well in PPI,198 and the economic case, as PPI is relatively
resource-intensive.30 However, our survey and scoping, and previous systematic and structured reviews of PPI
in research, showed that there is little recording of PPI activity and costs in publicly accessible research study
information, and in published papers.19,29 Our analysis of the case studies clearly showed that outcomes of
PPI were far easier to identify than the mechanisms and context that led to them. The majority of PPI-related
outcomes were those expected and desired by the research team.
Impact of patient and public involvement
There is a drive towards public involvement and engagement in a number of sectors beyond health
research. Impact of public or community engagement in these sectors may shed light on the PPI impact
we may expect in health research.
Community engagement in housing through, for example, tenant management organisations has been
cited as an approach leading to improved processes and outcomes in social housing.199 A systematic
review200 on the impact of community engagement on health and social outcomes found that community
engagement helped with planning and management of housing services, enabled partnership working and
better communication between stakeholders and provided a conduit to a broader community. Although
there was evidence of impact on members of the public, such as development of skills, conclusive evidence
of the impact of community engagement on service delivery could not be found. The authors suggest this













FIGURE 18 Skills and traits for managing relationships in PPI (adapted from Williams187).
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There is also a broad body of work on public participation and involvement in ecological and conservation
work.201 Desired longer-term outcomes for PPI in this arena include sustained conservation202 and
empowerment for the public involved.203 However, as in social housing, longer-term impacts of PPI are
rarely measured and noticeable long-term outcomes may occur only 10 years or more after the project has
been set up.201 Nevertheless, evaluation of PPI within social housing and conservation suggests that PPI
enables positive outcomes in:
l processes including management and governance
l accessing knowledge that would otherwise be unavailable
l improved partnership working, communication and broader links with the community.
Impact and outcomes of patient and public involvement in the
RAPPORT study
The most commonly reported outcome of PPI was in improving recruitment rates, particularly through
refining participant information literature, and also through providing links with participant populations.
However, there was no evidence on how this affected research outcomes. This effect of PPI on study
recruitment has been reported widely elsewhere,70,78–86,88 but the range of case studies within the RAPPORT
study allows the specific components to be teased out (Figure 19).
• Making participant information and consent understandable, sensitive
   and positively framed
• Advising on research design to make it manageable and palatable
for participants
PPI activities
• Iterative, face to face or more commonly via e-mail
• Selective adoption by researchers
• Fine-tuning process
Process
• Recruitment reaches target or improves
• Ethics committee approval facilitated
• Perceived increased confidence of participants in taking part in the study
Outcomes
• PPI as close as possible to the target population
• Availability to engage in a phase of intensive work with rapid response
• Ability to bridge the researcher–lay-language gap
What was needed?
FIGURE 19 Patient and public involvement processes and outcomes in study recruitment.
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Five out of the 22 case studies had PPI representatives involved in setting research priorities, and again this
has been previously demonstrated (see Chapter 2). Impact of PPI on this outcome was particularly
facilitated by formal structures which ensured that lay representatives were part of the decision-making
process and could influence the final decision.
Whereas the majority of outcomes from PPI for the research studies are reported previously, one notable
exception was an unexpected outcome in one case study where both researchers and PPI respondent
reported an impact on participant safety. Although this could be subsumed under PPI impact on the overall
research design, it is particularly interesting that the lay representative, by being able to put herself in the
shoes of the participants, could identify potential safety issues not seen by the research team. It is also
significant that this outcome was unexpected by the research team, and carried implications for research
teams who set strict boundaries on what outcomes PPI representatives may affect. It also raises some
questions about current developments in building evaluative frameworks for PPI, which will be discussed in
Evaluating patient and public involvement in research studies.
It should be noted that, while the RAPPORT studies did provide evidence of PPI impact on research design,
the research stakeholder (including PPI) consensus study by Barber et al.159 concluded that it was not possible
to evaluate PPI impact in this area. The positive impact of the fully intertwined model on the research process
was clearly observable, and ranged from identifying research questions to disseminating research findings;
however, this was not exclusive to this model. Some of the case studies typifying a more traditional approach
to PPI, such as two or more representatives involved in a project steering committee, also demonstrated a
positive impact on research processes. Rather than a specific model being the enabler, it was the six salient
actions as described in the CMO tables (see Chapter 6) that were key. However, it is significant that all the case
studies demonstrating an intertwined model achieved the salient actions and exemplified fully embedded PPI.
Nevertheless, as with other sectors it was difficult to tease out the impact of PPI on the research results.
This is unsurprising given the difficulties in distinguishing the impact of PPI from other factors, but, as
recognised in the Higher Education Funding Council for England Research Excellence Framework, impact
is often not immediate and can take 15 years to become visible.204 We are therefore not able to determine
whether or not the resources required for the fully intertwined model are merited in terms of long-term impact
on research findings. However, our findings suggest that the fully intertwined model is likely to lead to
increased relevance of research questions, and hence may have greater long-term outcomes in terms of
research orientated towards patient priorities.
This issue also illuminates the ongoing debate on what constitutes PPI success.205 Attaining seemingly small
PPI impacts on research processes may mark important steps in achieving greater change within the
complex system of health research.205 However, there is consensus that the impact of involvement on PPI
representatives themselves is easier to evaluate.159
Impact of involvement on patient and public representatives
As reported widely elsewhere (see Chapter 2), involvement had a significant impact on many of our PPI
respondents in terms of psychological outcomes and knowledge (see Chapter 6). It was also clear that, for
some, involvement in a single study had been the start of a PPI trajectory that moved as the individual’s
knowledge, confidence and interest grew. Some of the PPI co-ordinators had been patient representatives,
and the PPI respondents we interviewed from funding programmes also described a journey from
involvement at study level moving towards a more strategic level.
This PPI career trajectory is a hotly debated subject. Many of our researcher respondents expressed
concerns about the same PPI representatives being repeatedly involved and the need to ‘refresh’, a
euphemism generally denoting removing PPI incumbents and recruiting new ones. As raised by others,206
for the PPI representatives, the challenge was to remain authentically credible after having developed
enough research knowledge to reduce some demands on the research team’s time. The ‘ideal’ PPI
representative from many researchers’ perspectives would be at the stage indicated by the star
in Figure 20.
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Making judgements about which lay representatives were credible and competent involved shaping
processes and practice for PPI207 to exclude those moving beyond the star. So the argument ricochets
between training and ‘professionalisation’ of PPI resulting in the loss of the lay perspective22,208 and also to
counter the moral argument for PPI,208 and the need for some training209,210 to carry out certain tasks required
in the PPI role. Although this was not articulated by any of our PPI respondents, in the ethnographic study
conducted by Thompson et al.46 they describe the balancing act carried out by the PPI respondents to have
enough knowledge to be able to contribute within a trial steering committee, but also to remain credible.
It was clear in those RAPPORT case studies with strongly embedded PPI that developing knowledge and
skills in research was not seen as detracting from credibility as an authentic PPI representative. Indeed, in
many of these case studies the involvement trajectory was enabled and PPI representatives were
encouraged to take on more strategic roles or act as co-researchers or coapplicants. This fits well with
notions of equality, for it is unlikely that any researcher would in such cases be ‘refreshed’ because they
had become too skilled.
Evaluating patient and public involvement in research studies
As indicated in the findings chapter, the weakest NPT construct in our analysis of case studies was
appraisal, in which the PPI is evaluated and work is reconfigured in the light of this evaluation. There
were few case studies which provided any evidence of systematic evaluation (see CMO Table 17) and
these demonstrated very different approaches influenced by their research design. One RCT was able to
demonstrate that rises in recruitment rates could be linked to participant information amended by PPI
representatives. This was possible because of the duration of recruitment. However, in another case study,
which was a systematic review, linking PPI to recruitment rates would not be relevant. In this study all PPI
activities, input and outcomes were carefully recorded to provide a ‘storyline’ of impact.
The findings suggested that, in the case studies where PPI was strongly embedded, the research teams
were already intuitively following evaluative processes suggested by the Public Involvement Impact
Assessment Framework (PiiAF) project with values identification and impact theory.175 Their value sets and
understanding of PPI were coherent, and they were evaluating PPI impact appropriate for their study
design. However, for many other case studies such systematic evaluation would be difficult because








FIGURE 20 Credibility versus understanding research.
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scales, so would be unlikely to enter into the group thinking that the PiiAF project suggests lays the
foundation for impact evaluation. However, outside the research study, it is likely that the value
clarification exercises suggested by PiiAF would contribute much to the training and preparation for PPI
requested by many of the less experienced researcher respondents. A point of note is that any evaluative
framework must be flexible enough to capture any unforeseen outcomes; simply measuring whether or
not expected outcomes had been met would not provide a full evaluation.
A key challenge for some of our researcher respondents (mainly clinical) was that their research
approaches were clearly placed within the positivist paradigm, so they found it very difficult to articulate
how they would evaluate PPI by preserving their focus on measurable and observable changes.
It should be noted here that some case studies were recruited to the RAPPORT study because they wanted
an external evaluation of their PPI. Having regular tracking interviews revealed the complex temporal
dynamics of PPI in some case studies; the challenge for these researchers is now to provide published
evidence of the impact of PPI in as robust a form as in reporting their RCT findings.21
Summary
A widespread lack of transparency in how PPI is operationalised, and with what impact, impedes any clear
summative assessment of the extent of PPI embeddedness within the research infrastructure. Our case
studies clearly indicated a widespread lack of any systematic evaluation of PPI. This is compounded by the
inherent difficulties in assessing PPI impact on research outcomes due to the time required for impact to
become visible and the difficulties in teasing out individual contributions. However, the widespread and
diverse impact on all those involved and the research process was marked and should not be underestimated
within the context of a complex system such as health research.
One clear constraint on PPI becoming embedded is the drifting of definitions between involvement and
participation. While this sometimes illustrated a lack of common coherence, there was also evidence of a
deliberate dual role. This poses the potential of ethical concerns, but there also appeared to be a positive
impact when taking on such a dual role was well-managed through clear boundaries, transparency and
informed choice. Within a dynamic framework of PPI we found evidence of traditional models of PPI with
two or more representatives fully involved as part of a steering committee, and three specific models of PPI
which resulted in different levels of PPI impact.
The one-off model at one end of a continuum of involvement was characterised by tokenistic and limited
PPI where full impact could not be realised. At the opposite end of this continuum, the fully intertwined
model displayed PPI as integral to the research impact, which resulted in a range of positive outcomes.
However, for the host organisations and research teams this model proved also to be resource-intensive.
The outreach model provided a way of linking with a broader target population through a credible and
well-connected lay representative. To avoid tokenism required a collaborative and iterative process
between research team, PPI representative and the broader community. While more resource-efficient for
the research team and host organisation, this entailed resource and workload implications for the lay
representative taking on this role.
Such a ‘bridging’ role with a broader community was also undertaken by some PPI co-ordinators, who
appeared to be central in leading and enabling PPI. Part of this role was to develop and sustain
relationships, which we found to be the fundamental enabler for PPI. However, it was important that the
co-ordinator role was not being used by other researchers within the team to abdicate engagement
with PPI.
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Chapter 8 Conclusions
The RAPPORT study looked at studies started more than 6 years after PPI became a statutory part of thehealth research governance framework.5 This policy was reflected in many of the case studies where
there was evidence of well-established structures to support and resource PPI. However, the complex
nature of PPI means it is challenging to pinpoint its impact and distinct contributions to research
studies.19,100 The varied nature of PPI in terms of structures, roles and relationships required a methodology
capable of exploring and evaluating context-specific mechanisms.32 It was also important to evaluate how
far PPI had become embedded as normal practice within research adopted by the UKCRN portfolio.
This chapter revisits the research objectives and provides a summary of the key findings under each
objective. We then present the main conclusions and reflect on the RAPPORT study research process and
limitations. We discuss the implications for PPI practice derived from our findings and highlight the
responses to these from our stakeholder dissemination events (Appendix 5). Finally we present
recommendations for future research.
The RAPPORT study research objectives were to:
1. determine the variation in types and extent of public involvement in funded research in the areas of
diabetes mellitus, arthritis, CF, dementia, public health and IDDs
2. describe key processes and mechanisms of public involvement in research
3. critically analyse the contextual and temporal dynamics of public involvement in research
4. explore the experience of public involvement in research for the researchers and for members of the
public involved
5. assess the mechanisms which contribute to public involvement being routinely incorporated in the
research process
6. evaluate the impact of public involvement on research processes and outcomes
7. identify barriers and enablers to effective public involvement in research.
What was the variation in types and extent of patient and
public involvement across the topic areas?
The six research topic areas were purposively selected to ensure a diverse range of study design, study
participants and different histories of engagement with PPI, traditions and associated models of PPI. Within
the scoping and survey phase it was clear that our assumptions about some of the topic areas were
supported. In particular, IDD, with its long history and focus on service user involvement and inclusion,139
had the largest proportion of studies which included PPI. We had expected that, with its well-established
PPI networks and a clear drive towards inclusive practices for people with reduced capacity,78 dementia
studies would have a large proportion of studies with PPI. However, although this proved to be the case in
our survey findings, significantly fewer dementia studies with PPI were found through the scoping study.
This pattern of a larger proportion of topic-specific studies with PPI in the survey than in the scoping was
also found for diabetes mellitus studies, perhaps reflecting the fact that researchers who used PPI were
more likely to respond to the survey. The topic area of CF was particularly interesting as an example of
where PPI has developed from minimal engagement to a strategic commitment to patient and family
involvement in research. CF was selected not only because it would include younger research participants,
but also because it is a research area orientated towards biomedical, laboratory-based research. There
were few CF studies on the UKCRN portfolio so our sample was very small. Within the CF area it proved
very difficult to identify PPI leads, and many research centres we contacted (with the exception of the
centre where the one CF case study was hosted) suggested that, that for them, PPI was not a top priority,
as very close relationships already existed between research participants and research teams. As the
RAPPORT study progressed there were clear signs of involvement beginning to develop in this area.
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These indicators were present both in the case study and in the latest research strategy of the CF Trust,
which states its aims as ‘to ensure people with cystic fibrosis are more fully involved in the design,
commissioning and management of clinical research, and we will be exploring ways to ensure the voice of
patients and their families are better heard in this area’ (p. 23).211
It was study design rather than topic area that was more predictive of the extent of PPI. Unsurprisingly, PPI
was likely to be limited in basic science or tissue bank designs, although we found noteworthy exceptions
to this in our case studies.
What were the key processes and mechanisms of patient and
public involvement in research?
Values were a key mechanism in shaping PPI within a research project and, at funder level, a finding
consistent with a previous study.174 Funding organisations often drew a focus on either the moral or the
methodological rationale for PPI, and this shaped requirements for PPI within research projects. Funders
primarily articulating the methodological perspective expected greater detail about PPI processes and
placed increasing emphasis on capturing the impact of PPI.
Key processes and mechanisms were also distinctively shaped by the model of PPI adopted. Three models
were identified within the RAPPORT study. The least common was that entailing a one-off PPI activity;
while addressing needs for PPI from the researcher’s perspective, this also limited the impact PPI could
have on research processes and outcomes. In contrast, there were seven studies with a fully intertwined
model where PPI was closely entwined with the research process. This model produced the greatest range
and extent of PPI-related outcomes but was also the most resource-intensive and so could only be
sustained by research centres with a well-developed infrastructure for PPI. The third model entailed an
outreach component whereby relatively few PPI representatives would engage with the study at regular
points, but would also act as a bridge to a wider constituency and so provided a two-way conduit to a
broader population. This model required lay representatives who could perform this function, but for the
research community it was less resource-intensive and demonstrated a range of PPI-influenced outcomes
for the study. However, charities undertaking this function expressed concerns about how sustainable this
model was without realistic funding. Case studies demonstrating a more traditional model of PPI, with two
or more lay representatives being members of a study steering committee, could also produce a range of
PPI-related impact. Rather than a specific model, achievement of six salient actions was central to the
effectiveness of PPI. These actions were having a clear purpose, role and structure for PPI; ensuring
diversity; whole research team engagement with PPI; mutual understanding and trust between the
researchers and lay representatives; ensuring opportunities for PPI throughout the research process; and
reflecting on, appraising and evaluating PPI within a research study.
The inherent pragmatism of PPI recruitment found in the case studies ran counter to the expectations of
INVOLVE and the list of potential sources of PPI.23 The process of finding lay representatives generally
meant recruiting those previously known to the research team or using an established PPI group or panel.
Only a few of our case studies actually recruited new representatives independently via other sources such
as the media. Ease of access and established support systems made pragmatic sense in time-constrained
projects. However, unless the researcher had worked with members of the group before, the relationship
between the PPI representatives and research team would be less developed, and the team would be more
likely to see PPI as a commodity to be bought in.
How PPI representatives and researchers came together was also an important mechanism, and for the
majority of studies the forum for this was a formal meeting. Some of our case studies took care that
meetings were arranged on neutral ground, but most were conducted in the researcher’s organisation.
The chairing of these meetings was an important process,23 and many of the lay respondents cited the
difference a facilitative chair could make.
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Meetings were also settings where relationships were often established and developed. However, it was
important that meetings allowed time for a social element to enable more informal engagement. On a
practical level, this has implications for hospitality costs. However, the creation and sustenance of
meaningful relationships between PPI representatives, specific researchers and the research team as a whole
proved to be a far more important mechanism than previously reported in the literature. This was a key
finding in the RAPPORT study. PPI underpinned by a lay/researcher relationship characterised by trust and
reciprocity determined positive processes and outcomes of PPI in research.
What are the contextual and temporal dynamics of patient and
public involvement in research?
Activities that provided a clear structure, and allowed enough time for trust to develop within a framework
where roles are defined and understood, supported relationships characterised by trust.23 This was
important even when lay representatives and researchers were familiar with each other. For PPI activity,
this tended to be most intense in the pre-funding and project set-up stages, and clearly PPI representatives
need to be aware of the timing of these concentrated periods of work.
The RAPPORT study evidenced the dynamic nature of PPI in research studies as recognised by INVOLVE.23
Hence, although clear structures and expectations are helpful, they may nonetheless need to be revised as
the circumstances of the research, and of all those involved, change. Some of these changes can be
foreseen and planned for, whereas others cannot. For example, the loss of a PPI lead had the potential for
negative impact on relationships; that could, however, be mitigated if other members of the research team
had been fully engaged with PPI.
How did researchers and lay representatives experience involvement?
For lay respondents, PPI was overwhelmingly a positive experience. While for some it improved
understanding about their condition or services they could access, for most the increased sense of
self-worth and confidence was most frequently reported. This echoes other studies87,93,212,213 and was
particularly marked in people who because of retirement, unemployment or family caring roles were
grateful for the mental stimulation provided through the PPI role. Moreover, this role opened up further
opportunities for them, with many describing a career trajectory of PPI.
Less positive experiences for lay representatives arose from role ambiguity, from whether or not PPI
knowledge was valued and from how much they felt part of the research team. The dual role we
described in Chapters 5 and 6 could be a problem for some when clear boundaries were not identified.
This dual role also encompassed being a consultant’s patient one day and then the PPI representative on
that consultant’s study the following day. Although many respondents welcomed the reciprocal nature of
this relationship, others felt their needs as a patient were not being fully met when the clinician continued
the lay–researcher relationship within the clinical environment. Other less positive experiences included
frustration or intimidation when the lay representative felt unable to contribute at meetings, when the
generalisability of their experience was questioned and when they lacked or lost contact with studies. Lack
of communication was one of the main triggers for a lay representative becoming disengaged with the
study, sometimes leading to longer-term disengagement with PPI.
Some of our researcher respondents also articulated some negative experiences of PPI, although more
often framed within previous studies rather than any of the case studies in the RAPPORT study. A small
minority felt that PPI could be tokenistic and an imposed add-on which had not been thought through
well. Others expressed frustration if they perceived lay representatives bringing only a personal agenda
rather than seeing the broader picture. However – and unsurprisingly, as researchers had agreed to
participate in the RAPPORT study – the vast majority spoke of their experience of PPI only in positive terms.
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On a practical level, PPI helped develop the skills of researchers, such as being able to communicate with
the public in an accessible way. Moreover, the depth of this positive experience was illustrated by the
often-used religious metaphors of PPI as being like an ‘epiphany’ or a ‘Damascene moment’. PPI had made
them look at their research in a completely new way and, further, a way to which they were fully
converted and which they would be unwilling to relinquish. The transformative effect of PPI is often
represented as an aspiration linked to what is morally the right thing to do; these findings provide
evidence of PPI as a mechanism for change and for redefining research questions and interpretation
of findings.
What mechanisms were needed to routinely incorporate
patient and public involvement into research?
Normalisation Process Theory134 was used to guide our data collection and analysis to understand which
mechanisms were needed to routinely incorporate PPI into research. In the case studies with the most
embedded PPI, researchers and lay representatives clearly had a shared understanding of PPI. However, our
tracking of studies also showed that understandings could change with time, generally towards more
coherence but occasionally away from it. For the newer researchers and the majority of lay representatives,
PPI was not a new concept. However, newer researchers found it more challenging to distinguish between
research participation and involvement, which may reflect their inexperience in developing grant
applications requiring a detailed PPI strategy. This was further compounded by a lack of training on PPI
for researchers.
Patient and public involvement was significantly helped by having a defined lead for PPI.23 If this person
was a member of the research team, it was important that they had enough time to fully carry out this
role, and often the demands of the role were hidden, particularly when providing a ‘lay representative
centred approach’ by going the extra mile. Dedicated PPI co-ordinators appeared to be most effective if
they were colocated with research teams.
The operational work required to incorporate PPI routinely was considerable. This included ways of managing
payments in good time, having a central point of contact, regular communication and engagement. Having
a developed infrastructure to support this operational work reaped benefits in terms of embedding PPI.
Although clear in INVOLVE guidance,189 for some of our respondents the principle of reimbursement for
time was a contentious issue. A minority of researchers felt that payment for time was in danger of
professionalising PPI,208 which should be undertaken as volunteer activity. This view was not articulated in
case studies with embedded PPI. However, some lay representatives who led patient organisations felt strongly
that lack of reimbursement for time was devaluing PPI and those undertaking this role. This was confirmed
by other PPI respondents, who saw symbolic value in the payment. Interestingly, few of our case studies had
formal job descriptions for their PPI representatives, which contrasts with INVOLVE guidance.23 The emphasis
was more on enabling a flexible approach that could be hindered by any prescriptive roles; nevertheless, there
remained a need to clarify expectations at the beginning of a study. Equally, few lay respondents reported any
particular need for training, or highlighted previous training as essential. Instead they described learning on
the job and the need for a supportive relationship with the research team. This contrasted with several of the
newer researchers we interviewed, who highlighted their lack of preparation for PPI and voiced this as a need.
However, as discussed earlier, the most important operational work was the building and sustaining of
relationships. This was enhanced when people had confidence in each other and a relationship based on
trust was established. If this relationship between lay representatives and researchers was present and
maintained, then PPI was enabled to have positive impact even in studies with minimal infrastructure.
There was very little systematic evaluation of discussion of the processes and impact of PPI within a study.
There was some evidence of informal evaluations, with respondents describing how they might refine
processes in the future. There were a number of reasons for this. First, some researchers had not thought
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of evaluating PPI, as they just saw it as part of the whole research process and so as not requiring
particular evaluation. Second, there was no time built into the study to do this. Third, because of the
dynamic and flexible nature of PPI it was difficult for researchers to know which parts to ‘capture’. Finally,
and reflecting previous commentaries on evaluating PPI,19 researchers felt that PPI was too complex to
evaluate in any objective way.
What was the impact of patient and public involvement on
research processes and outcomes?
The majority of researcher respondents readily offered their perceptions of PPI impact on processes and
outcomes of their study, but most PPI respondents found it more difficult to articulate what difference they
had made. However, this proved markedly different in the case studies with embedded PPI, probably
reflecting the robust feedback mechanisms to assess lay participation employed in these case studies.
One case study linked improvement in recruitment rates to PPI. Apart from this example, the impact of PPI
was rarely quantified. Recruitment was the most frequently mentioned area in which PPI was seen as
having a ‘visible’ impact, and is a recurring focus in the literature.70,78–86 Recruitment processes were part
of the overall research design and provided a natural entry for PPI. Case studies had evidence of PPI
impact on other elements of the design such as choice of outcome measures, ensuring tools were
participant-sensitive or involvement in developing the intervention.
The impact of PPI on research priority and question setting was most evident in the case studies categorised
as exemplifying the fully intertwined model. The potential safety of participants was a particularly interesting PPI
impact. There has been a growing interest in PPI and its potential impact on improving patient safety in health
care.214–218 Arguments for PPI in patient safety include providing a final ‘buffer’ to prevent errors214 and
reinforcing the moral argument that patients should be included in processes regarding their own care and
treatment.216 However, what is surprising is the lack of consideration of PPI in health-care research acting as the
final check for participants. The RAPPORT study did not include the perspective of those participating in the
research of each case study (unless in a dual role). However, a recent consultation exercise conducted by Ipsos
MORI and the NHS Health Research Authority identified that potential participants feel reassured if they know
that there has been PPI during the design of the study.219 Teasing out the impact of PPI on research participant
safety and lessons to be drawn from broader health-care delivery merits further exploration.
What are the barriers and enablers to effective patient and
public involvement in research?
A lack of a shared understanding of what PPI was, and of its purpose, was seen to be the main barrier
to effective PPI. The discourse of the RAPPORT respondents tended to be framed within either a
methodological or a moral perspective, but these viewpoints were not mutually exclusive, and did not
appear to have a negative impact on each other. For example, researchers may articulate PPI more from
the methodological perspective (to improve research quality), whereas lay representatives within the case
study may frame their involvement more from the moral viewpoint (a right to be involved or an altruistic
motive). As suggested by others,25,174 as long as both of these perspectives were acknowledged then
PPI was enabled. However, there were a few examples when conflict arose because, rather than being
synergistic values, they worked in tension, for example PPI role in management and governance of study
versus PPI right to have joint ownership of data because of charitable funding of the study.
Other barriers to PPI impact derived from how far lay involvement was limited and constrained by the
researchers as indicative of the one-off model of PPI. Although we acknowledge that modest levels of PPI
activity may be appropriate in certain studies, our concerns are that adopting such modest levels should be
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justified. For example, the impact of PPI on potential safety issues for participants had an unexpected
outcome and might not have happened if the lay representative had not been so fully involved. On a practical
level, lack of time was a significant barrier to PPI. Short, intense projects with relatively small research teams
found it more difficult to operationalise PPI in their study.
Access to established PPI groups or panels was seen as an efficient and time-saving approach to PPI.
However, this also ran the risk of being a tick box exercise and worked against the relationship building so
necessary for effective PPI within a study. Equally, while we endorse the guidance from INVOLVE on
identifying a lead for PPI,23 we found that the PPI co-ordinator role also had potential for research team
members to abdicate responsibilities for engaging with PPI. However, a co-ordinator working alongside
fully engaged research teams was a significant enabler. This is linked to the establishing and sustaining of
relationships based on mutual trust and respect as being the over-riding principal enabler. This endorses
current guidance on organisational responsibilities.23 The RAPPORT study findings suggest that case studies
with fully embedded PPI treated lay representatives in the same way as other valued members of the team,
including considering their long-term future beyond the current study.
Key conclusions
Relational work appears to be the foundation stone for effective PPI and, while relationships are
acknowledged to be part of the architecture of PPI,29,101,137 their central importance above other processes
and resources has not been previously highlighted. These relationships are framed by trust, mutual respect
and responses between researchers and lay representatives being framed by synergistic team membership.105
A dedicated PPI co-ordinator either within or outside the team is a significant enabler of PPI. However,
there can also be unintended consequences of this role in that acting as a bridge188 between the research
team and lay representatives could result in research teams abdicating any responsibilities for PPI engagement.
Equally, PPI panels such as those established in the NIHR78 or regional15,144 research infrastructure could also
have the unintended consequence of PPI becoming a commodity and, in a few examples, reinforce the
separation between lay and research worlds.
Finally, concerns raised elsewhere that there is little systematic evaluation of PPI by researchers in their
studies21,30 were also highlighted in the RAPPORT study findings. Research teams that are already fully
engaged with PPI and well resourced in terms of PPI staff and time are likely to work towards systematic
evaluation of impact, for example as suggested by the PiiAF project.175 However, for research teams with
fewer resources it is unlikely that without further incentives they will undertake any evaluative work which
diverts them from the intense nature of running a study with limited staff and time. There is still an
argument for developing instruments to measure impact in the future,21 and also a more formalised
accountability framework to increase transparency of PPI reporting and monitoring.
Reflections on and limitations of the research
The RAPPORT study sample was limited to six topic areas; while these were purposively selected to provide
a broad range in terms of designs, settings and target participant populations, we acknowledge that this
does not include areas where, for example, there is a growing body of user-led research, such as in mental
health.173,220 Basing data collection on the UKCRN portfolio will have also excluded smaller charity-funded
projects; however, the portfolio does represent mainstream health-care research. In addition, some numbers
within a topic area are very small, making analysis/significant differences difficult to calculate in the scoping
and survey. Because publicly accessible documents were rarely available within the scoping we had to
request documents from research teams. Therefore, in all three phases of the research our respondents
were more likely to be positive towards PPI than those who did not accept the invitation to participate.
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We identified case studies through the survey, and our sampling frame ensured a range of study designs
and topic areas. However, we did not include in the frame the range of possible PPI activities and roles,
and it was not possible to explore the increasing use of codesign methods and co-researcher roles that
define the study approach.
We had case studies at the early stages of the research process. Whereas we were able to capture PPI-specific
issues relating to project start-up and recruitment, this meant that PPI outcomes and impact were more
challenging to assess within the study time frame.
The RAPPORT study is one of the most extensive in-depth empirical studies of PPI in research with
international relevance. To the best of our knowledge it is also one of the first studies to combine the use
of NPT and a RE framework. We found NPT to be particularly useful in teasing out why PPI appeared to
work better in some case studies, and it fitted well within the RE framework.
Implications for patient and public involvement practice
There already exists a great volume of guidance for PPI in health research, for example from INVOLVE,23
the Mental Health Research Network,221 RDS,222 British Paediatric Surveillance Unit,223 Dementias and
Neurodegenerative Diseases Research Network224 and CLAHRCs.225 Rather than produce another set of
guidance, this section presents the key learning from the RAPPORT study as practical points that further
illuminate existing guidelines. These are based on our key findings presented in the six CMO configuration
tables (see Chapters 5 and 6):
l the purpose, role and structure of PPI
l recruiting lay representatives likely to have an understanding of the diverse viewpoints of the target
study population
l whole research team engagement with PPI
l mutual understanding and trust between researchers and lay representatives
l opportunities for PPI in all parts of the research process.
Reflection, appraisal and evaluation
Purpose, role and structure of patient and public involvement
l Shared understanding of the purpose of PPI can be enabled if time is set aside as early as possible to
discuss both researcher and lay perspectives and understanding.
l Training on PPI, particularly for early-career researchers, could address some of the misconceptions.
The dissemination events confirmed this as a priority area, suggesting that this training would be best
undertaken jointly with lay representatives. Incorporating input on PPI within good clinical practice
training was also identified as a way of enhancing understanding.
l Clarity of roles with terms of reference should be developed early on, but these must be flexible to ensure
that roles can adapt to the individual lay representative’s needs and the needs of the research study.
Recruiting lay representatives likely to have an understanding of the diverse
viewpoints of the target study population
l Specific models of PPI are more likely to enable links with a more diverse population. The fully intertwined
model involved drawing in a broad range of PPI representatives who were fully involved in the research
process. Typically, a large number of lay representatives are involved in this model who need support from
a dedicated co-ordinator, training and supplementary social events outside the research study core
business. This model requires adequate resources in terms of reimbursement (financial or other, such as
accredited training) for PPI, research organisation staffing, time and costs for support.
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l The outreach model involves smaller numbers of PPI representatives whose role is to link out with a
diverse population. However, to succeed they must have the links and credibility with the wider
community and networking skills. As with all models, there should be appropriate reimbursement which
is realistic and sustainable, including adequate funding for any charity or voluntary group involved.
l The dual role whereby study participants are also invited to advise or be involved in the study is one way
of ensuring the perspective of the target population is captured. Our dissemination stakeholders voiced
concerns over potential ethical issues, but also acknowledged its potential advantages. As in all models,
no individual can represent a whole population, so careful thought is required about specifically which
and how many participants are playing this dual role. Most importantly, the potential ethical issues
must be thought through. For example, how roles should be separated, at times when an individual is a
participant and also involved, what terms of reference are necessary and how participants may be
approached to avoid any sense of obligation.
l Some case studies used advertising as a successful way of recruiting more diverse PPI representatives.
Our dissemination stakeholders suggested that spreading the message more widely about PPI needed
to be undertaken at a more strategic level.
Whole research team engagement with patient and public involvement
l Having a PPI co-ordinator and ease of access to existing PPI groups is an enabler of PPI. However, all
those involved need to reflect on whether or not reliance on a single individual to lead PPI and
pragmatically using existing groups are hindering whole team engagement with PPI.
l To engage researchers with PPI, the added value to them needs to be made clearer. For example,
engaging the public with science is increasingly a remit for researchers, and PPI can help develop and
hone the skills required for this.
Opportunities for patient and public involvement in all parts of the
research process
l Researchers and lay representatives need to work together to ensure that the potential impact of PPI is
fully realised. This may require research teams to try out new approaches in partnership with lay
representatives, and learn from other research teams’ experiences.
Mutual understanding and trust between researchers and lay representatives
l If PPI representatives and research team are not already known to each other, time must be built in
early on for social engagement; hospitality costs should also be covered.
l Building early relationships with representatives in virtual PPI must be carefully planned.
l Lack of feedback is a major cause of disengagement. Feedback should always be given to PPI
representatives on responses to their suggestions, and studies’ results.
l Maintain links with PPI representatives even after the project has completed; regular communication
(e.g. biannual emails/newsletters) maintains engagement. Enable or signpost further PPI opportunities
for representatives when a study completes.
Reflection, appraisal and evaluation
l Build in the evaluation strategy early on so that information on PPI impact and outcomes can be
collected and reflected upon as the study progresses. This strategy should be kept simple and
manageable. Evaluative frameworks should be utilised that can also capture unforeseen PPI outcomes.
l Information should routinely be collected on the level and extent of PPI, methods of recruiting PPI,
impact on research processes and, where possible, impact on research outcomes.
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Implications for lay representatives
Our dissemination events confirmed that the RAPPORT study had several implications for lay representatives.
These are summarised as key messages in Box 34.
Recommendations for future development and research
It was clear from the RAPPORT study that research host organisations with core funding and stability for PPI
were able to embed PPI as routine practice, which has implications for the national research infrastructure.
However, it was also evident that PPI could be enabled if the relational work was appropriately achieved. A
focus on this area of work needs to be incorporated into training for researchers, particularly those less
experienced in PPI and research. Seven clear areas have been identified from the RAPPORT study:
1. Virtual PPI needs further evaluation. The move towards virtual PPI can be mapped within health-care
commissioning and delivery,226 and is a common model for general practice patient participation groups.57
It is also becoming increasingly common in health research. However, as the RAPPORT study has highlighted
the importance of relationships in PPI, further research is required to evaluate how this can be best
managed within the virtual world. The requirement of access to e-mail and its impact on including
seldom-heard groups should also be included in this evaluation.
2. Virtual PPI is potentially an effective way of involving younger people. Only one case study had lay
representatives primarily from this age group, and there were challenges in maintaining engagement.
Further research is therefore recommended into the particular issues of engaging young people in PPI.
3. The PPI training needs of researchers need to be explored, using the findings of the study and the NPT
process as a framework for the curriculum. So does understanding the balance between supportive
infrastructure and the potential for research teams to abdicate engagement with PPI and externally
source it for a one-off activity.
4. Further evaluation is required of the impact of PPI on issues of participant safety in clinical trials.
5. A future costs analysis and economic evaluation of the different models of PPI is recommended that
could consider relative impact on key outcomes such as recruitment, study milestones and
dissemination and uptake of study findings by patient groups.
6. Little is known about the extent, experience, outcomes and implications of the dual role in PPI.
More research is required to explore this further, and specific guidance should be developed.
7. Outcomes of PPI on research findings and impact on services and clinical practice requires a longer-term
follow-up study. The RAPPORT study has collected rich data from 18 months of a research study.
Tracking the longer-term impact of these studies and how PPI has influenced this would be a unique
opportunity to determine longer-term PPI outcomes.
BOX 34 Key messages for lay representatives
l As a minimum, you and the research team need to clarify your PPI role and responsibilities and maintain a
good working relationship with you to support you to undertake tasks.
l There should be a named link person on the research team with whom you feel comfortable liaising with in
the first instance.
l Be prepared to challenge the research team if there are things that need to be changed for you to undertake
these tasks, or to renegotiate them. You may feel that you need support to do this, so have some options.
l Be aware of existing support structures locally and nationally that can offer advice, support and
opportunities for further involvement or training.
l Keep researchers informed of any changes in circumstances that may affect your ability to undertake
specific tasks, what to put in place to support you or how tasks could be reallocated or changed.
l Wherever possible, work with the research team to record both your input and associated outcomes.
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Appendix 1 Online survey




1. How many lay people/service users are or have 
been involved in the study? 
 
      0                                (please go to question 10) 
 
      1 
 







                              3        
 
                              4  
 
                              5 or more 
2. How did they get involved in the study? 
(Please tick all that apply) 
 
They responded to an open invitation (e.g. 
Newspaper, website) 
 
You approached a voluntary organisation 
 
You approached the RDS 
 
You approached the CLRN 
 






You approached patients/service 
users known to the clinicians 
involved in the study 
 
You approached an established 
Patient/service user/public involvement 
Group in your research centre/HEI 
 
Other (please specify) 
 
3. From which groups are the lay people/service 
users involved in the study from?  
(Please tick all that apply) 
 
Children & younger people under 18  
 







Members of the general public 
 
Older people over 65 
 
4. In what capacity were these people involved? 
(Please tick all that apply) 
 
As people with prior experience of a  
condition/disease/service 
 
As a member of the general public with 
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5. At what stage have or will the lay 
people/service users been involved in the project?  
(Please tick all that apply) 
Identification of the research topic 
 
Design of the research methodology 
 
Development of participant information 
materials 
 









Review of reports, lay summaries etc 
 
Dissemination activities (please specify) 
Free text 
 
Other (please specify) 
Free text 
6. Have the lay people/service users received any 











7. Has service user/public involvement in the 
study been directly costed for in the grant 
application? 
 




If so how much? 
 
 
8. Are service users/lay people involved in the 
study reimbursed for the following? 




Travel and out of  
pocket expenses  




No reimbursement                    (please go to  
                                                       question 
10) 
 
9. How is/was the reimbursement managed?
(Please tick all that apply) 
 
Service user/lay person submits regular travel  
& out of pocket expense claim form 
 
 




Other (please specify) 
Free text  
10. Do you know of any local or regional PPI 
groups that support research? 
 





No                      (please go to question 13)         
11. How often do you use this group as your first 
resource for PPI? 
















12. Has working with these groups altered your 







If so how? 
Free text 
 
ABOUT THE STUDY 
 
 
13. What is the study design? 
 
Clinical trial of an investigational medicinal  
Product 
 
Clinical investigation or other study of 
a medical device 
 
Combined trial of an investigational 
medicinal product & an investigational 
medical device 
 
Other clinical trial or clinical 
investigation 
 
Study administering questionnaires/interviews 









Study involving qualitative methods 
only 
 
Study limited to working with data 
and/or human tissue samples or other 
biological samples 
 




Other (please specify) 
 
Free text 
14. What group are you recruiting as research 
participants? (i.e. research SUBJECTS) 
(Please tick all that apply) 
 
Children & younger people under 18  
 
Adults under 65 
 










Members of the general public 
 
Not applicable 
15. Who is funding the research? 
 
NIHR Research for Patient Benefit 
 
NIHR Programme Grant 
 
 
NIHR Service Delivery & Organisation 
 
NIHR Health Services Research 
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NIHR Health Technology Assessment 
 
NIHR Invention for Innovation (i4i)
 




Other (please specify) 





16. What was the amount of grant awarded? 
 










































17. In your opinion at what stage of the research 
does service user/public involvement have the 






18. In your opinion, what are some of the 










Thank you very much for taking the time to complete this survey. We will feedback the results 
as soon as possible. 
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Appendix 2 RAPPORT interview schedule
Researchers and funders
NPT statement
1 Has patient and public involvement been a feature of your research/the research you fund for some
time – or is it a fairly new way of working for you/your organisation?
Can you tell me a little bit about how this way of working has developed?
2, 3 In your opinion, what is the purpose & role of PPI in research?
4, 14, 15 In your opinion, how does PPI bring added value?
Do you find your colleagues share this view?
5, 11 Is there someone in particular who is responsible for PPI in your research team/organisation?
6, 9 What do you think are the best ways to enable PPI to work well? What needs to be in place?
7, 8, 10 What do you think are the downsides to PPI?
12 Do you feel that PPI is embedded within your organisation? If so, how?
Prompts:
Is there a local or regional PPI group?
Is this group always used as the first resource in PPI?
13, 15 How do you judge whether PPI has made a difference to your study(ies)?
16 Can you give me any examples of how you have changed your study/the way you fund studies
because of PPI?
Normalisation Process Theory statements
1. Participants distinguish the intervention from current ways of working.
2. Participants collectively agree about the purpose of the intervention.
3. Participants individually understand what the intervention requires of them.
4. Participants construct potential value of the intervention for their work.
5. Key individuals drive the intervention forward.
6. Participants agree that the intervention should be part of their work.
7. Participants buy in to the intervention.
8. Participants continue to support the intervention.
9. Participants perform the tasks required by the intervention.
10. Participants maintain their trust in each other’s work and expertise through the intervention.
11. The work of the intervention is appropriately allocated to participants.
12. The intervention is adequately supported by its host organisation.
13. Participants access information about the effects of the intervention.
14. Participants collectively assess the intervention as worthwhile.
15. Participants individually assess the intervention as worthwhile.
16. Participants modify their work in response to their appraisal of the intervention.
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Service user/public interview schedule
1 Can you tell me how long you have been involved in research? How did your involvement come about?
2, 3 In your opinion, what is the purpose & role of PPI in research?
4, 14, 15 In your opinion, how does PPI bring added value?
Do you think that members of the research team share this view?
5, 11 Who do you deal with most in the research team? What kind of things do they do for you?
6, 9 What do you think are the best ways to enable PPI to work well? What needs to be in place?
7, 8, 10 What do you think are the downsides to PPI?
12 In your experience do you feel that PPI is really believed in or more of a tick box exercise?
13, 15 How do you judge whether PPI has made a difference to the study you are involved in?
16 Can you give me any examples of how the study has been changed because of PPI?
Normalisation Process Theory statements
1. Participants distinguish the intervention from current ways of working.
2. Participants collectively agree about the purpose of the intervention.
3. Participants individually understand what the intervention requires of them.
4. Participants construct potential value of the intervention for their work.
5. Key individuals drive the intervention forward.
6. Participants agree that the intervention should be part of their work.
7. Participants buy in to the intervention.
8. Participants continue to support the intervention.
9. Participants perform the tasks required by the intervention.
10. Participants maintain their trust in each other’s work and expertise through the intervention.
11. The work of the intervention is appropriately allocated to participants.
12. The intervention is adequately supported by its host organisation.
13. Participants access information about the effects of the intervention.
14. Participants collectively assess the intervention as worthwhile.
15. Participants individually assess the intervention as worthwhile.
16. Participants modify their work in response to their appraisal of the intervention.
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Easy speak interview schedule
1 Tell me about how you started helping the researchers with this study
Prompts: How did they know about you?
Who asked you to help?
What happened?
2, 3 Why do you think the researchers ask people like you to help them with their study/work?
3, 4, 14, 15 How do you help the researchers?
5, 11 Who do you talk to most in the research team? How do they help you?
6, 9 What kind of things helps people like you to be involved in research?
4, 7, 8, 10, 14, 15 What do you like best about being involved in the research?
What do you find difficult when helping the researchers/being involved?
12 Have you been involved/helped out with other research studies? What was that like?
13, 15, 16 Do the researchers tell you if they have changed anything in their study because of what you have
said? Tell me a bit more about this
Normalisation Process Theory statements
1. Participants distinguish the intervention from current ways of working.
2. Participants collectively agree about the purpose of the intervention.
3. Participants individually understand what the intervention requires of them.
4. Participants construct potential value of the intervention for their work.
5. Key individuals drive the intervention forward.
6. Participants agree that the intervention should be part of their work.
7. Participants buy in to the intervention.
8. Participants continue to support the intervention.
9. Participants perform the tasks required by the intervention.
10. Participants maintain their trust in each other’s work and expertise through the intervention.
11. The work of the intervention is appropriately allocated to participants.
12. The intervention is adequately supported by its host organisation.
13. Participants access information about the effects of the intervention.
14. Participants collectively assess the intervention as worthwhile.
15. Participants individually assess the intervention as worthwhile.
16. Participants modify their work in response to their appraisal of the intervention .
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Appendix 4 Consent form
 
Centre for Research in Primary and Community Care 
Director: Professor Sally Kendall 
 
 
Participant Identification Code for this study: 
CONSENT FORM 
Research with Patient and Public Involvement: a Realist Evaluation: The RAPPORT 
Study. 
 
Researchers: Patricia Wilson, Claire Goodman, Sally Kendall, Amanda Howe, Diana 
Munday, Stephen Peckham, Fiona Poland & Sophie Staniszewska. 
Initial box 
 
1. I have read and understand the information leaflet dated 2/8/11 (version 1)  
about the study.  I have had the opportunity to consider the information,  
ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to  
withdraw at any time without giving any reason. 
3. I understand that data collected during the study may be looked at by  
individuals from the research team, from regulatory authorities or from  
the NHS Trust, where it is relevant to my taking part in this research. 
 
4. I understand that the researchers are obliged to break confidentiality if they hear of 
malpractice or safeguarding issues 
5. I agree to take part in the above study. 
 
__________________ ____________ ___________________ 
Name of participant  Date   Signature 
 
__________________ ____________ ___________________ 
Name of researcher  Date   Signature 
When completed, 1 for participant, 1 for researcher. 
 
University of Hertfordshire 
College Lane, Hatfield 
Hertfordshire AL10 9AB 
 
Telephone 01707 284000 
Fax 01707 284115 
www.herts.ac.uk 
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Appendix 5 Dissemination events
Dissemination
The four events
Area Date Local partners
London 19 March 2014 London Diabetes Research Network PPI panel
North East 27 March 2014 Dendron, Voice North
South West 1 April 2014 Researchers at University of the West of England, CLAHRC South West Peninsula
East of England 28 April 2014 CLAHRC East of England, RDS
In total 221 people attended the events and the mixture was roughly twice as many researchers/health
professionals (n= 147) as PPI representatives (n= 74). The gender balance was roughly twice as many
females as males.
Number signing attendance sheet (attendance may have been slightly higher)
Area ‘Professionals’ Lay members Total
London 28 19 47
North East 20 24 44
South West 40 14 54
East of England 59 17 76
Total 147 74 221
Feedback from the small group work
There was a variety of feedback to the RAPPORT study findings from the small group work; training for
researchers came out as a clear top priority at the London event. There was a general feeling the NIHR
needs to ‘self-publicise’ and help the public understand what patient and public is and how to get
involved. The need to widen participation and representativeness of PPI representatives were repeated at
each event. The feedback from the four events is given below.
London dissemination event
Top priorities
Table 1: representativeness, population, age, gender.
Table 2: spread the news, catchy, government funding, positive outcomes, NIHR to advertise in the media.
Table 3: training, resources (caps on funding), providing feedback to participants, PPI involved throughout.
Table 4: NIHR training requirement for research (like GCP training), qualify, evaluating impacts of PPI, NIHR
to take a role in this.
Table 5: training for researchers.
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North East dissemination event
Top priorities
Table 1: publicity – widening participation, general public, NIHR.
Table 2: defining PPI – umbrella term, one definition, branches and categories, evaluation PPI, where is
the evidence?
Table 3: PPI co-ordinator – identified, ease/help research, ‘tick box’ exercise, a set point of contact.
Table 4: researcher training – PPI training – ALL. Not tokenistic, genuine, PPI before ethics.
Table 5: training – who needs it? Overall, capacity, more people, the right people, funding and time,
evaluation, impact, research base.
Table 6: ageing, extended to all research, contacts with existing groups, training for researchers.
Table 7: NIHR – what does it stand for? Need for clarity, how can people get involved?
Raising awareness, do general public know what PPI is? Does the public and research community know it
is more than just engagement?
South West dissemination event
Top priorities
Table 1: raising awareness of the general public, meaningful PPI, feedback (specific feedback at all stages
of research).
Table 2: engagement; NIHR role, ability of general public working in partnership whichever part of the
NIHR it is, throughout NIHR.
Table 3: amount of time. Training (joined up), clinicians, researchers, PPI in same room, same training.
Partnership working, skills for high-quality research, modular, different stages to dip in and out, accredited
training (university accredited).
Table 4: NIHR – funding issue, what is the quality of PPI in bids that get funded? Whether the research
gets funded or not. Culture change.
Table 5: do you want patients to be involved or evidence of better care and outcomes?
Table 6: joined-up thinking, ethics and NIHR. PPI should be traceable throughout. Do what you said you
would do in the protocol. Standalone report for PPI, lay summary/plain English.
Table 7: CLAHRCs – evidenced, make a difference, making PPI inescapable and making PPI part of medical
curriculum (student level).
Table 8: communicate – NIHR plain English, benefits of research to public, PPI Healthwatch, how fitted
together, how relevant.
Table 9: NIHR self-publicise, man on the street, more aware of what NIHR is doing and how they can
get involved.
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East of England dissemination event
Table 1: Top Priority: Ownership of PPI – it always happens under the radar and someone should take
ownership – should this be Healthwatch?
Finance – lead up to grants (no resources), visible hubs (e.g. PPI groups to spread message), pathways for
involvement and engagement.
Table 2: Top Priority: Making PPI standard across all research topic areas and healthcare areas –
standardisation but at a local level.
Health research authority needs to make IRAS form more robust to make CI think about PPI throughout
the research cycle.
Table 3: Top Priority: Educating researchers – researchers to listen to understand patient representatives –
get them young when at university – get them to understand PPI right from the start. For more established
researchers help them to understand barriers and enables of effective PPI.
Involving younger people more and understanding what incentivises young people.
Table 4: Top Priority: Overall marketing strategy needed, very difficult to get an understanding of who and
what are involved, normalising PPI.
Who is mentoring lay representatives etc. succession planning etc.
Make sure we get the views of younger people and the older person.
Campaigns like the Australian one for sun protection to increase research participation.
Employment status of people in PPI – and their performance management.
Table 5: Top Priority: Feedback to 1. lay representatives and 2. general public re: possibilities of PPI. Start at
school level and people must feel comfortable in challenging.
Involve lay people right from the beginning – need a balance of new and experienced lay people.
NIHR should have more of a monitoring role in PPI.
Publicity re: research at primary care level especially in GP surgeries.
Table 6: Education – start in schools e.g. health literacy and introduce partnership working.
Joint training, service users and researchers.
Training on innovative approaches for researchers.
Continue to build evidence base on PPI.
Co-ordination of different organisations involved in PPI, reduce confusion.
PPI has become an industry and is at risk of becoming introverted.
Increase diversity; Increase embedding of PPI.
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Table 7: Evaluation of impact (e.g. Til Wykes) and qualitative research approaches.
Cost-effectiveness – public investment so need to be at least cost neutral.
Don’t lose good practice through transition to new structures.
One-stop shop to hear of local innovations and get out nationally.
Raising awareness – can’t do anything if people aren’t aware.
Table 8: Involvement should be at different levels so public, carers, service users, etc. should be able to be
involved at what level they’re comfortable at.
Skill mix – new PPI reps and experienced PPI group meetings.
Grant allocation should be available and reflect the model of PPI; training for researchers.
Table 9: Top Priority: Annual audit (as per MRC [Medical Research Council]) of PPI, this will need costing.
Data analysis @ NIHR.
Strategic level – people having PPI activities audited and include lay representatives.
More realistic costings of PPI.
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Appendix 6 Amander’s Levels of Patient and
Public Involvement Significance (ALPS), reproduced
with permission [Amander Wellings, Norfolk and
Suffolk Patient and Public Involvement in Research
(PPIRes) panel, 2014, personal communication]













2. Please use the space below to reflect on any ‘mountain tools’ gained, for example new knowledge or
good practices you experienced at the Group meeting.
3. Please use the space below to reflect on any ‘avalanches’ or negative experiences you experienced at
the group meeting.
4. Are there any places during the expedition where you can now see that help from your fellow climbers
would have eased your ascent?
5. Please think of any’ base camps’ you could build, so as you need not start from the bottom each time
(use the answers from 2, 3 and 4 to help inform this).
Reproduced with kind permission from Amander Wellings, RAPPORT advisory group member.
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